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 Abstract 
Phospholipase C enzymes are important cell signalling enzymes that catalyse the 
cleavage of phosphatidylinositol 4,5-bisphophate PI(4,5)P2 into two biologically 
active second messenger molecules. These are the inositol 1,4,5-trisphosphate which 
initiates Ca
2+
 release from the endoplasmic reticulum and the diacylglycerol that 
activates protein kinase C. Although this basic function is shared between the 
different isoforms, the PLC family encompasses a diverse collection of proteins with 
various domain structures in addition to the PLC-specific domains. 
The neuron-specific “6th family” of these enzymes, PLCηs have most recently been 
identified with two members, PLCη1 and PLCη2. The aim of the thesis is to 
characterise the PLCη2 variant from several aspects. Firstly, it describes that PLCη2 
possesses a high sensitivity towards Ca
2+
. Secondly, it investigates how the Ca
2+
-
induced enzymatic activity of PLCη2 is controlled by its different domains. Also it 
provides evidence that the pleckstrin homology domain targets PLCη2 to membranes 
by recognising PI(3,4,5)P3. Moreover, the uniquely structured EF-hand is responsible 
for the Ca
2+
-sensitivity of the enzyme. Finally, it is demonstrated that the C2 domain 
is important for activity. 
The initial biochemical characterisation is followed by the description of a 
physiological role for PLCη2. It is shown using a neuroblast model that PLCη2 is 
crucial for neuronal differentiation and neurite growth. Further efforts were made to 
assess how PLCη2 is responsible for this effect. It was revealed that it might be 
involved in regulating intracellular Ca
2+
 dynamics, transcriptional activity and actin 
reorganisation in differentiating neurons.  
As the functions of PLCη2 are just beginning to come to light, more aspects for 
future research are also suggested in the thesis. Hopefully, this and the data presented 
within the thesis will stimulate even greater interest in this fascinating new field of 
research. 
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Chapter 1 focuses on two main topics that are essential to understand the results of 
Chapter 3 and 4 and their outcome. The first part of this Chapter provides an overall 
view of calcium signalling and how it is regulated by introducing the main groups of 
molecules that are involved in this process. The second part concentrates on the 
phospholipase C (PLC) family, an effector of the calcium signalling toolkit, and its 
newly identified member PLCη2. This latter enzyme is the subject of the analysis 
described within Chapters 3 and 4. 
1.1. General overview of calcium signalling  
1.1.1. The versatility of calcium signalling 
A central role for Ca
2+
 has been described in various cellular processes such as 
fertilisation, muscle contraction and neurotransmission (Miledi 1973; Steinhardt et 
al. 1977; Ringer 1882). The most intriguing aspect about Ca
2+ 
signalling is provided 
by its diversity. In principle, its action is simple: when a calcium signal is generated, 
the concentration of Ca
2+
 rises from 100 nM to 500-1000 nM in the cytosol (Berridge 
et al. 2000). The versatility of actions is likely to reside in the complex temporal and 
spatial nature of Ca
2+
 signalling (Thomas et al. 1996). Also, the wide range of 
effector molecules broadens the diversity of activated processes. 
A possible classification of the various Ca
2+
 signals was provided by Berridge and 
colleagues (Figure 1.1) (Berridge et al. 2000), who organised the existing terms and 
built a comprehensive system for this purpose. Ca
2+
 is derived from extra- or 
intracellular sources. The most characterised intracellular source of Ca
2+
, the 
endo/sarcoplasmic reticulum (ER/SR), generates Ca
2+
 signals mainly via ryanodine 
or inositol 1,4,5-trisphosphate receptors (RyRs or IP3Rs) (Imagawa et al. 1987; 
Miyawaki et al. 1990). These receptors are focused into clusters on the ER/SR 
membrane. When a stimulus is generated, it activates individual channels producing 
small discharges of Ca
2+
 termed as a `blips` (from IP3R) or `quarks` (from RyR). A 
stronger stimulus may activate a whole cluster of receptors that provides Ca
2+
 ’puffs’ 
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(from IP3R) or `sparks` (from RyRs). The resulting elevation in Ca
2+
 concentration is 
high, but transient and localised to a small cytoplasmic region. Transient Ca
2+
 spikes 
are able to evoke the opening of neighbouring receptor clusters. In some cases, this 
activation spreads in a saltatory manner triggering the generation of a Ca
2+
 wave 
throughout the cell. In cells which are connected by gap junctions assembled from 
connexins, the Ca
2+
 wave may be transmitted from cell to cell (Berridge et al. 2000).  
 
Figure 1.1: The mechanism of Ca
2+
 release from the ER/SR. A: The ER/SR 
membrane is enriched in IP3Rs and RyRs. B: Weak stimulation results in the opening 
of individual receptors. The generated Ca
2+
 signals are termed blips and quarks, 
respectively. C: Clusters of these receptors are activated by a stronger stimulus 
providing a larger Ca
2+
 release called ’puff’ (from IP3R) or `spark` (from RyRs). D: 
Ca
2+
 transients provided by a specific receptor cluster may activate neighbouring 
receptors that may result in a Ca
2+
 wave along the ER/SR membrane. E: Ca
2+
 signal 
may be transmitted to another cell via gap junctions. Figure was produced by the 
author of this thesis.  
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The existence of Ca
2+
 waves was first implicated in the process of muscle contraction 
and fertilisation (Fatt and Ginsborg 1958; Endo et al. 1970; Steinhardt et al. 1977; 
Gilkey et al. 1978; Kort et al. 1985). It was followed by the recognition that the local 
rises in Ca
2+
, also known as Ca
2+
 microdomains, possess similar importance in cell 
signalling (Rizzuto and Pozzan 2006). The transient surges in Ca
2+
 concentration are 
restricted to defined regions of the cell due to the limited range of diffusion of this 
ion within the cytosol directed by different Ca
2+
-binding mechanisms (Allbritton and 
Meyer 1993). 
1.1.2. Further regulation of intracellular calcium levels: ON and 
OFF reactions.   
A wide range of molecules participate in the regulation of Ca
2+
 signalling. These are 
collectively known as the Ca
2+
 signalling toolkit. The toolkit consists of receptors, 
transducers, ion pumps, ion exchangers, ion channels, Ca
2+
 buffers, Ca
2+
 sensors and 
Ca
2+
 sensitive enzymes (Berridge et al. 1998). Each cell type expresses a unique set 
of components from the Ca
2+ 
signalling toolkit to create Ca
2+
 signalling dynamics 
with different spatial and temporal properties.  
Ca
2+
 signals are generated from both external and internal sources of Ca
2+
 primarily 
by the activation of various ion channels, ion exchangers and ion pumps (Berridge et 
al. 2003; Bootman et al. 2001). These events, which increase cytoplasmic Ca
2+
 
levels, are the ON reactions. To maintain the ability of the ON reactions to evoke 
efficient rises in Ca
2+
, the OFF reactions restore the resting level of Ca
2+
 after each 
signal. This occurs by the transport of cytoplasmic Ca
2+
 into internal stores or to the 
extracellular space. At any time the level of cytosolic free Ca
2+
 depends on the 
balance between the ON and OFF reactions (Bootman et al. 2001; Berridge et al. 
2003). 
In the following sections, the molecular machinery directing the temporal and spatial 
distribution of Ca
2+
 will be introduced based on where they regulate Ca
2+
 transport in 
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the cell. According to this, Ca
2+
 inflow to the cell may arise from the extracellular 
space or from intracellular Ca
2+
 stores such as the ER/SR, mitochondria, golgi 
apparatus (GA), nuclear envelope or such unusual compartments as lysosomes or 
transmitter vesicles at the neuronal synapse (Verkhratsky and Petersen 1998; 
Mitchell et al. 2001; Churchill et al. 2002). The description of the molecular groups 
that direct the movement of Ca
2+ 
across membranes is given in the following section. 
 
1.1.3. Regulators of calcium
 
transport: pumps, exchangers and 
channels 
Molecular groups that regulate Ca
2+
 movements are explained based on G.R. 
Dubyak`s description (Dubyak 2004). Ca
2+
 transporters move ions against their 
electrochemical gradient and therefore they require external energy for the process. 
Traditionally, Ca
2+
 transporters are divided into two groups: Ca
2+
 pumps and Ca
2+
 
exchangers (Dubyak 2004; Gadsby 2004). Ion pumps selectively recognise ions 
which bind and initiate a conformational change in the transporter protein to permit 
the movement of the ion across the membrane. The typical energy source which 
utilises the transfer of the ion pumps is adenosine 5'-triphosphate (ATP). Ion 
exchangers use the energy of a passively flowing ion to transport another ion against 
its electrochemical gradient. Pumps and exchangers are usually responsible for 
maintaining the resting level of ions and to preserve the releasable Ca
2+
 pool within 
intracellular stores. 
Ion channels permit the movement of ions down their electrochemical gradient 
(passive flow) which allow a relatively low energetic interaction between the channel 
protein and the ion. Ca
2+
 channels structurally consist of a membrane-crossing pore 
and a highly regulated gate which only opens when it is activated. When a channel 
opens, the ion flow is much higher than in transporters, allowing the channel to 
generate a rapid intracellular response upon sensing the extracellular stimuli. These 
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stimuli may be receptor ligands (receptor-operated channels, ROCs), changes in 
membrane potential (voltage operated channels, VOCs), or second messengers 
(second messenger-operated channels, SMOCs) (Dubyak 2004; Gadsby 2004). 
1.1.4. Calcium signalling at the plasma membrane 
1.1.4.1. Basics of cell communication 
 
Figure 1.2: Chemical communication of cells. Molecules liberated from the cell 
surface or released from the inside of the cell by diffusion or secretion may act on 
different cells in the body. These messengers may enter the blood stream and reach a 
different organ than the original (endocrine) or they may diffuse in the tissue of 
origin and act on a neighbouring cell (paracrine). A cell may regulate its own activity 
by binding its previously released molecules (autocrine). Moreover, a specific type of 
chemical communication may occur between two cells when the ligand of a receptor 
is presented on the cell surface and its specific receptor appears on another cell, the 
transfer of information is linked to cell-to-cell interaction (juxtacrine). Figure was 
produced by the author of this thesis.  
Cell communication in an organism is crucial and is maintained in a highly regulated 
manner. Two cells may interact directly by transmitting an electrical current 
(electrical communication) or otherwise, messenger molecules may be secreted to 
reach their target cell by diffusion (chemical communication). The transfer of the 
chemical information is classified based on the distance that the messenger molecule 
is required to travel from the donor to the recipient cell. According to this, the 
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molecule may travel a long distance in the blood stream to act upon a different tissue 
(endocrine), it may target a neighbouring cell in the same tissue (paracrine), or may 
have a direct feedback on the donor cell (autocrine). A special form of 
communication occurs when the ligand of a receptor is membrane bound and the 
receptor on another cell is activated upon the direct contact of the donor cell 
(juxtacrine) (Berridge 2012b).  
1.1.4.2. Receptor-operated calcium channels (ROCCs) 
Chemical messengers bind to specific receptors, some of which bear ion-channel 
properties (ROCs) and gate calcium in response to ligand-binding. ROCs are present 
in the receptor groups cysteine-loop receptors (CLRs), glutamate receptors (GluRs) 
and the ATP-sensing P2X receptors (Berridge 2012c).  
From the members of CLRs only the nicotinic variant of acetylcholine receptors 
(nAChR) and the type 3 serotonin receptor (5-HT3) gate Ca
2+
. The nAChR is 
differentiated from its metabotropic variant in that the stimulation of the latter is 
linked to the generation of second messengers (Liu et al. 1996; Unwin 1993). 
Neuronal variants of nAchRs are found on pre-, post- and extrasynaptic membrane 
surfaces (cholinergic synapses) (Horch and Sargent 1995). Presynaptic Ca
2+
 
transients derived from nAchR activation are involved in the stimulation of 
transmitter release (Li et al. 1998) and their activation has been implicated in the 
physiology of learning (Matsuyama et al. 2000). Cholinergic projections are often 
mixed with non-cholinergic components which might be explained by the 
stimulatory effect of nAChR on the release of other transmitters (Rye et al. 1984). 
Apart from the brain, nAChR is dominant on neuromuscular junctions where it 
transmits the excitation of the nerve onto skeletal muscle cells (Tsuneki et al. 1997). 
As stated before, from all serotonin receptors, only the 5-HT3 is a ligand-gated Ca
2+
 
channel (Hargreaves et al. 1994). 5-HT3 directs neurotransmission in 
parasympathetic synapses of the gut and in the central nervous system in 
hippocampus, amygdala and hypothalamus (Akasu et al. 1987; Tecott et al. 1993). 
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Similarly to nAChR, serotoninergic stimulation of presynaptic Ca
2+
 release is 
implicated in the facilitation of neurotransmitter release (Turner et al. 2004). 
Glutamate is a frequently appearing neurotransmitter in the brain activating both 
ionotropic (ion-gating) and metabotropic (second messenger coupled) receptors. 
Ionotropic GluRs have been classified on the basis of their activation properties in 
response to different chemical compounds (Nakanishi 1992). N-methyl-D-aspartic 
acid (NMDA) stimulated receptors are highly permeable to Ca
2+ 
(Mayer and 
Westbrook 1987). Moreover, a subset of α-amino-3-hydroxyl-5-methyl-4-isoxazole-
propionate (AMPA)- and kainate-stimulated GluRs are also able to gate Ca
2+
 ions in 
addition to Na
+
 (Murphy and Miller 1989; Gilbertson et al. 1991). Cooperation 
between AMPA and NMDA receptors has also been demonstrated. It is initiated by 
the AMPA receptor which triggers the depolarisation of the membrane leading to the 
removal of a Mg
2+
 ion from the NMDA receptor which serves to block the Ca
2+
 flow 
in its unstimulated state (Rao and Finkbeiner 2007).  
The ionotropic P2X receptors are ATP-gated cation
 
channels widely distributed in 
the central and peripheral nervous system (Collo et al. 1996). They are thought to 
play a role in nociception, through sensing ATP leakage from damaged cells (North 
2004). In addition, P2X receptors have diverse functions in the developing and adult 
brain (Majumder et al. 2007). 
1.1.4.3. Voltage-operated calcium channels (VOCCs) 
Electrical communication of cells is directed by voltage-sensitive channels, some of 
which are Ca
2+
 channels. The classification of VOCCs is based on their structural 
and pharmacological properties, but also on their ability to induce different currents 
(Ertel et al. 2000; Catterall et al. 2005). Accordingly, 3 groups of VOCCs are 
distinguished: CaV1, CaV2 and CaV3. CaV1 channels are activated by a strong 
depolarisation evoking the prolonged opening of the channel. They are also called L-
type channels referring to their long lasting activation. Cav1.1/dihidropyridine 
receptor (DHP) has a critical role in skeletal muscle contraction. DHP interacts with 
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ryanodine receptors on the sarcoplasmic reticulum (SR), and the conformational 
change in the activated channel protein triggers Ca
2+
 release from the SR (Flucher et 
al. 1993). Additionally, the DHP induced Ca
2+
 influx also stimulates ryanodine 
receptors which are not DHP-coupled and together, these events are responsible for 
the Ca
2+
 rise that evokes the contraction of muscle fibers (Meissner and Lu 1995). 
Members of the CaV2 channel family (N-, P-,Q- and R-type VOCCs) also require 
strong depolarisation (Ertel et al. 2000). They are classified by selective toxin 
antagonists used to detect their specific contributions to neurotransmission (Wright 
and Angus 1996). Their main role is to direct excitation-coupled secretion at 
synapses (Scheuber et al. 2004; Kaja et al. 2007). The currents induced by T-type 
VOCCs (CaV3) are transient, and they possess a low threshold for activation (Perez-
Reyes et al. 1998). Their presence was demonstrated in a variety of cell types with 
different functions (Perez-Reyes 2003). 
1.1.4.4. Capacitive calcium
 
entry 
In addition to the mechanisms described above, Ca
2+
 may also enter to the cell when 
the intracellular stores are depleted and extracellular Ca
2+
 is required for the 
reconstitution of basal Ca
2+
 concentrations of cell compartments. A model for the so-
called capacitive Ca
2+
 entry was first proposed by Ginsborg et al., who suggested that 
the hyperpolarizing responses to dopamine in cockroach salivary gland cells depend 
on a calcium influx from the extracellular space which is filled into an intracellular 
store (Ginsborg et al. 1980). The first proteins which were implicated in directing the 
ER/SR depletion-dependent Ca
2+
 uptake were identified by a siRNA screen against 
2,304 proteins in HeLa cells. In this study, the stromal interaction protein 1 (STIM1) 
was identified to play an important role in maintaining Ca
2+
 stores as the 
downregulation of these proteins resulted in decreased Ca
2+ 
uptake after store 
depletion by thapsigargin or histamine (Liou et al. 2005). Later the following 
mechanism for capacitive Ca
2+ 
entry was proposed: the channel is formed by the 
interaction of STIM1 on the ER/SR and the ORAI1 pore forming protein on the 
plasma membrane (Prakriya et al. 2006). The luminal part of STIM1 contains a SAM 
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(sterile α motif) structure and an EF hand which undergoes dimerisation in the 
absence of Ca
2+
 initiating the opening of the channel (Stathopulos et al. 2006). 
Transient receptor potential channel (TRPC) family has been also implicated to 
interact with STIM1 and direct store operated Ca
2+
 uptake under certain conditions 
(Alicia et al. 2008).  
1.1.4.5. Second messenger-operated channels (SMOCs) 
Extracellular stimuli are able to induce Ca
2+
 uptake indirectly via the activation of 
receptors coupled to second messenger generation (metabotropic receptors). 
Although metabotropic receptors of the Ca
2+
-signalling toolkit will be mentioned 
later, this section describes Ca
2+
 channels which are sensitive to the molecules 
produced by these receptors. Ca
2+ 
channels in this group are collectively known as 
SMOCs. 
Cyclic nucleotide gated channels (CNGCs) are activated by cAMP (cyclic adenosine 
monophosphate) or cGMP (cyclic guanosine monophosphate) and are permeable not 
only to Ca
2+
 but also to Na
+
 and K
+
. CNGCs are well characterised in photoreceptors 
where cGMP as a second messenger was first established (Fesenko et al. 1985; 
Gerstner et al. 2000). CNGCs are active participants of phototransduction being 
permeable to cations in dark when the cGMP level is high and shutting the inward 
current when cGMP is hydrolysed in response to light (Koch et al. 2002). 
Arachidonic acid (AA) regulated Ca
2+
 channels (ARCs) are novel members of 
SMOCs (Mignen and Shuttleworth 2000). AA is generated by the Phospholipase A2 
enzyme in response to receptor stimulation (Murakami and Kudo 2002). ARCs are 
composed of ORAI1 (plasma membrane constituent of capacitive Ca
2+
 entry, section 
1.2.2.4.) and Orai3 subunits (Mignen et al. 2009). Unfortunately, little is known 
about their function. They have been found to trigger Ca
2+
 oscillations in pancreatic 
acinar cells in response to cholecystokinin (Mignen et al. 2005).  
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A subgroup of the diverse family of TRPCs is activated by the second messenger 
diacylglycerol (DAG) (Hofmann et al. 1999). Their contribution is required for the 
transduction of sensory signals such as nociception (Woo et al. 2008). The 
mechanism which provides the production of DAG will be discussed later.  
1.1.4.6. Calcium pumps and -exchangers of the plasma membrane 
As described earlier, transporters and pumps maintain the resting levels of Ca
2+ 
in the 
cytoplasm. The most critical partners in this process are the plasma membrane Ca
2+
-
ATPase (PMCA) and the Na
+
/Ca
2+
 exchangers (NCXs). PMCA senses the levels of 
the intracellular Ca
2
 by being stimulated directly by Ca
2+ 
or by the Ca
2+
-binding 
molecule calmodulin. It utilises the energy of ATP to move Ca
2+ 
across the 
membrane (Wetzker et al. 1987). By possessing high affinity to Ca
2+
 and a slow rate 
of Ca
2+
-transport it has been implicated in the fine tuning of intracellular Ca
2+
 levels 
(Brini and Carafoli 2011). In contrast, NCXs utilise the energy of the passively 
flowing Na
+
 to transfer 2 Ca
2+
 against its electrochemical gradient. NCX has a low 
affinity towards Ca
2+ 
whereas its transport rate is high indicating its role in rapid 
response to high Ca
2+
 levels. Consequently, PMCA and NCX possess a dynamic 
cooperation to extrude Ca
2+
 from the cells and restore basal levels (Juhaszova et al. 
2000). In addition, NCX is capable of switching into a reverse mode (transporting 
Ca
2+
 to the cytosol) during depolarisation or when the intracellular Ca
2+
 or Na
+
 
concentrations are low or high, respectively (Pieske et al. 2002; Weber et al. 2002). 
This further substantiates its role in restoring physiological basal Ca
2+
 levels.  
1.1.4.7. Second messenger-coupled receptors involved in Ca
2+
 
signalling 
G-protein-coupled receptors (GPCRs) constitute the largest protein family in the 
human body comprising more than 1,000 members (Nemoto et al. 2011). The 
common feature of GPCRs is the ability to activate heterotrimeric G proteins which 
is accompanied by the separation of the trimer into the second messengers Gα and the 
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Gβγ dimer. In the heterotrimeric form, Gα is bound to GDP which is released upon 
GPCR activation. The subsequent binding of GTP triggers the dissociation of the 
subunits, however the intrinsic GTPase activity of the Gα leads back to the formation 
of the receptor-heterotrimer complex (Morris and Malbon 1999). All GPCRs have 
seven transmembrane segments connected by extra- and intracellular loops (Unger et 
al. 1997). GPCRs are divided into 3 subfamilies (Gether 2000): the rhodopsin/β2 
adrenergic receptor like subfamily (classical structure, receptors for gonadotropins, 
neurotransmitter amines, oxytocin, vasopressin, melatonin and others), the 
glucagon/vasoactive intestinal polypeptide/calcitonin receptor like subfamily (long N 
terminus with disulfide bridges, receptors for growth hormone releasing hormone, 
glucagon, corticotropin-releasing factor, calcitonin, vasointestinal peptide and others) 
and the metabotropic neurotransmitter/calcium receptors (long N and C terminus, 
short third intracellular loop, receptors for metabotropic glutamate and GABA 
receptors, calcium receptors, pheromone and taste receptors and others). 
The diversity of GPCR functions resides in their specific coupling to one of the 
numerous G-proteins. Classification of G proteins is based on the Gα subunit. 
According to this, 4 subfamilies are distinguished: the Gs (Gs, Golf), the Gi/o (Gi, Gt, 
Go, Ggust and Gz) the Gq/11 (Gq, G11, G14, G15, G16) and the G12/13 families (G12, G13) 
(Hamm and Gilchrist 1996; Neves et al. 2002). In each subfamily, G-protein 
activation is coupled to the regulation of different effectors. Members of the Gq 
family are linked to PLC activation (Smrcka et al. 1991). PLCs cleave 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and generate the second 
messengers, inositol 1,4,5-triphosphate (I(1,4,5)P3) and diacylglycerol (DAG). 
I(1,4,5)P3 triggers Ca
2+
 release from I(1,4,5)P3 sensitive stores and DAG activates 
protein kinase C (PKC) (Wu et al. 1992a; Jhon et al. 1993). Activation of PLCs and 
the importance of their enzyme activity will be further discussed later in this Chapter. 
GαS triggers the activation of the adenlylate cyclase enzyme (AC) resulting in an 
elevation in cAMP concentration that consequently activates protein kinase A (PKA) 
(Alousi et al. 1991). This cascade continues with the stimulation of Ca
2+
 channels 
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such as L-type VOCs or dihydropyridine-sensitive channels by the activated PKA 
(Rotman et al. 1995; Kavalali et al. 1997; Basavappa et al. 1999). Conversely, Gi 
reduces intracellular cAMP level, by inhibiting the activity of AC (Taussig et al. 
1993). Transducin, a photoreceptor-specific Gi, directs the molecular process of 
photoreception by activating the cGMP phosphodiesterase to hydrolyse cGMP in 
response to light which leads to the closure of CNGCs (section 1.2.2.3) (Deterre et 
al. 1988). A unique type of Gi, gustducin, has also been found to participate in the 
signalling events of bitter taste sensation (Yan et al. 2001).  
The G12 and G13 proteins are recently discovered members and they have been shown 
to interact with a range of proteins including Rho guanine nucleotide exchange factor 
(RhoGEF), Ras GTPase activating protein, phospholipase D, and PLCε (Kurose 
2003).  
The Gβγ dimer that remains after the dissociation of Gα from the heterotrimer also 
exerts stimulatory activity on a range of proteins. For instance, it activates several 
PLC isoforms (Boyer et al. 1992; Park et al. 1993; Wu et al. 1993; Wang et al. 2000; 
Wing et al. 2001; Zhou et al. 2008), stimulates phosphoinositide 3-kinase (Zaballos 
et al. 2008) and induce the phosphorylation of the transcription factor STAT3 (Yuen 
et al. 2010).  
An additional receptor family whose activation is involved in the regulation of Ca
2+ 
dynamics are the receptor tyrosine kinases (RTKs). RTKs are predominantly 
monomers that undergo dimerisation upon ligand-induced stimulation which event 
triggers the autophosphorylation of the C-terminus facing the cytoplasm. In certain 
cases they may possess a tetrameric structure which was described for insulin 
receptors (Van Obberghen et al. 1985; Hubbard et al. 1998). The activated RTK 
recruits and phosphorylates SRC homology 2 (SH2) or phosphotyrosine-binding 
domain (PTB)-containing proteins such as PLCγ1, small G-proteins or the GTPase 
activating protein (Anderson et al. 1990; Hubbard et al. 1998).  
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1.1.5. Calcium stores and their molecular machinery 
1.1.5.1. What is the importance of accumulating calcium in the cell? 
Releasable intracellular Ca
2+ 
pools have a major role in regulating the physiological 
response to cellular processes. As described before, the resting intracellular Ca
2+
 
concentration is maintained at a low level (~10
-7 
M) by ion pumps and exchangers of 
extra- and intracellular membranes (Usachev et al. 1995; Bygrave and Benedetti 
1996). By the accumulation of Ca
2+
 into membrane enclosed structures nature has 
found an incredible way to broaden the versatility of Ca
2+
 dynamics in the cell. The 
most studied and perhaps most important Ca
2+
 store is the ER/SR. Although since its 
discovery many intracellular organelles have been shown to deposit and release Ca
2+ 
in response to stimuli (Fatt and Ginsborg 1958; Endo et al. 1970; Koch 1990; 
Verkhratsky and Petersen 1998; Calcraft et al. 2009;). These stores differ in the 
concentration of Ca
2+ 
they are capable of accumulating. The ER/SR is able to 
maintain a Ca
2+ 
concentration of
 
10
-3
 M at rest. In contrast, the mitochondrial basal 
Ca
2+ 
level is similar to that of the cytosol and its Ca
2+ 
uptake is associated with 
cytosolic Ca
2+ 
rises (Bygrave and Benedetti 1996; Moreau et al. 2006). In the 
following sections the molecular machinery that controls Ca
2+
 uptake and release in 
these stores is discussed.  
1.1.5.2. Calcium homeostasis of the ER/SR 
As mentioned above the ER/SR is a crucial Ca
2+
 store being able to maintain a large 
pool of Ca
2+
. Its Ca
2+ 
uptake mechanism is controlled by the sarco/endoplasmic 
reticulum ATPase (SERCA). SERCA is similar to the PMCA, however, it is capable 
of transporting two Ca
2+ 
ions from the energy generated by a single ATP molecule
 
whereas its plasma membrane equivalent only carries one Ca
2+
/ATP (Filomatori and 
Rega 2003). A large proportion of the accumulated Ca
2+
 is not free but rather bound 
by local Ca
2+ 
buffers such as calreticulin (luminal) and calnexin (integral to the 
membrane) (Tjoelker et al. 1994; Mery et al. 1996). This buffering capacity is crucial 
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for the ability of the ER/SR to store large amounts of Ca
2+ 
(Mery et al. 1996). 
Additionally, Ca
2+ 
buffers of the ER/SR serve as chaperones and Ca
2+ 
regulates the 
folding of newly synthesised proteins (Lodish et al. 1992; Saito et al. 1999). 
The release of the ER/SR-based Ca
2+
 pool is dictated by two main receptor groups 
RyRs and IP3Rs. RyRs have been identified in the SR of skeletal muscle cells where 
they are physically coupled to DHP receptors and are stimulated by depolarisation 
(Lai et al. 1988; Marty et al. 1994). However, extracellular Ca
2+
 inflow is able to 
induce Ca
2+ 
release from the SR generating calcium-induced calcium release (CICR) 
from the uncoupled RYRs and this mechanism of activation is crucial in non-muscle 
cells where DHP is absent (Kim et al. 1983; McPherson et al. 1991). Recent evidence 
also suggests that intraluminal Ca
2+
 modulates the open probability of RyR (Gyorke 
and Gyorke 1998). Additionally, RyRs are activated by other factors or second 
messengers such as ATP, Mg
2+
 or cyclic adenosine diphosphate ribose (cADPR) 
(Meissner et al. 1986; Ogunbayo et al. 2011)  
Ca
2+ 
release by IP3Rs is stimulated by the PLC enzymatic product, I(1,4,5)P3. IP3Rs 
are also stimulated by intracellular Ca
2+
, although if the cytosolic [Ca
2+
] reaches
 
300 
nM it becomes inhibitory on IP3R activity (Iino 1990). Ca
2+
 release by IP3R 
activation or by other sources is able to stimulate the activity of Ca
2+
-sensitive PLCs 
(PLCδ, PLCζ and PLC η) and this pathway has been proposed as a unique PLC-
dependent CICR mechanism (Popovics and Stewart 2012b; Yamamoto et al. 2000). 
IP3Rs and RyRs coexist in a variety of cells and crosstalk between the two has been 
described (Boittin et al. 1999; Haak et al. 2001; Gordienko and Bolton 2002).  
1.1.5.3. Mitochondrial Ca
2+
 transporters 
It has been long known that mitochondrial Ca
2+
 sensitive enzymes are finely tuned 
by small changes in matrix Ca
2+
 levels (Denton and McCormack 1980; Jouaville et 
al. 1999). Subsequently, it was revealed that mitochondria are capable of 
sequestering Ca
2+ 
in a rapid manner (Rizzuto et al. 1992) which may lead to the 
matrix Ca
2+
 concentration reaching millimolar levels in certain cases (Montero et al. 
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2000). In contrast to the ER/SR, the mitochondrial Ca
2+ 
uptake is activated only 
when the cytosolic Ca
2+
 concentration rises above 300 nM (Colegrove et al. 2000). In 
addition, the matrix Ca
2+ 
concentration precisely follows cytosolic Ca
2+
 oscillations 
and therefore a role for mitochondria in buffering intracellular Ca
2+ 
signals has been 
widely suggested by numerous groups (Werth and Thayer 1994; Robb-Gaspers et al. 
1998).  
The inner and outer mitochondrial membranes (OMM and IMM) largely differ in 
Ca
2+ 
permeability. Transport across the OMM is regulated by the voltage dependent 
anion channel (VDAC) which lets small molecules including Ca
2+
 pass non-
selectively (Hodge and Colombini 1997; Gincel et al. 2001). However, the 
depolarisation-induced closure of VDAC blocks the transport of small metabolites 
and facilitates the transport of Ca
2+
 to mitochondria (Tan and Colombini 2007). 
Although, a variety of mechanisms have been proposed to direct the transfer of Ca
2+
 
through the IMM, only the role of the Ca
2+
 uniporter (MCU) has been verified (Jean-
Quartier et al. 2012). MCU, contrary to its name, acts more like a channel as it does 
not require energy for the transport. Moreover, it is activated by Ca
2+
 itself and 
therefore directs Ca
2+
-induced Ca
2+
 uptake to the mitochondria (Moreau et al. 2006). 
Recent findings suggest that MCU is a multiprotein complex but only two of its 
components have been identified to date (Perocchi et al. 2010; Baughman et al. 
2011).  
Mitochondrial Ca
2+
 efflux is provided by the mitochondrial Na
+
/Ca
2+
 exchanger 
(NCXmito) and the H
+
/Ca
2+
 antiporter. Although their existence and mechanism have 
been known for some time, candidates for the genes encoding NCXmito and H
+
/Ca
2+
 
antiporter (HCA) have only recently been suggested (Jiang et al. 2009; Palty et al. 
2010). NCXmito operates similarly to its plasma membrane relative, however its main 
role is the opposite: it extrudes Ca
2+
 from the mitochondria to the cytosol (Palty et al. 
2010). HCA is able to change the direction of Ca
2+
 transport depending on the extra- 
and intramitochondrial Ca
2+
 levels and pH suggesting a possible interplay with the 
Ca
2+
 uniporter in Ca
2+ 
uptake (Jiang et al. 2009).  
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The mitochondrial permeability transition pore (mPTP) is a molecular complex that 
forms across the IMM and OMM when mitochondria are overloaded with Ca
2+ 
at 
micromolar cytosolic [Ca
2+
] (Crompton 1999). It is composed of at least three 
proteins: the previously mentioned VDAC in the outer membrane, the adenine 
nucleotide translocase (ANT) in the inner membrane and the cytosolic protein, 
cyclophilin D (CypD) (Crompton 1999). The channel complex is suggested to 
exhibit two phases of activation. In its low conductance state, mPTP opens in a pH 
dependent manner and only extrudes small ions such as Ca
2+
 out of the mitochondria. 
The pore is switched to a high conductance state depending on the matrix Ca
2+
 
concentration and leads to a nonspecific release of both metabolites and ions. The 
opening of the second type of mPTP is usually paired with apoptotic cell death (Ichas 
and Mazat 1998; He and Lemasters 2002). In conclusion, the mitochondrial Ca
2+
 
transporting system has an important role in modifying cytoplasmic Ca
2+
 signals and 
regulating apoptosis.  
A newly evolving field in the research of Ca
2+
 store dynamics is the investigation of 
the cross-talk between ER/SR and mitochondrial membranes. Ca
2+
 released by IP3Rs 
is immediately taken up by the mitochondria. This mechanism is most pronounced at 
the mitochondria-associated ER-membranes where a direct contact of the two 
organelles has been shown (Rizzuto et al. 1998). Interestingly, IP3R and VDAC is 
physically coupled through GRP75/mortalin which further indicates the existence of 
a direct Ca
2+
 flow from the ER to the mitochondria (Szabadkai et al. 2006). In 
addition, ER/SR-depletion-controlled store-operated Ca
2+ 
entry is inhibited by 
mitochondrial depolarisation (Glitsch et al. 2002). Mitochondrial Ca
2+
 uptake also 
inhibits the positive feedback of Ca
2+
 on IP3Rs substantiating the existence of a 
strong interplay between these 2 organelles (Hajnoczky et al. 1999).  
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1.1.5.4. Endosomes, lysosomes and secretory vesicles as calcium 
stores 
Secretory vesicles are also capable of behaving as releasable Ca
2+
 stores. 
Interestingly, secretory vesicle membranes contain RyRs rather than IP3Rs (Mitchell 
et al. 2001). The Ca
2+
-induced Ca
2+
 release from this store has been proposed to 
modulate the exocytosis of already primed vesicles (Mitchell et al. 2001). 
Lysosomes, endosomes and secretory vesicles are functionally related in responding 
to nicotinic acid adenine dinucleotide phosphate (NAADP) by releasing Ca
2+
 
(Churchill et al. 2002; Mitchell et al. 2003). NAADP is converted from nicotinamide 
adenine dinucleotide phosphate (NADP) by ADP ribosyl cyclase, however little is 
known as to how its enzyme activity is regulated by extra- or intracellular stimuli 
(Rutter 2003). The receptors for NAADP have recently been identified as  the two-
pore channels (TPCs) (Calcraft et al. 2009; Ruas et al. 2010), however, subsequent 
studies revealed that a linker protein is required for the NAADP-dependent activation 
of TPCs (Walseth et al. 2011). Patch-clamp studies reported that the TPC channels 
on their own are Na
+
-selective and are unresponsive to NAADP - hence the scientific 
attention shifted towards the identification of the proposed linker protein (Wang et al. 
2012).  
1.1.5.5. Nuclear calcium signalling 
Local elevations of Ca
2+
 in the nucleus are crucial for the regulation of nuclear 
processes (Dolmetsch et al. 1998). The involvement of nuclear Ca
2+
 signals in cell 
proliferation was shown by the utilisation of a Ca
2+
 buffer that was artificially linked 
to a nuclear localisation signal (NLS) and upon its transfection to the cell it 
specifically reduced nuclear Ca
2+
 levels (Rodrigues et al. 2007). Although Ca
2+
 
signals are registered throughout the nucleus, Ca
2+
 is likely to be stored within the 
nuclear envelope (NE), as it is able to freely diffuse through the nuclear pore 
complex (Eder and Bading 2007). The NE is continuous with the ER/SR which 
suggests a high similarity between their molecular strategies to handle Ca
2+
. Thus it 
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is not surprising, that Ca
2+
 release from the NE is directed by RyRs and IP3Rs 
(Humbert et al. 1996; Erickson et al. 2004). In addition, NE Ca
2+
 stores are also 
sensitive to NAADP and cADPR (Gerasimenko et al. 1995; Adebanjo et al. 2000). 
Moreover, the nuclear envelope is able to enter the nucleoplasm and form a reticular 
network which extends the surface of the NE and may allow the generation of local 
Ca
2+
 transients inside the nucleus (Wu and Bers 2006). There is still a lot to learn 
about nuclear Ca
2+
 signalling and hopefully more details will come to light in the 
near future. 
1.1.5.6. Is the Golgi apparatus a calcium store? 
Recently, the Golgi apparatus (GA) as a potential Ca
2+
 store has also been suggested. 
This idea is clearly supported by the presence of SERCA, IP3R and a unique Ca
2+
 
ATPase (secretory pathway Ca
2+
 ATPase, SPCA) on GA-related membranes 
(Gunteski-Hamblin et al. 1992; Taylor et al. 1997; Pinton et al. 1998). SPCA differs 
from other similar pumps in that it transports Mn
2+
 in addition to Ca
2+ 
(Dode et al. 
2005). It has been shown to be crucial for the maintenance of GA-Ca
2+
 homeostasis 
required for neuronal differentiation (Sepulveda et al. 2009). In addition, it has 
recently been revealed that transport of the Ca
2+ 
via the SPCA is the main process to 
restore basal Ca
2+
 level between transients in human spermatozoa (Harper et al. 
2005). 
Interestingly, the free Ca
2+
 concentration gradually decreases with the distance of 
GA compartments from the ER (cis-, medial- and trans-compartments), but this 
effect seems to be due to the increasing buffering capacity down the secretory 
pathway (Pizzo et al. 2010). Nevertheless, the hypothesised differences suggest that 
the molecular composition of the Ca
2+
 signalling toolkit throughout the GA is not 
uniform.  
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1.1.5 Calcium dynamics of the cytosol 
1.1.5.1. Cytosolic calcium
 
buffers 
Ca
2+
 buffers serve to modulate the temporal and spatial aspects of calcium signals by 
decreasing the amount of available free Ca
2+
. Buffering capacity of the cytosol is 
essential for the maintenance of normal cell homeostasis, especially in neurons 
(Baimbridge et al. 1992). Abnormal expression of Ca
2+ 
buffers leads to disturbances 
in the Ca
2+
-handling of the cell. Decreased levels of the cytosolic buffer, calbindin 
D-28 were found in aging neurons and in Alzheimer`s disease, which may contribute 
to the elevated Ca
2+
 levels registered in these conditions (Kirischuk et al. 1992; 
Sutherland et al. 1993; Lally et al. 1997). Calretinin is involved in the modulation of 
neuronal excitability and long-term potentiation (LTP) (Schurmans et al. 1997) and 
parvalbumin contributes to the fine tuning of skeletal muscle cell Ca
2+
 levels 
(Muntener et al. 1995). These examples indicate the crucial role of the buffering 
capacity of the cytosol for the maintenance of cell physiology.  
1.1.5.1. Calcium sensors of the cytosol 
The diverse group of Ca
2+
 sensors convert changes in intracellular Ca
2+
 levels to the 
activation of their target proteins. This is usually directed by a conformational 
change in their protein structure upon Ca
2+
-binding. Calmodulin participates in the 
activation of a number of different proteins as a Ca
2+
 sensor. It stimulates 
downstream signalling elements, such as Ca
2+
/calmodulin-dependent protein kinases 
(CaMKs), adenylate cyclase, cyclic nucleotide phosphodiesterase and PLCβ enzymes 
(Huang et al. 1981; Eliot et al. 1989; McCullar et al. 2003). Stimulation of the 
myosin light chain kinase by calmodulin, is an essential step for actin-myosin 
interaction in skeletal muscle cells (Hathaway and Adelstein 1979). Interestingly, the 
activated calmodulin exerts a feedback effect to decrease the intracellular Ca
2+
 level 
by stimulating PMCAs, which extrude Ca
2+
 to the extracellular space (James et al. 
1988). Another Ca
2+ 
sensor, troponin C, is essential for skeletal muscle contraction. 
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When troponin C is activated by Ca
2+
, binding sites on myosin become accessible to 
the actin filament (Ogawa 1985). In the above mentioned molecules, Ca
2+
 triggers a 
conformational change upon binding, however, other sensors may undergo 
dimerisation. This mechanism regulates the function of synaptotagmin which is a 
molecule essential for vesicle exocytosis (Chapman et al. 1996). These molecules are 
just a subset of the many sensors identified to date. For instance, the neuronal 
calcium sensor family is comprised of 14 members possessing crucial roles in 
neuronal Ca
2+ 
signalling, such as regulating neurotransmission, synaptic plasticity, 
receptor trafficking, neuronal growth and survival (Burgoyne 2007).  
1.1.5.1. Calcium sensitive enzymes and processes - the effectors 
Effectors of the Ca
2+
 signalling toolkit comprise Ca
2+
 sensitive enzymes, 
transcription factors and ion channels. Ca
2+
 sensitive enzymes are mostly kinases 
such as CaMKs which are activated by both calmodulin and Ca
2+
. Apart from many 
other of their targets, they phosphorylate CREB (cAMP responsive element binding 
protein) transcription factor to regulate the expression of genes containing CREB 
responsive elements in their promoters (Montminy and Bilezikjian 1987; Matthews 
et al. 1994). The protein kinase C family also contains Ca
2+
 sensors, although they 
are not directly stimulated by Ca
2+
. The effect of Ca
2+
 is translated by PLCs by 
generating the second messenger DAG which stimulates certain PKC isoforms 
(Shinomura et al. 1991). Nitric oxide synthase (NOS) produces the small diffusible 
hormone/transmitter, nitric oxide. It was shown that the various NOS subtypes are 
activated by Ca
2+ 
directly or
 
indirectly via calmodulin (Forstermann et al. 1991). 
As mentioned, ion-channels are also effectors of the Ca
2+
 pathway. Ca
2+
-activated 
potassium channels which are regulated by calmodulin modulate neuronal 
excitability (Faber and Sah 2003; Schumacher et al. 2001). Moreover, calcium 
activated chloride channels play important roles in sensory transduction, neuronal 
depolarisation and muscle contraction (Hartzell et al. 2005). 
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PLCs are also effectors of the Ca
2+
-signalling toolkit. Whilst the purpose of the thesis 
is to characterise a PLC subtype, PLCη2, the following part of this Chapter describes 
the PLC family and introduces the unique features of PLCη2 that encouraged the 
scientific work on this topic. 
1.2. The classification and comparative description of Phospholipase 
C enzymes 
1.2.1. Phospholipids: their regulation and their importance in 
cellular signalling 
Phospholipid metabolism is a highly organised process and involves the participation 
of multiple intermediary molecules, many of them possessing biological activity as 
second messengers. As the basic element, phosphatidate (or otherwise known from 
its acidic form, phosphatidic acid (PA)) serves as the substrate for reaction cascades 
resulting in the production of phosphatidylcholine (PC), phosphatidylethanolamine 
(PE), phosphatidylserine (PS), phosphatidylglycerol (PG) and most importantly 
phosphatidylinositol (PI) (Kent 1995). The latter is produced by the PI-synthase from 
the PA derivative, cytidine diphosphate- (CDP-) diacylglycerol and myo-inositol 
(Figure 1.3) (Paulus and Kennedy 1960).  
Enzymatic phosphorylation of PI provides the basis for the production of numerous 
phosphatidylinositol- (Figure 1.4.) and inositol phosphates (Figure 1.5.). Specific 
kinases join a phosphate group to the 3, 4 or 5 positions of the inositol ring to create 
PI-monophosphates, -bisphosphates or trisphosphate with different biological 
activities. Phosphatidylinositol 4-phosphate (PI(4)P) is enriched in trans-Golgi-
membranes and regulates trafficking of membranes to cell surface by recruiting 
transport proteins (Godi et al. 2004). Some kinases exhibit important signalling 
functions by being activated in response to extracellular stimuli and producing PI-
phosphates with important second messenger functions. For instance, PI 3-kinases 
(PI3K) are stimulated by insulin or GPCRs and the generated PI(3,4,5)P3 serves as a 
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docking site for proteins (Whitman et al. 1988; Murga et al. 1998; Brown et al. 
1999). One example is the recruitment of AKT to the plasma membrane that allows 
its phosphorylation and consequently its activation by PDK1 (3-phosphoinositide 
dependent protein kinase-1) (Meier and Hemmings 1999). 
 
Figure 1.3.: Biosynthesis of phosphatidylinositol. PI-synthase catalyses the 
production of PI from cytidine diphosphate diacylglycerol and myo-inositol. The 
figure does not demonstrate the subsequent exiting of citidine monophosphate 
(CMP) from the reaction. Figure is downloaded from: 
http://lipidlibrary.aocs.org/lipids/pi/index.htm.  
The link between PI-phosphate and inositol phosphate metabolism is provided by the 
hydrolysing activity of phospholipase c enzymes (detailed in the next section). 
Several molecule arise from I(1,4,5)P3 which are generated by the actions of 
numerous kinases and phosphatases (Figure 1.5.). A subset of these soluble inositol 
phosphates possesses regulatory roles on signalling molecules. For example, the 
inositol 3,4,5,6-tetrakisphosphate (I(3,4,5,6)P4) regulates plasma membrane chloride 
channels (Xie et al. 1996). Inositol-monophosphatases recycle the inositol-ring for 
phospholipid biosynthesis. Interestingly, their activity is inhibited by LiCl, a 
chemical traditionally given to treat manic depression, which effect is thought to be 
based on the preservation of the inositol phosphate-pool (Belmaker et al. 1996). 
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Although this is not the only effect of Lithium treatment as for example it 
downregulates Glycogen synthase kinase 3 β affecting gene expression levels (Yin et 
al. 2006). 
As a whole, phospholipid metabolism plays a central role in cellular signalling by 
possessing multiple steps, some of which are regulated by unique external stimuli. 
Their cleavage by phospholipases introduces an additional level for the generation of 
lipid second messengers. The next section aims to describe these enzymes.  
 
Figure 1.4.: Phosphatidylinositol metabolism. Phosphatidylinositol and its mono-, 
bis-, and trisphosphate forms are converted into each other by multiple phosphatases 
and kinases (indicated by numbers). Phospholipase C enzymes catalyse the cleavage 
of phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol 1,4,5-
trisphosphate which latter serves as the basis of the inositol phosphate metabolism. 
The inositol ring is recycled for the synthesis of phosphatidyl-inositol. Note that 
abbreviation scheme of phospholipids is altered in the text. Figure is taken with 
permission from Portland Press Ltd, (Berridge 2012a). 
CHAPTER 1. INTRODUCTION  
26 
 
 
Figure 1.5.: Inositol-phosphate metabolism. Inositol 1,4,5-trisphophate serves as the 
source of the various inositol phosphates that may carry a phosphate group on any of 
the 6 position of the inositol ring. According to this, a range of inositol phosphates 
from the monophosphates to the one hexaphosphate are known to exist. Moreover, 
formation of diphosphate groups are also possible (PPInsP4, PPInsP5 and [PP]2InsP4). 
Dephosphorylation of inositol-monophosphates produce an inositol ring which is 
recycled to phosphoinositol synthesis. Note that abbreviation scheme of 
phospholipids is altered in the text. Figure is taken with permission from Portland 
Press Ltd. (Berridge 2012a) 
1.2.2. Phospholipase enzyme superfamily  
The classification of phospholipases is based on their ability to hydrolyse 
phospholipids at different chemical bonds resulting in the generation of various 
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products/second messengers (Figure 1.6). Accordingly, phospholipases have been 
divided into 5 groups: phospholipase A1, A2, B, C and D (PLA1, PLA2, PLB, PLC 
and PLD). 
 
Figure 1.6.: The site of hydrolysis catalysed by different phospholipases. 
Description is found in the text. Figure is taken with permission from Wiley-VCH 
Verlag GmbH & Co (Wilton 2005). 
PLA1 cleaves in the sn-1 position whereas PLA2 attacks the sn-2 bond to produce 
acyl-lysophospholipids and fatty acids (Aoki et al. 2007; Burke and Dennis 2009). 
Diversity also occurs within the PLA1 family; depending on the substrate specificity 
of PLA1 the 2 main products are lysophosphatidic acid or lysophosphatidylserine 
cleaved from phosphatidic acid or phosphatidylserine, respectively (Aoki et al. 
2007). AA is often sequestered at the sn-2 bond of phospholipids and therefore 
released to the cytosol upon stimulation of PLA2 (Perez-Chacon et al. 2009).  
PLB enzymes possess the enzymatic activity of both PLA1 and PLA2 (Gassama-
Diagne et al. 1992). In mammals, PLBs have important roles in the digestion of 
dietary lipids and participate in the molecular machinery of neutrophil immune 
response (Xu et al. 2009). PLDs hydrolyse the distal phosphodiester bond to produce 
phosphatidic acid and lipid headgroups such as choline (Liscovitch et al. 2000). PA 
is important regulator of cellular processes such as exocytosis/membrane trafficking 
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(Jones et al. 1999). With the generation of PA, PLDs also stimulate the membrane-
associated PA-selective PLA1 enzyme group (Aoki et al. 2007). 
PLCs catalyse the cleavage of the proximal phosphodiester bond to produce inositol-
1,4,5-trisphosphate (I(1,4,5)P3) and diacylglycerol (DAG) from phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2, Figure 1.7..) (Fukami 2002). PLC mediated pathways 
are crucial for receptor mediated responses in a variety cell types throughout the life 
from the oocyte and to ageing neurons. The following sections will discuss their 
discovery, classification, domain structure, regulation and physiological role. 
 
Figure 1.7.:  Generation of second messengers by PLCs. PLC catalyzes the cleavage 
of PI(4,5)P2 at the proximal phosphodiester bond to generate the accumulation of 
DAG at the membrane and to release the diffusible I(1,4,5)P3 to the cytosol. Figure is 
taken with permission from Biochemistry and Molecular Biology (Suh et al. 2008). 
1.2.3. Phospholipase C enzymes  
1.2.3.1. A short history of the discovery of PLCs 
The road towards the discovery and characterisation of PLCs began with the 
discovery by Hokin & Hokin in 1953. They measured increased P
32
 incorporation 
into phospholipids in pancreatic tissue slices in response to cholinergic drugs which 
was followed by increased amylase secretion (Hokin and Hokin 1953). At this time 
neither the transducing mechanism nor the identity of the lipid was known. After a 
long break, Abdel-Latif et al. and Allan and Michell reached the next breakthrough 
in 1978. They reported the breakdown of P
32
 labelled PI(4,5)P2 in response to 
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norephinephrin in rabbit iris muscle cells  and determined the Ca
2+
-dependence of 
the phosphodiesterase activity (Abdel-Latif et al. 1978; Allan and Michelle 1978). 
This study also identified I(1,4,5)P3 as the possible derivative of PI(4,5)P2. Following 
these findings a number of articles appeared reporting rapid breakdown of PI(4,5)P2 
and elevation in I(1,4,5)P3 levels following treatments by various receptor agonists 
(Putney 1982; Weiss et al. 1982; Agranoff et al. 1983; Berridge et al. 1983). Berridge 
et al. combined the anion exchange and ionophoresis techniques to identify and 
measure inositol metabolites in the water soluble fraction of tissues with different 
origins. It was found that the primary product of activated cells is the I(1,4,5)P3 and 
other metabolites such as inositol 1-phosphate or inositol 1,4-bisphosphate are 
produced subsequently by phophatases (Berridge et al. 1983). I(1,4,5)P3 was then 
found to initiate Ca
2+ 
release from the ER in permeabilised pancreatic cells (Streb et 
al. 1983) but the exact mechanism was still a debate. Soon after, a number of 
publications revealed the presence of [
32
P]I(1,4,5)P3 in the microsomal cell fraction 
indicating the existence of specific I(1,4,5)P3 receptors (Baukal et al. 1985; Spat et 
al. 1986a; Spat et al. 1986b; Guillemette et al. 1987). In the following 2 years the 
receptor was purified from rat cerebellum (Supattapone et al. 1988) and the cDNA of 
the first variant was cloned (Furuichi et al. 1989a; Furuichi et al. 1989b).  
In parallel, other studies focused on the membrane bound derivative of PI(4,5)P2, 
DAG, which also rapidly increases following external stimuli (Kennerly et al. 1979; 
Takai et al. 1979). DAG participates in the activation of several PKC isoforms (Takai 
et al. 1979). Interestingly, the initial PLC stimulated rapid accumulation of DAG is 
followed by a short decline and a delayed increase which is not derived from PLC 
activity directly (Nishizuka 1995). 
Subsequently, proteins possessing the proposed phospholipase activity were also 
identified. The first successful purification of a PLC was in 1981 by Takenawa et al. 
from rat liver by using multiple chromatography steps (Takenawa and Nagai 1981). 
In addition, several biochemical properties, such as Ca
2+
 sensitivity, pH optimum and 
lipid preference were assessed. This study was followed by the identification of other 
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isozymes in sheep seminal vesicular gland (Hofmann and Majerus 1982), bovine 
brain (Ryu et al. 1986; Katan and Parker 1987; Rebecchi and Rosen 1987; Ryu et al. 
1987), guinea pig uterus (Bennett and Crooke 1987), rat brain and liver (Fukui et al. 
1988; Homma et al. 1988) and human platelets (Banno et al. 1988). The accelerated 
occurrence of new isoforms made it necessary to establish a system for their 
classification PLCs. Rhee et al. was the first to standardise the nomenclature of PLCs 
and to group them into α, β, γ, δ and ε classes sorted by immunoblotting comparisons 
with the existing antibodies (Rhee et al. 1989). The order of the groups was 
consistent with the chronology of their purification date. Subsequently, the DNA 
sequence of various PLC isoform was published (Bennett et al. 1988; Katan et al. 
1988; Suh et al. 1988). After cloning and expression in mouse fibroblast cells, PLCα 
did not exhibit phospholipase activity and its transfer into Trp-Cys-Gly-His-Cys-Lys 
motif containing proteins was required (Hirano et al. 1994). Currently six distinct 
classes of PLCs are known to exist in mammals; PLC-β, -γ, -δ, -ε, -ζ and –η (Table 
1.1.). They have been classified on the basis of amino acid sequence, domain 
structure, and by the mechanism through which they are recruited in response to 
activated receptors (Suh et al. 2008). 
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1.2.3.2. Domain structure of PLCs  
1.2.3.2.1. General overview 
Five conserved domains are found in almost all PLC isozymes; the pleckstrin 
homology domain (PH domain), the EF-hand like domain, X and Y catalytic 
domains and the C2 domain (Figure 1.8). Apart from these, other PLC subtype 
specific domains also exist such as SRC homology domains in PLCγ or Ras 
activation related domains in PLCε (Suh et al. 2008). 
 
Figure 1.8.: Domain structure of PLCs. Abbreviations: PH: Pleckstrin homology 
domain, EF: EF-hand domain, EFL: EF hand-like domain, X: Catalytic X domain, Y: 
Catalytic Y domain, C2: C2 domain, SH2,SH3: SRC homology domains, RasGEF: 
guanine nucleotide exchange factor domain for Ras-like small GTPases, RA: Ras 
association domain, variable C-term: variable C-terminal domain. Figure was 
produced by Dr. Alan Stewart. 
1.2.3.2.2. Pleckstrin homology domain 
The approximately 100-120 amino acid long PH domain appears in a range of 
proteins that possess roles in cell signalling and cytoskeletal function (Haslam et al. 
1993). The domain was named after its first identification as an internal repeat in 
pleckstrin (Tyers et al. 1989). The domain is formed by a 7 stranded β-sandwich and 
a C-terminal amphipathic α-helix (Yoon et al. 1994). This structure enables the PH 
domain-containing proteins to bind phospholipids and the small variations between 
PH EFL X Y C2PLCβ
PH EF X Y C2EFLPLCδ
EFLPHRasGEF X Y C2 RA1 RA2PLCε
PH X Y C2SH2SH2 SH3P HPLCγ EFEFL
EF X Y C2PLCζ EFL
EF X Y C2PLCη PH EFEFL variable C-term
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the domains allow the development of selectivity towards a specific phospholipid in 
certain proteins (Wang and Shaw 1995). 
Apart from PLCζ, all PLC isozymes possess at least one PH domain on the N-
terminus. In PLCγ, an additional PH domain occurs between the X and Y catalytic 
domains (Burgess et al. 1990; Haslam et al. 1993). This PH domain is split by SH2 
and SH3 domains but the insertion does not prevent the formation of the canonical 
PH domain structure (Wen et al. 2006). Although the phospholipid binding is lost by 
this domain, it was identified as an interaction site for the regulatory protein, Rac2 
(Walliser et al. 2008).  
The N-terminal PH domains of the different PLC isozymes often have a preference 
towards different phospholipids which is directed by 3 positively charged regions of 
the domain (Singh and Murray 2003). PH domains of PLCβs seem to bind 
phospholipids non-specifically (McCullar et al. 2007). The membrane binding 
dynamics and the subcellular localisation of PLCβs might be also regulated by the C-
terminal extension which also possesses a nuclear localisation signal (Kim et al. 
1996). In contrast, the N-terminal PH domains of PLCγs specifically target 
phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3, Falasca et al. 1998) whereas 
for PLCδ1 PI(4,5)P2 is the preferred phospholipid (Lomasney et al. 1996). This latter 
interaction is so specific and strong that the construct consisting of the PH domain of 
PLCδ1 fused to green fluorescent protein (GFP) became a general tool to specifically 
visualise PI(4,5)P2 in cells (Varnai and Balla 2008). Little is known about the lipid 
binding properties of the PLCε PH domain. Computerised modelling predicted that 
this PH domain mainly tethers non-specifically with membrane phospholipids (Singh 
and Murray 2003). The sperm-specific PLCζ lacks the PH domain although it is still 
able to bind phospholipids by the X-Y linker region (Nomikos et al. 2011a). The 
binding of the PLCδ1 PH domain to the enzymatic product, I(1,4,5)P3, was also 
shown implicating the existence of a feedback mechanism whereby PLCδ1 is 
liberated from the membrane after a sustained activation (Ferguson et al. 1995). 
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1.2.3.2.3. The EF-hands 
The EF-hand is a domain frequently found in Ca
2+
-binding molecules. One EF-hand 
consists of 2 α-helices and a Ca2+-binding loop in-between. The name EF-hand was 
given by Kretsinger and Nockolds based on the mechanism by which the E and F 
helices move between the open and closed conformations in parvalbumin (Figure 
1.9.) (Kretsinger and Nockolds 1973). In this model, the helices are creatively 
described as the forefinger and the thumb on a hand. The Ca
2+
- binding of the loop 
induces the movement of the “thumb-helix” away from the “forefinger-helix” which 
transforms the EF-hand from the closed (apoprotein) to the open conformation 
(holoprotein, Figure 1.9.) (Lewit-Bentley and Rety 2000). To attain structural 
stability, usually two EF-hands team up to induce the formation of a short 
antiparallel β-sheet between the Ca2+-binding loops (Grabarek 2006). This 
connection, termed EF-hand β-scaffold, also plays an important role in the Ca2+ 
dependent structural changes of the domain (Grabarek 2005).  
EF-hands have different selectivities toward Ca
2+
 and Mg
2+
 although the binding of 
Mg
2+
 generates a conformation which is more related to the closed form (Malmendal 
et al. 1999). Ca
2+
-binding ligands are provided by negatively charged amino acids 
such as aspartic acid or glutamic acid. Canonical EF-loops consist of 12 residues and 
provide 7 oxygen ligands to form a septadentate Ca
2+
-binding site (Figure 1.9.) 
(Gifford et al. 2007). The glycine in the 6 position is a highly conserved residue 
which produces a 90
o
 turn in the loop essential for the coordination of the Ca
2+ 
with 
the 7 ligands. Moreover, the NH and CO groups of the hydrophobic residue in the 8. 
position constitute the previously mentioned short β-sheet with the paired EF-hand 
(Gifford et al. 2007).  
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Figure 1.9.: Structure of the EF-hand. A: The hand model of the EF-hand describing 
the structural change in the domain upon Ca
2+
-binding as moving one of the helices 
away from the other like the movement of the thumb in a hand. This open 
conformation (holoform) returns to the closed state (apoform) when the Ca
2+
 
dissociates from the binding site. Figure is taken with permission from Elsevier Ltd. 
(Lewit-Bentley and Rety 2000). B: Schematic representation of Ca
2+
-coordination of 
the EF-hand-loop in relation to the helices (red). Residues supplying ligands for Ca
2+
 
are shown in blue. The 9. residue asparagine coordinates Ca
2+
 by the substitution of a 
water molecule (W). A glycine residue which directs an essential turn in the loop is 
shown in green. The hydrophobic residue constituting the short β-sheet with the 
parallel EF-loop, is shown in purple. Figure is taken with permission from Portland 
Press Ltd. (Gifford et al. 2007). 
The EF-hand like motifs found in PLCs are similar to the canonical EF-hands 
although their involvement in Ca
2+
-binding is not certain (Bairoch and Cox 1990). 
The deletion of the EF-hand in PLCδ1 resulted in a decrease in enzyme activity but 
this effect was independent from Ca
2+
 concentration (Nakashima et al. 1995). 
Although, a later study suggested that Ca
2+
-binding of this domain in PLCδ1 
regulates membrane-association of the PH domain (Yamamoto et al. 1999). It is 
likely that the EF-hand has lost its Ca
2+
 -binding ability in most of the PLCs and 
functions only as a hinge-like domain between the PH domain and the catalytic site 
(Stewart et al. 2007). 
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In contrast, much more is known about the functionality of the EF-hands in PLCζ 
(Kouchi et al. 2005; Nomikos et al. 2005). Distinctively, PLCζ exhibits a 100-fold 
higher Ca
2+
 sensitivity than PLCδ1 which is due to the functional EF-hands 
(Nomikos et al. 2005). PLCζ is only expressed in sperm and it is a crucial factor for 
the initiation of Ca
2+
 oscillations upon fertilisation (Saunders et al. 2002).  
1.2.3.2.4. The catalytic domains 
The X and Y domains fold to form the catalytic site which is responsible for the 
cleavage of the substrate, PI(4,5)P2. The catalytic core is highly conserved across 
mammalian PLCs (Rhee and Choi 1992). Apart from PI(4,5)P2, it is able to catalyse 
the enzymatic cleavage of phosphatidylinositol (PI) and phosphatidylinositol 4-
monophosphate (PI(4)P) but it never cleaves 3-phosphoinositides. Moreover, Ca
2+ 
is 
essential to be present at the catalytic site and the substrate preference may be 
slightly altered at different Ca
2+
 concentrations (Ellis et al. 1998). In contrast, the 
phospholipid hydrolysis of bacterial PLCs is independent from [Ca
2+
] and prefers PI 
and glycerophospholipids (Griffith et al. 1991). The X and Y domain forms one 
structural unit of the catalytic core composed of alternating α-helices and β-strands. 
This structure is analogous to the common enzyme core known as TIM-barrel (triose 
phosphate isomerase-barrel) (Essen et al. 1997b). The X and Y domains are usually 
separated by a linker region which may contain other functional domains. These are 
not integral parts of the TIM-barrel but rather they possess regulatory function on the 
enzyme activity and are sometimes referred to as Z-region (Rebecchi and Pentyala 
2000). This region in PLCγ contains a PH domain split by two SH2 and one SH3 
domains and phosphorylation events on Tyr residues result in the rise of the 
accessibility of the enzyme core to the substrate (Humphries et al. 2004; Ozdener et 
al. 2002). In general, the XY-linker (lacking any additional domains in PLCβ, δ, ε 
and η) possesses an autoinhibitory function on PI(4,5)P2 hydrolysis (Hicks et al. 
2008). Whereas this part is mainly negatively charged in other PLCs, it consists of 
positively-charged amino acids in PLCζ and contributes its non-specific association 
of the protein to phospholipids (Nomikos et al. 2011b). 
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1.2.3.2.5. The C2 domain 
The C2 (constant 2) domain was first described in PKCs as the second conserved 
domain (Xu et al. 1997). Since then, the domain was identified in a wide range of 
proteins with phospholipid binding capability, such as phosphatidylinositol 3-kinase 
(Hiles et al. 1992), RasGAP (Yamamoto et al. 1995), synaptotagmin (Perin et al. 
1990) and PLCs (Rhee et al. 1989). The C2 domain is the second most frequent lipid 
binding domain after the PH domain (Cho and Stahelin 2006), and binds 
phospholipids either selectively or non-selectively. This interaction is Ca
2+
-
dependent although some exceptions do exist (Davletov and Sudhof 1993; Cho and 
Stahelin 2006). The domain is composed of eight parallel β-strands connected by 
variable loops at the margins (Figure 1.10.) (Sutton et al. 1995). Three loops on one 
side of the molecule represent the Ca
2+
 binding site where 1-3 Ca
2+
 are able to bind 
depending on the C2 domain subtype (Sutton et al. 1995; Perisic et al. 1998; Sutton 
and Sprang 1998). 
The C2 domain is a basic element of all PLCs. In PLCδ1, two Ca2+ is coordinated by 
ligands supplied mainly by aspartates (Grobler et al. 1996). Interestingly, the lipid 
specificity is not similar between the PLCδ isoforms. Whereas the C2 domain of 
PLCδ1 and PLCδ2 prefers the Ca2+-directed binding of phosphatidylserine, a 
substitution of an asparagine Ca
2+
 coordinating residue (Asp717) to serine in PLCδ4 
renders the domain less selective and the requirement of Ca
2+
 for lipid-binding is 
diminished (Ananthanarayanan et al. 2002). It was suggested in PLCδ1, that Ca2+ 
ligands are also supplied by the phospholipids and the interaction of the C2 domain 
with membranes are strengthened by the developing “Ca2+-bridge” (Grobler et al. 
1996). A PLCζ mutant lacking the C2 domain possesses no detectable enzyme 
activity. This supports the idea that binding of the membrane via the C2 domain is 
essential for the enzymatic cleavage of the substrate. PLCζ-C2 domain possesses the 
highest sensitivity towards PI(3)P and PI(5)P and the interaction is not Ca
2+
-
dependent (Kouchi et al. 2005). 
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Figure 1.10.: Structure of the rat PLCδ1 C2 domain. The domain is composed of 8 
parallel β-sheets. The Ca2+ binding site consists of three loops found on one side of 
the β-sheets. Ca2+ ions are represented as red spheres. Structure was modelled by the 
author of this thesis with Accelrys Discovery Studio 3.1 from the structural data 
found at PDB: 1DJI, Essen et al. 1997a).  
1.2.3.2.6. PLC isozyme-specific domains  
Some PLC enzymes possess functional domains that are specific to individual 
classes. PLCβ enzymes contain a C-terminal extension lacking any identifiable 
domains. Although this extension may seem unimportant at first sight, it was shown 
to be a protein interaction site and was termed as C-terminal domain (CT). PLCβ 
enzymes function as homodimers through CT-CT interactions which are regulated by 
Gαq (Singer et al. 2002). Moreover, an autoinhibitory segment was also found in this 
region in a cephalopod PLCβ homolog, which interacts with the catalytic site to 
negatively regulate the enzyme activity. According to this study, Gαq binding 
requires the dissociation of the CT from the catalytic site and its stimulatory effect 
resides in the inhibition of the autoinhibitory feedback (Lyon et al. 2011).  
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As previously mentioned, PLCγ contains a split PH domain separated by two SH2 
and an SH3 domain. PLCγ is phosphorylated by tyrosine kinase receptors (RTKs) 
between the second SH2 and the SH3 domains. It seems that the binding affinity to 
receptors is regulated by the N-terminal SH2 domains (Rotin et al. 1992). From the 
three tyrosine residues which are phosphorylated upon activation (Y771, Y783, and 
Y1253), Y783 interacts with the C-terminal SH2 domain and this intramolecular 
interaction stimulates the enzyme activity by an unknown mechanism (Poulin et al. 
2005).  
PLCε is uniquely involved in the signalling mechanism of a group of small GTPases 
known as Ras-proteins. The RA (Ras association) domains found on the C-terminus 
of PLCε serve as the binding site for Ras proteins (Song et al. 2001). This interaction 
induces the translocation of PLCε to the perinuclear area upon EGF (epidermal 
growth factor) receptor stimulation (Jin et al. 2001). Additionally, a Ras guanine 
nucleotide exchanger domain (RasGEF) is located on the N-terminus to facilitate the 
exchange of GDP to GTP on Ras proteins (Song et al. 2001). By this mechanism, 
upon interaction, both molecules are activated (Lopez et al. 2001). 
Apart from these domains, there are additional differences in the sequences of the 
conserved domains which lead to the diversity of regulatory mechanism affecting the 
different PLC isoforms. These alterations will be discussed in detail in the following 
section.  
1.2.3.3. Regulation of PLCs 
After the discovery of the first PLCs, the classical PLC activation was thought to be 
driven by GPCR-stimulated release of Gq/11, however, with the subsequent 
identification of other subtypes, a far greater complexity for the regulation of PLCs 
has been revealed (Figure 1.11.). PLCβ activation is highly dependent on Gq/11 
activation as it is stimulated by several members of the GPCRs linked to this G-
protein (Taylor et al. 1991; Wu et al. 1992b; Offermanns and Simon 1995; Singer et 
al. 2002). It seems that none of the other PLC classes are activated by Gq/11 proteins, 
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however some data suggest that transglutaminase/Gh which binds to atypical GPCRs 
is able to translate GPCR activation onto PLCδ1 (Murthy et al. 1999; Xu et al. 2006). 
The regulatory mechanism of Gα variants on PLC activity may also be directed by 
the insertion of non-receptor coupled small G-proteins into the activation cascade. 
G12 and G13 trigger the activation of PLCε via the stimulation of the small G-protein, 
Rho which binds to the Y catalytic domain (Wing et al. 2003). Gβγ dimers dissociated 
from activated G-proteins are also able to act as messengers of GPCR activation and 
contribute to PLC stimulation. A comparison of Gβγ stimulation on the activity of 
various PLCs showed that PLCβ1, PLCβ2, PLCβ3 and PLCδ1 activities were 
upregulated (PLCδ<PLCβ1<PLCβ2<PLCβ3) whereas PLCγ was unaffected by the 
dimer. Due to the altered susceptibilities of the different PLCβ isoforms for Gβγ and 
Gαq they are possibly differently regulated by various GPCR signals (Park et al. 
1993). The release of Gαq is always paired with an increase in Gβγ levels, however by 
using specific scavenger molecules their individual effect could be revealed. One 
such experiment  reported that Gβγ generates Ca
2+
 oscillations whereas Gαq induces a 
prolonged elevation in intracellular Ca
2+
 level of pancreatic acinar cells. This effect 
might be directed by different subsets of PLC isotypes and highlights the importance 
of the fine tuning of PLCs to G-protein activation (Zeng et al. 1996). Gβγ regulates 
the enzyme activity of PLCβ by binding to its PH domain, a feature that is conserved 
when the domain is inserted into PLCδ1 (Wang et al. 2000). As mentioned before, 
the stimulatory effect of Gβγ seems to reside in its ability to dissociate inhibitory 
intramolecular connections of the PH and catalytic domain (Drin et al. 2006). PLCε 
is also stimulated by various Gβγ subtypes although the mechanism of binding is 
uncertain (Wing et al. 2001). 
PLCγ is activated by receptor tyrosine kinases. As earlier described, upon ligand 
induced autophosphorylation of the receptor, PLCγ is tethered to RTKs and 
subsequently phosphorylated and activated by the receptor (Poulin et al. 2005). 
Additionally, receptors which do not possess intrinsic tyrosine kinase activity may 
still be able to stimulate PLCγ by phosphorylation. For instance, this occurs by the 
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activation of the B-cell antigen receptor which stimulates PLCγ via activating the 
Bruton's tyrosine kinase (Takata and Kurosaki 1996). Alternatively, other PLC 
subtypes may be phosphorylated by specific kinases. The phosphorylation of PLCβ3 
by PKA or PKC inhibits Gα and Gβγ stimulated activity (Yue et al. 1998; Yue et al. 
2000). In contrast, phosphorylation of PKCδ1 by PKC seems to potentiate its enzyme 
activity in vitro (Fujii et al. 2009). 
Small GTPases are able to translate receptor activation to PLCs (Figure 1.6b). 
Gs/cAMP coupled GPCRs stimulate PLCε via the activation of Rap small GTPase 
(Schmidt et al. 2001). Upon growth factor-dependent stimulation, both Ras and Rap 
are activated. Whereas Ras stimulation is transient, Rap is responsible for a sustained 
activation of PLCε (Song et al. 2002). Rac contributes to the regulation of PLCβ and 
PLCγ. PLCγ2 but not PLCγ1 is regulated by Rac by its association with the split PH 
domain (Walliser et al. 2008). Only PLCβ2 of PLCβs is activated by Rac2 by their 
interaction through the N-terminal PH domain (Illenberger et al. 2003). 
All PLC subtypes require Ca
2+
 for PI(4,5)P2 hydrolysis which is directed via its 
binding to the catalytic site. The mutation of the metal-binding residues to alanine in 
the PLCδ1 catalytic core decreased basal enzyme activity to a great extent and based 
on this finding, Ca
2+
 dependence of all subtypes has been described by this 
mechanism (Ellis et al. 1998). In contrast to being a cofactor for enzyme activity, in 
PLCδ and PLCζ, Ca2+ is also able to directly activate the hydrolysis of the substrate 
possibly via the EF-hand although the exact mechanism is uncertain (section 
1.2.3.3.). The half maximal concentration of Ca
2+
 which stimulates PI(4,5)P2 
hydrolysis by PLCδ1 and PLCδ3 was determined between 100 nM and 1 µM Ca2+ 
which corresponds to the physiological range of cytosolic Ca
2+
 signals (Cheng et al. 
1995; Ghosh et al. 1997). In contrast, the sperm-specific PLCζ is activated between 
10 nM and 100 nM Ca
2+ 
which suggests that it is activated by basal cytosolic Ca
2+
 
levels. This Ca
2+
-induced activation and the subsequent inactivation and depletion of 
I(1,4,5)P3 sensitive Ca
2+
 stores may be responsible for the developing oscillations in 
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Ca
2+
 concentration upon the administration of PLCζ into oocytes (Nomikos et al. 
2005). 
 
Figure 1.11.: Various activation of PLC isoforms. A: Receptor induced activation of 
PLCs. GPCR activation triggers the dissociation and the subsequent activation of Gα 
and Gβγ. Gα (from Gq/11 or transglutaminase/Gh) stimulates PLCβ and PLCδ whereas 
the Gβγ dimer increase PLCβ, PLCδ and PLCε activity. RTKs directly phosphorylate 
and consequently activate PLCγ. Phosphorylation of PLCβ by PKA or PKC 
negatively regulates PLCβ activity, whereas PKC potentiates PLCδ activity. PLCδ 
and PLCζ are directly activated by Ca2+ signals which may arise from Ca2+ influx or 
Ca
2+
 release from intracellular stores. They might be involved in the amplification of 
Ca
2+
 signals by their activation in response to small Ca
2+
 levels and the Ca
2+
 
releasing effect of the consequently generated I(1,4,5)P3. Solid and dashed lines 
represent activation or inhibition, respectively. B: Activation of PLCs by small G 
proteins. Rac stimulates PLCβ and PLCγ activity. PLCγ, in which the main 
regulation of enzymatic cleavage is regulated by the small GTPases, is activated by 
Rho, Rap and Ras, but the mechanism of activation greatly differs (see text for 
description). Abbreviations: GPCR: G protein-coupled receptor, PI(4,5)P2: 
phosphatidylinositol 4,5-bisphosphate, I(1,4,5)P3: inositol 1,4,5-trisphosphate, DAG: 
diacylglycerol, PKC: protein kinase C, PKA: protein kinase A, IP3R: inositol 1,4,5-
trisphosphate receptor, RTK: receptor tyrosine kinase, ER/SR: endo/sarcoplasmic 
reticulum. Figure was produced by the author of the thesis 
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In conclusion, PLC isozymes have distinct upstream regulators that may also differ 
between closely related members of a subfamily. These alterations allow the PLC 
family members to take part in alternative physiological processes. In the next 
section, the role of PLCs in neurophysiology will be discussed.  
1.2.3.4. The role of PLCs in neuronal physiology 
1.2.3.4.1. Neuronal pattern of PLC expression 
Various PLC isoforms are distributed in the brain which strongly suggests that this 
enzyme family play crucial roles in neuronal physiology (a summary of the existing 
literature is found in Table 1.1.). The mRNAs of all four PLCβ isoforms are 
expressed in the brain with alternating distribution in different brain tissues. PLCβ1 
is abundant in the cerebral cortex, striatum and hippocampal formation whereas 
PLCβ2 is expressed in structures of the white matter. PLCβ3 specifically appears in 
cerebellar Purkinje cells. PLCβ4 is abundant in regions opposite to PLCβ1; it is 
found in the olfactory bulb, thalamus, brainstem and cerebellum (Watanabe et al. 
1998). Only low levels of PLCγ1 appear in the brain, mainly in the olfactory bulb, 
hippocampal formation, cerebellum, piriform- and frontal cortex (Ross et al. 1989). 
In addition, PLCγ2 is found in a small portion of the cerebellum (Tanaka and Kondo 
1994). PLCδ1 mRNA is expressed in all brain areas tested (Lee et al. 1999). In a 
comparative study, the expression of all PLCδ isoforms were studied in cerebellar 
granule cells and PLCδ3 was found to be the predominant form. In addition, high 
levels of PLCδ3 were also detected in the cerebral cortex (Kouchi et al. 2011). The 
latest PLCδ isoform, PLCδ4 is also abundant in the brain, however, there has not 
been any attempt in the literature to assess its regional specific distribution (Lee and 
Rhee 1996). Limited expression of PLCε1 was also detected in human brain lysates 
by Northern blot analysis (Lopez et al. 2001). In the developing mouse, PLCε1 
seems to be upregulated in neuronal precursor cells which are committed to become 
neurons indicating its role in neuronal differentiation (Wu et al. 2003). PLCζ 
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expression is restricted to the sperm and therefore has no functions in brain 
physiology (Saunders et al. 2002).  
isoform 
expression 
in the brain 
brain regions Reference 
PLCβ1 yes 
cerebral cortex, striatum, hippocampal 
formation, amygdala, lateral septum 
Watanabe et 
al., 1998 
PLCβ2 yes 
white matter structures (corpus callosum, 
fimbria and medulla of the cerebellum) 
PLCβ3 yes Purkinje cells of the cerebellum 
PLCβ4 yes 
Purkinje and granule cells of the 
cerebellum, olfactory bulb, medial septal 
nucleus, most thalamic nuclei 
PLCγ1 yes 
olfactory bulb, hippocampal formation, 
cerebellum, piriform- and frontal cortex  
Ross et al., 
1989 
PLCγ2 yes no data available 
Tanaka and 
Kondo, 
1994 
PLCδ1 yes 
all areas tested: cerebellum, cortex, 
hipocampus, hypothalamus, mid-brain, 
pons and striatum 
Lee et al., 
1999 
PLCδ3 yes 
all areas tested: cerebral cortex, 
cerebellum, hippocampal formation 
Kouchi et 
al., 2011 
PLCδ4 yes no data available 
Lee and 
Rhee, 1996 
PLCε yes no data available 
Lopez et al., 
2001 
PLCζ no - 
Saunders et 
al., 2002 
Table 1.2.: Summary of known information relating to the distribution of PLC-
isoforms in the brain. 
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Apart from the above mentioned spatial differences, temporal changes in PLC-
activity and expression levels have also been detected. In the rat cerebellum, overall 
I(1,4,5)P3 levels increase with age with the subsequent decrease in IP3R sensitivity 
and binding (Igwe and Filla 1995). Receptor-induced I(1,4,5)P3-accumulation is also 
augmented by ageing in the striatum and the cortex (Mundy et al. 1991; Igwe and 
Filla 1997). A study by Shimohama et al., compared the age-related changes in the 
protein levels of PLCβ1, PLCγ1 and PLCδ1 in separated cytosolic and particulate 
fractions of brain extracts. PLCβ1 protein levels elevated after birth, reached 
maximum at the age of 4 months and then slowly declined. Whereas until the 8. 
week, PLCβ1 was predominant in the cytosolic fraction, after this time-point the 
particulate fraction was found to be more enriched in this isoform. PLCγ1 and 
PLCδ1 were always found primarily in the cytosolic fraction. PLCγ1 expression 
gradually decreased with age. In contrast, PLCδ1 expression increased after birth and 
only declined at late ages (18 month-old rats) (Shimohama et al. 1998). To 
summarise, the levels of the numerous PLC isoforms are tightly regulated both 
spatially and temporally. 
1.2.3.4.2. PLC activity-linked neuronal functions 
Various neuronal processes are linked to PLC activation from neuronal 
differentiation to synaptic plasticity. A number of studies reported the importance of 
phospholipase activity and IP3R-driven Ca
2+
 release in neuronal transduction. PLC 
activity is coupled to various neurotransmitter receptors, such as serotonergic, 
adrenergic, histaminergic, muscarinic and cholinergic receptors (Wallace and Claro 
1990; Xu and Chuang 1987). In addition, decrease in the PI(4,5)P2-pool produced by 
NMDAR-stimulated PLC activity was implicated in the generation of long-term 
potentiation by liberating the protein kinase A anchoring scaffold protein, 
AKAP79/150 from the membrane, and downregulating the level of F-actin and the 
membrane distribution of AMPAR (Horne and Dell'Acqua 2007). In the absence of 
PLC activation, the actin depolymerising protein cofilin is bound to PI(4,5)P2. Upon 
stimulation of PLCs in cortical neurons, PI(4,5)P2 is cleaved, releasing cofilin, which 
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in-turn potentiates the rearrangement of the actin cytoskeleton. The internalisation of 
NMDAR is also accelerated by this process due to its connection to the actin 
cytoskeleton (Mandal and Yan 2009). Binding of the brain-derived neurotrophic 
factor (BDNF) to its tyrosine kinase receptor (TrkB) on both pre- and postsynaptic 
membranes activates PLCγ by phosphorylation. In hippocampal neurons, this process 
is important for the generation of LTP via the stimulation of CREB-dependent 
transcription and the phosphorylation of TRPC3 (Li et al. 1999; Gartner et al. 2006; 
Cunha et al. 2010). In addition, gabaergic stimulation of Purkinje cells is enhanced 
by BDNF-PLCγ signalling (Cheng and Yeh 2005).  
Apart from playing important roles in neurotransmission within the adult brain, PLC 
activity also contributes to the regulation of neuronal differentiation. A study by 
Kouchi et al. highlighted the importance of PLCδ3 in directing neurite outgrowth and 
migration of cerebral and cerebellar neurons by in vivo and in vitro knockdown 
experiments. PLCδ3 acts on neurite outgrowth through the inhibition of RhoA/Rho 
kinase signalling (Kouchi et al. 2011). In contrast, high levels PLCγ1 inhibited the 
NGF-induced differentiation of a pheochromocytoma cell line (PC12) by altering the 
expression pattern of cell cycle regulators (CDK1, CDK2 and cyclin D1) and 
promoting cell proliferation (Nguyen Tle et al. 2007). As mentioned before, PLCε 
expression has been suggested to play important roles in cell fate decision of 
neuronal precursors based on its specific expression in only MAP2 positive cells 
during embryogenesis (Wu et al. 2003). Neurogenesis also occurs in restricted 
regions of the adult brain, namely in the olfactory bulb and the dentate gyrus of the 
hippocampal formation (Kaneko and Sawamoto 2009). Interestingly, this is 
influenced by PLCβ1 activity as shown by the elevated rate of neurogenesis in the 
hippocampus of the PLCβ1-knockout mice (Manning et al. 2012). PLC-signalling is 
important for chemoattractant-directed migration of granule cells. The SDF-1 
(stromal derived factor-1) receptor CXCR4 (CXC chemokine receptor 4) is a Gi-
coupled GPCR which has been suggested to stimulate PLCβ1 activity by the released 
Gβγ dimer (Busillo and Benovic 2007).  
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1.2.3.5. The latest PLC family, PLCηs 
1.2.3.5.1. First characterisation of PLCη enzymes 
The latest PLC family with two members (PLCη1 and PLCη2) was independently 
reported in 2005 by four groups. Identification of this distinct PLC group was a result 
of a screen of the existing sequence databases such as the HUGE database (Kazusa 
DNA Research Institute) the Celera and the NCBI databases (Hwang et al. 2005a; 
Nakahara et al. 2005; Stewart et al. 2005; Zhou et al. 2005). Although the PLCη-
domain structure is most related to that of PLCβs, their sequence is highly similar to 
PLCδs (Hwang et al. 2005a; Nakahara et al. 2005; Stewart et al. 2005). All PLC-
specific domains were identified in PLCη structure (PH, EFL, X, Y, and C2 domains, 
Figure 1.12.) with an additional C-terminal extension lacking any known functional 
domain organisation. A His-tagged PH domain of PLCη1 was purified by a Ni-NTA 
agarose followed by cation-exchange chromatography. Circular dichroism spectra of 
this PH domain suggested that the secondary structure is composed of β-sheets 
similarly to other PLCs (Imai et al. 2007). Alignment of the catalytic site of PLCηs 
with other PLCs showed that the enzymatically necessary residues are conserved 
suggesting that their basic catalytic functions are equivalent. From the two histidines 
which are crucial in the specific binding of phospholipids (Essen et al. 1997b), one in 
each PLCη (mutations: H358Q in PLCη1 and H341Q in PLCη2) was mutated to 
generate a catalytically-inactive variant (Hwang et al. 2005a; Nakahara et al. 2005). 
 
Figure 1.12.: Domain structure of PLCη enzymes. Both isoforms contain the PLC-
specific structural composition with an N-terminal PH domain, EF-hands, X and Y 
catalytic domains connected by a short link (157 residues in hPLCη1 and 151 
residues in PLCη2), a C2 domain, and the alternatively spliced C-terminus. Figure is 
taken with permission from The American Society for Biochemistry and Molecular 
Biology (Nakahara et al. 2005). 
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At the C-terminus, a class II PDZ-binding motif was identified in both PLCη1 and 
PLCη2 which provides the possibility for interactions with PDZ-domain containing 
proteins (Zhou et al. 2005). In addition, the C-terminus of PLCη2 contains a number 
of proline rich motifs which is a known target of SH3 domain containing proteins 
(Cohen et al. 1995). SH3 domains frequently occur in signalling proteins such as the 
Ras GTPase activating protein (RasGAP), phosphatidylinositol 3-kinase (PI3K) and 
PLCγ (Kohda et al. 1993; Pamonsinlapatham et al. 2009; Batra-Safferling et al. 
2010). The C-terminal domain is also rich in serine/threonine residues suggesting 
possible regulation via protein kinases/phosphatases (Figure 1.13.). In the light of 
these data, the variable C terminus is potentially a major protein interaction site. 
 
Figure 1.13.: Amino acid motifs of the PLCη2 C-terminal that might be targeted by 
kinases/phosphatases. The sequence shown is the C-terminus of the longest splice 
variant of PLCη2 (21b/23). Yellow: two proline intercepted by two other amino 
acids, green: serine and threonine residues, blue serine/threonine residues are integral 
to the PxxP motif. Figure was produced by the author of this thesis. 
Alternative splicing of the C-terminus may possess an important regulatory role as 
this mechanism gives rise to a number of splice variants in both PLCη1 and PLCη2. 
This idea is supported by the appearance of the previously mentioned PDZ-binding 
motif only in certain spliceforms (Zhou et al. 2005). Three splice variants of PLCη1 
(with sizes: 1002, 1693 and 1035 amino acids of the human isoform) (Hwang et al. 
2005a), whereas five spliceforms of PLCη2 (with sizes 989, 1156, 1211, 1416 and 
1583 amino acids in human) (Zhou et al. 2005) were suggested to be processed. 
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Interestingly, the different splice variants of PLCη2 exhibit tissue specific 
distribution, however, consequences of this process are largely unknown (Zhou et al. 
2005). PLCηs are generally thought to be brain-specific, however, their presence in a 
limited number of other tissues were also shown. Both PLCη1 and PLCη2 are 
expressed in the lung, whereas only PLCη1 is represented in the spinal cord (Hwang 
et al. 2005a; Nakahara et al. 2005). High levels of PLCη2 expression were also found 
in the retina (in photoreceptors, and in horizontal-, bipolar- and amacrine cells) and 
in neuroendocrine cells (Stewart et al. 2007; Kanemaru et al. 2010). PLCη1 is 
expressed throughout the brain but it is most abundant in the olfactory bulb, 
hippocampal formation, cerebellum, cerebral cortex, zona incerta, habenula and 
hypothalamus (Hwang et al. 2005a). High amounts of PLCη2 were also detected in 
these regions with the exception of the zona incerta. Interestingly, PLCη2 protein 
levels gradually increase during postnatal development in both mouse brain and 
retina (Nakahara et al. 2005; Kanemaru et al. 2010). In primary cell cultures, PLCη 
was abundant in hippocampal pyramidal cells whereas in astrocyte-enriched cultures 
it was absent (Nakahara et al. 2005). These results highlight the importance of PLCη 
enzymes in neuronal physiology. 
1.2.3.5.2. Biochemical properties 
The capability of PLCη enzymes to hydrolyse PI(4,5)P2 was confirmed by using 
purified enzymes. PLCη1 catalytic activity possesses high sensitivity towards Ca2+ 
(10-100 nM) and its maximal activation is achieved by a ten-fold lower 
concentration compared to PLCβ1 (Hwang et al. 2005a). Ca2+ sensitivity of PLCη2 
mirrors PLCη1 and its highest activity is reached at a ten-fold lower Ca2+ 
concentration than that of PLCδ1. These results indicate that the threshold for Ca2+-
activation is much lower in the PLCη than in PLCβ or PLCδ1 families. 
ηUnfortunately, the purified PLCη2 showed decreased, 10-fold lower maximal 
activation (at any [Ca
2+
] ) than what was registered with PLCδ1 However, this 
difference could be due to the altered requirements of enzyme activity in PLCη2 and 
PLCδ1 which were not equally supported during the in vitro measurement. 
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Hydrolysing activity of PLCη2 is also dependent on pH with an optimum of pH 7 
(Nakahara et al. 2005). 
To describe the regulatory mechanism of PLCηs, several known PLC-regulating 
proteins were co-administered with PLCηs in cells that was followed by the 
measurement of PI(4,5)P2-hydrolysisng activity. PLCη2 activity was not stimulated 
by any of the Gα subunits examined or by the numerous small G-proteins tested 
(Zhou et al. 2005). Of those examined, only Gβγ dimers (most efficiently Gβ1γ2) were 
able to stimulate PLCη2 activity. In contrast, PLCη1 enzymatic activity was not 
affected by the co-expression of Gβ1γ2 and therefore it seems that the two isoforms 
are differently regulated by GPCRs (Zhou et al. 2008). Consequently, the 
mechanisms by which PLCη1 is activated are less understood. Currently, its only 
known activator is Ca
2+
 and it has been implicated in the interplay with other PLCs 
by amplifying Ca
2+
 transients (Kim et al. 2011).  
The cellular localisation of PLCη1 and PLCη2 was assessed in human immortalised 
cell-lines (HEK-293 and HeLa cells) using green fluorescent protein (GFP) tagged 
PLCη constructs. PLCη1 possessed equal distribution between membranes and the 
cytosol, whilst PLCη2 predominantly localised to membranes prior to stimulation 
(Hwang et al. 2005a; Nakahara et al. 2005).  
1.4. Thesis outline 
As highlighted in this Chapter, PLCηs are new members of the PLC family and our 
knowledge on their regulation and their involvement in cellular processes is 
relatively poor. The aim of the thesis is to characterise the second PLCη isoform, 
PLCη2 from several biochemical and functional aspects. Key questions addressed 
are how enzyme activity and cellular localisation are regulated by the different 
domains. In addition, the specific role(s) that this enzyme plays in neuronal 
physiology is also examined. 
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The activation of PLCη2 by mitochondrial Ca2+ release is demonstrated in COS-7 
cells overexpressing PLCη2 by the administration of various Ca2+-mobilising agents 
and inhibitors. This is followed by the investigation of the PH domain, EF-hand and 
the C2 domain from several aspects. Deletion of the PH domain results in the loss of 
membrane binding capability. To further characterise this domain, its preference 
towards different phospholipids is also assessed. It is hoped that this study improves 
our understanding on the regulation of PLCη2 shuttling inside the cell. Ca2+-
dependent secondary binding to the membrane by the C2 domain is also shown to be 
critical for enzyme activity, however this does not contribute to the Ca
2+
-sensitivity 
of the enzyme. In addition to an EFL-domain (which is found in all PLCs), a unique 
EF-hand was identified in PLCη enzymes. Using site directed mutagenesis it was 
found that a Ca
2+
-binding loop is responsible for the unique Ca
2+
-sensitivity of 
PLCη2 catalytic activity. Collectively, these results assist the formation of the better 
understanding of how PLCη2 is regulated. 
In addition, acquiring information as to the physiological function(s) of PLCη2 in 
neuronal cells is of great importance. A previous study by Nakahara et. al. (2005) 
reveals that PLCη2 expression increases during postnatal development. This led me 
to investigate whether this enzyme is involved in neuronal differentiation. Using an 
established cell model for neuronal differentiation/neurite growth (Neuro-2a cells), 
PLCη2 expression and the role of the enzyme in this process were assessed. It was 
found that when PLCη2 levels are reduced Neuro-2a cell differentiation is 
compromised, implying its importance in this process. PLCη2 may direct 
differentiation by influencing retinoic acid regulated gene expression as implicated 
by a dual-luciferase assay. A possible interaction partner (LIMK1) was also 
identified by a bacterial two hybrid screen which links PLCη2 function to the 
regulation of actin rearrangement. It is hoped that this work will generate further 
interest relating to the role of PLCη2 in the brain.  
 
 52 
 
  
 53 
 
 
 
 
Chapter 2. 
 
 
Materials and Methods 
  
 
 54 
 
 
CHAPTER 2. MATERIALS AND METHODS  
 
55 
 
2.1. Cell Culture Methods 
2.1.1. Cell lines and their maintenance 
Cell lines were maintained at 37
o
C in a humidified atmosphere at 5% CO2 in 
appropriate medium as shown in Table 2.1. (media unless otherwise stated are 
obtained from Sigma-Aldrich, Poole, UK). Cells were split twice a week into a new 
75 cm
2
 flask. The medium was removed and the cells were washed twice with 10 ml 
sterile PBS. Cells were harvested with 2 ml of pre-warmed (37
o
C) Trypsin-EDTA 
solution (Life Technologies, Paisley, UK). Trypsin was inactivated by 8 ml of 
complete medium and a small portion (0.5-2.5ml) was added to a new flask 
containing 25 ml medium (1:50- 1:10 ratio). COS-7 cells were a gift from Prof. 
Robert P. Millar (Queen’s Medical Research Institute, Edinburgh, UK) and Neuro-2a 
cells were obtained from The European Collection of Cell Cultures (ECACC). 
 
Cell type Origin Maintenance 
COS-7 immortalised kidney cells 
from African green monkey 
(Gluzman 1981) 
DMEM (Dulbecco`s modified Eagle`s 
medium) with high glucose 
(4500mg/L) supplemented with 2 mM 
L-glutamine and 50 units/ml of 
penicillin/streptomycin mixture 
(Invitrogen). Cells were maintained at 
37
o
C, 5% CO2. 
Neuro-2a murine neuroblastoma cell 
line (Klebe and Ruddle 1969) 
EMEM (Eagle's minimal essential 
medium) supplemented with 2mM L-
glutamine, 50 units/ml of 
penicillin/streptomycin mixture. Cells 
were maintained at 37
o
C, 5% CO2. 
Table 2.1.: Cell-lines and there maintenance. 
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2.1.2. Cryopreservation of cell lines 
A cell suspension acquired after trypsinisation of a confluent 75 cm
2
 flask was spun 
at 800 rpm (Neuro-2a) or at 1,500 rpm (COS-7) for 3 minutes at 4
o
C in a Beckman 
JS-4.2 rotor. The cell pellet was resuspended in 4 ml freezing medium (Life 
Technologies) and was aliquoted into 4 cryovials (Nunc, Thermo Fisher Scientific, 
Waltham, MA, USA). The cells were kept at -20
o
C for 24 hours then at -80 
o
C for 
24 hours and were transferred to a liquid nitrogen filled container for long-term 
storage. 
2.1.3. Rescue of frozen cells 
Liquid nitrogen-stored cells were quickly thawed at 37
o
C. The cell suspension was 
diluted with 10 ml fresh growth medium and cells were harvested as previously by 
centrifugation. The cell pellet was resuspended in 25 ml fresh medium and was 
transferred into a 75 cm
2 
flask. 
2.1.4. Transfection by electroporation  
Electroporation was used to transiently transfect COS-7 cells or to transfect and 
select stable clones from Neuro-2a cells (antibiotic selection will be described later). 
The following method was used for both cell types. Cells were trypsinised and 
seeded into 14 cm diameter tissue culture dishes with 25 ml growth medium which 
were allowed to grow for 3 days prior to transfection. Approximately 1.5 × 10
7
 cells 
were used for each transfection (2/3 of a dish). When multiple transfections were 
required, they were done in parallel. Cells were trypsinised and collected with 10 ml 
growth medium as described previously. Cells were harvested by centrifugation and 
the pellet was washed with 10 ml Optimem/transfection (Life Technologies). 
Centrifugation was repeated and the pellet was resuspended in 0.7 ml 
Optimem/transfection and each 0.7 ml was aliquoted into an electroporation cuvette 
containing 15-20 µg plasmid. Cells were electroporated by using a Bio-Rad Gene 
Pulser at 230 V, 950 μF. Cells were recovered for 10 minutes, and the suspension 
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was mixed with growth medium to seed into cell culture dishes for subsequent 
experiments as appropriate. 
2.1.5. Lipofection of Neuro-2a cells 
Lipofectamine 2000 (Life Technologies) was used to transfect Neuro-2a cells with 
constructs encoding fluorescently-tagged proteins (GFP-PLCη2, GFP-PLCη2 PH 
domain or mCherry-PLCδ1, more information is given later in this Chapter). Cells 
(100 cells/mm
2
) were seeded in antibiotic-free EMEM into a 6-well plate containing 
coverslips. The following day, 2 µg of plasmid and 5 µl Lipofectamine were mixed 
in 500 µl Optimem, respectively for each well. After 5 minutes, the two solutions 
were mixed and further incubated for 30 minutes. Each mixture was added to one 
well in the 6–well plate dropwise and mixed gently by rocking the plate. Cells were 
returned to the incubator and the growth medium was changed to fresh EMEM after 
6 hours.  
2.1.6. Generation of stable PLCη2 knock-down cell lines  
The expression of PLCη2 was downregulated in Neuro-2a cells by the transfection of 
psi-H1 vectors encoding shRNAs designed to target PLCη2 expression (obtained 
from GeneCopoeia, Rockville, MD, USA). Four different shRNA constructs were 
tested and two stable clones were selected (shRNAPLCη2-1 and shRNAPLCη2-1). 
Target and the control sequences are shown in Table 2.2. Plasmid maps are presented 
in Chapter 7. Cells were transfected by electroporation as described previously. 
Stably transfected cells were selected after 48 hours by adding 3 µg/ml puromycin to 
the growth medium (InvivoGen, San Diego, CA, USA). Growth medium was 
renewed every second day until colonies appeared. One cell derived colonies were 
cloned with custom-made metal cloning rings and were transferred into 6-well plates. 
Knock-down efficiency in the different clonal lines was detected by western blot 
analysis. 
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construct 19-mer target sequences and control 
shRNAcontrol 5`-TCAAGAG-3` 
shRNAPLCη2-1 5`-TGACTGCAAGCTCCTCAAT-3` 
shRNAPLCη2-2 5`-GGACCTAGTGAAATATACC-3` 
shRNAPLCη2-3 5`-TCTGCAGCTGCTACATAAA-3` 
shRNAPLCη2-4 5`-TCTGCGCCTTCTACAAGAT-3` 
Table 2.2.: PLCη2-specific sequences in shRNA constructs. 
2.2. Cell assays and treatments 
2.2.1. Immunocytochemistry and fluorescent microscopy 
For microscopic analysis cells were grown on coverslips in 6-well plates. For the 
specific staining of mitochondria, MitoTracker Red CMXRos (Life Technologies) 
was diluted in DMSO and was added to the culture medium (to a final concentration 
of 250 nM) an incubated at 37°C for 30 minutes. Cells were fixed with altered 
methods afterwards. 
COS-7 cells transfected with constructs encoding GFP-fused proteins were fixed in 
ice-cold methanol for 10 minutes and dried on air. Fixed cells were washed twice 
with PBS and nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, 
Sigma-Aldrich) in PBS. Coverslips were mounted in Mowiol solution (Sigma-
Aldrich) and left to dry in the dark at 4
o
C. 
Neuro-2a cells transfected with GFP- or mCherry-tagged constructs were fixed with 
4% formaldehyde in PBS for 10 minutes and were washed with PBS three times. 
Coverslips were incubated in 2.1% citrate buffer containing 0.5% Tween-20 and in 
11.8% citrate buffer containing DAPI for 5-5 minutes. The remaining of the last 
solution was removed by PBS and coverslips were mounted with Mowiol solution. 
For the detection of endogenous proteins cells were fixed and permeabilised in one 
step with 4% formaldehyde and 0.2% Triton-X containing PBS. This solution was 
removed after 5 minutes and cells were washed with PBS 3 times. Coverslips were 
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incubated with blocking buffer containing 10% FBS in PBS for 1 hour. A custom 
rabbit primary antibody raised against a short peptide of PLCη2 
(SKVEEDVEAGEDSGVSRQN) was used to stain endogenous PLCη2. Other 
primary antibodies were obtained from Abcam (LIMK1, dilution 1:100, Cambridge, 
UK) or Echelon Biosciences Inc. (PI(3,4,5)P3 dilution: 1:100, Salt Lake City, UT, 
USA). Actin was labelled with tetramethylrhodamine B isothiocyanate-conjugated 
phalloidin (TRITC-phalloidin, Sigma-Aldrich) which eliminated the requirement of a 
secondary antibody. Primary and secondary antibodies were diluted in 5% FBS in 
PBS. Coverslips were incubated with primary antibody solution for an hour followed 
by 3 washing steps with PBS. Secondary antibodies (anti-rabbit Dylight 488 or 594 
and anti-mouse Dylight 594 from Jackson, West Grove, PA, USA) were diluted 
1:300 and applied for an hour. When incubation time finished, cells were washed 
with PBS 3 times and incubated in 2.1% citrate buffer containing 0.5% Tween-20 in 
PBS for 5 minutes. DAPI was added in 11.8% citrate in PBS and cells were 
incubated for 5 minutes. Coverslips were washed once in PBS and mounted in 
Mowiol solution.  
To verify the specificity of the PLCη2 antibody the short peptide which was used to 
raise the antibody in rabbit (SKVEEDVEAGEDSGVSRQN) was resynthesised 
(Peptide Protein Research Ltd., UK). One µl of PLCη2 antibody was incubated with 
1 or 10 µg or without the peptide in 500 µl primary antibody solution overnight prior 
to addition to the cells. Rest of the immunostaining was conducted as described 
before. Loss of the antibody binding in the presence of the peptide verified its 
specificity towards PLCη2 and its suitability for further experiments. 
Slides were examined with a DeltaVision deconvolution microscope (Applied 
Precision, GE Healthcare, Little Chalfont, UK) or with a multiphoton confocal 
microscope (TCP SP2 system, Leica Microsystems GmbH, Wetzlar, Germany). The 
confocal microscope is equipped with a Leica DM IRE2 inverted microscope and 
HeNe (633 nm), another HeNe (594 nm), Arg (488 nm) and diode (405 nm) lasers 
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for excitation. A 60x and a 63x oil objectives were used with the DeltaVision and the 
Leica confocal systems, respectively.  
2.2.2. Differentiation of Neuro-2a cells 
Differentiation of Neuro-2a cells was initiated as described previously by Zheng and 
Zhou (2008). Cells were seeded at a density of 100 cells/mm
2
 and medium was 
changed the next day to differentiation medium (EMEM with 2% FBS, 2 mM L-
glutamine and 20 µM retinoic acid). Cells were treated for 4 days by changing the 
medium on each day. To detect morphological changes during differentiation, 
micrographs were taken every day by a Zeiss Axiovert 40 CFL microscope with a 
10× objective (Carl Zeiss Ltd., Cambridge, UK). Four micrographs were taken by 
random selection from all experimental conditions. Experiments were repeated 
3 times. Cells possessing at least one neurite with a length at least twice the cell body 
were accepted as differentiated and their ratio was expressed as a percentage of the 
total cell number. Neurite outgrowth was calculated based on a previously described 
stereological approach (Lucocq 2008; Ronn et al. 2000). Briefly, an unbiased 
counting frame was superimposed on the micrographs containing 100 µm x 100 µm 
squares. This was followed by counting the number of neurite intersections on both 
vertical and horizontal lines of the frame (one marginal line was excluded from both) 
and the cell number. The length of neurites was estimated with the equation: 
  
  
 
  
in which L is the total length of neurites, d is the distance between lines in the frame 
(100 µm) and l is the total number of neurite intersections (vertical + horizontal 
lines). In order to calculate the total length of neurites/cell L was divided by the cell 
number. 
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2.2.3. [
3
H]Inositol-phosphate release assays (IP-assay) 
COS-7 cells were electroporated as previously described. The transfection mixture 
was diluted in serum free DMEM and cells were seeded into 12-well plates 
(1 ml/well). The medium was changed the following day to serum- and inositol-free 
DMEM (MP Biomedicals, Illkirch, France) containing 1 μCi/ml myo-D-[3H]inositol 
(GE Healthcare) and was incubated for 24 hours. On the third day, cells were pre-
treated with 10 mM LiCl (inhibitor of inositol monophosphatases) containing 
HEPES-buffered DMEM to enable the accumulation of inositol phosphates. 
Thereafter, cells were stimulated at 37
o
C for 3 hours with various drugs in HEPES-
buffered DMEM containing 10 mM LiCl. These drugs and their dilution are listed in 
Table 2.3.  
 
Table 2.3.: Agents used in combination with [
3
H]inositol phosphate release assays. 
*: Tocris Biosciences, Bristol, UK. 
Treatments were terminated by the removal of the medium and addition of 1 ml 
10 mM formic acid for 30 minutes. Formic acid, containing 
3
H-labelled inositol 
phosphates, was transferred onto Dowex AG 1 resin (0.5 ml slurry containing 50 % 
water, Bio-Rad Laboratories, Inc., Hemel Hempstead, UK). Resin was washed with 
water and 60 mM ammonium formate/5 mM sodium tetraborate. Inositol phosphates 
were eluted with 1 ml of 1 M ammonium formate/0.1 M formic acid, from which 
800 µl was transferred into scintillation tubes. Subsequently, 2.5 ml Optiphase Hisafe 
name of agent effect dilution vehicle
monensin (Sigma-Aldrich) Na
+
-ionophore 0-70 µM ethanol
ionomycin (Tocris *) Ca
2+
-ionophore 0-1 µM DMSO
A23187 (Tocris *) Ca
2+
-ionophore 0-5 µM DMSO
thapsigargin (Tocris *) inhibitor of the SERCA pump 0-5 µM DMSO
bafilomycin A1 (Tocris *) inhibitor of vacuolar H
+
-ATPases 0-0.5 µM DMSO
ethylene glycol tetraacetic acid (EGTA, Sigma-Aldrich) Ca
2+
-chelator 0-2.5 mM water
U73122 (Sigma-Aldrich) inhibitor of PLCs 0-10 µM DMSO
CGP-37157 (Tocris *)
antagonist of the mitochondrial 
Na
+
/Ca
2+
 exchanger
0-5 µM DMSO
SKF-96365 (Tocris *) non-specific Ca
2+
-channel inhibitor 0-10 µM water
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3 (Perkin Elmer) was mixed with the content of the tubes and activity was measured 
with a MicroBeta
2
 scintillation counter (PerkinElmer, Waltham, MA, USA). 
A modified IP-assay was also conducted to assess phospholipid-turnover in stably 
transfected Neuro-2a cells. Cells were seeded into 14 cm diameter dishes at a density 
to yield ~ 70-80% confluence the next day. After 24 hours, medium was changed to 
serum- and inositol-free DMEM containing 1 μCi/ml myo-D-[3H]inositol. On the 
third day, cells were trypsinised and counted with a Z1 Coulter particle counter 
(Beckman Coulter, Brea, CA, USA). Cells were harvested by centrifugation and 
resuspended to equal cell density in Buffer A containing 140 mM NaCl, 20 mM 
HEPES, 8 mM glucose, 4 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 1 mg/ml BSA. 
Equal numbers of cells (5 x 10
5
) were split into tubes, containing 1 ml final volume 
of Buffer A with 10 mM LiCl and were incubated for 1 hour. Cells were harvested 
by centrifugation at 800 rpm and medium was changed to fresh Buffer A with LiCl 
containing 5 µM A23187 or its vehicle (DMSO). Incubation was terminated by the 
addition of a final 10 mM formic acid and cell debris was removed by centrifugation 
at 5,000 rpm for 3 minutes. The rest of the assay was conducted as described above. 
2.2.4. Permeabilisation of COS-7 cells to Ca
2+
 
To investigate the Ca
2+
-sensitivity of wild type and mutant PLCη2, the encoding 
plasmids were transiently transfected into COS-7 cells which were permeabilised in 
the presence of various free Ca
2+
 concentrations. Cells transfected by electroporation 
were transferred into 14 cm diameter dishes containing 25 ml complete DMEM and 
were treated with myo-D-[
3
H]inositol as previously described. On the third day, cells 
were trypsinised and washed once in 50 ml Buffer 1 (/ construct) containing 145 mM 
NaCl, 5.6 mM KCl, 5.6 mM glucose, 15 mM HEPES, 0.1 % BSA, pH 7.4. Cells 
were harvested by centrifugation at 1500 rpm, at 4
o
C for 3 minutes and the pellet was 
resuspended in 50 ml Buffer 2 containing 20 mM PIPES (K
+
 salt), 129 mM 
glutamate (K
+
 salt), 5 mM glucose, 5 mM ATP, 5.31 mM MgCl2, 5 mM EGTA, 
10 mM LiCl, 0.1% BSA, pH 6.6. At this point, cell number was counted and the cells 
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were harvested with centrifugation again. The pellets were resuspended in Buffer B 
to equal cell densities. One ml of each cell suspension was permeabilised by their 
exposure to 5 discharges of 3 kV/cm
3
 at both +ve and –ve polarities using a custom-
made device as previously described (Guild 1991). Suspension was aliquoted (40 µl) 
into eppendorf tubes containing 960 µl Buffer 2 and various free concentrations of 
Ca
2+
 in equilibrium with 5 mM EGTA (Table 2.4, Portzehl et al. 1964). Cell 
suspensions were incubated at 37ºC for 2 hours. The incubation was terminated by 
the addition of formic acid in a final concentration of 10 mM. Cell debris was 
removed by centrifugation at 5,000 rpm for 3 minutes. One 800 µl of supernatant 
was transferred onto Dowex AG 1- resin and the [
3
H]inositol phosphate release assay 
were performed as described before. 
[CaCl2] (mM) [MgCl2] (mM) Free [Ca
2+
] logM 
0 5.31 - 9 
0.020 5.30 - 8 
0.197 5.30 - 7 
1.460 5.29 - 6 
4.050 5.25 - 5 
5.159 5.10 - 4 
7.340 4.11 - 3 
Table 2.4.: Concentrations of CaCl2 and MgCl2 required to obtain various 
concentrations of free Ca
2+
 in equilibrium with 5 mM EGTA. 
2.2.5. Dual-Luciferase reporter assay 
Dual luciferase assay was conducted in order to measure retinoic acid stimulated 
gene-transcription in stably transfected Neuro-2a cells. Luciferase reporter vectors 
(Figure 4.16.) were obtained from SABiosciences (Qiagen Ltd., Crawley, UK). Two 
plasmids were transfected simultaneously; one containing an inducible firefly 
luciferase gene under the regulation of the retinoic acid responsive element (RARE, 
sequence: AGGTCACCAGGAGGTCA), and one encoding the constitutive 
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expression of the Renilla luciferase. This latter was used as an internal control of 
transfection efficiency. On the first day of the experiment, equal numbers of cells 
(5 x 10
4
/well) were seeded onto a 96-well plate in antibiotics-free medium. Twenty-
four hours later, transfection mixture was prepared as follows (calculated for each 
well): 100 ng plasmid mixture was diluted with 25 µl Opti-MEM and in parallel 
0.3 µl Lipofectamine 2000 was also mixed with 25 µl Opti-MEM. These were 
incubated for 5 minutes and then pooled together to be further incubated for 
30 minutes. The 50 µl transfection solution was added to the medium dropwise. The 
medium was changed 6 hours later to antibiotic- and serum-free EMEM. Cells were 
treated with retinoic acid or DMSO for 4 hours the next day. To terminate the 
treatment, cells were washed once with PBS. Cells were lysed by the Passive Lysis 
Buffer (20 µl) of the Dual Luciferase Reporter Assay Kit (DLRA, Promega, 
Southampton, UK) for 15 minutes. This kit also provides the materials required for 
the rest of the luciferase assay. Samples were stored at -20
o
C until further analysis. 
DLRA was conducted step-wise by the manual addition of the reagents and the 
activity was read out by a Fluostar Optima plate reader (BMG Labtech, Ortenberg, 
Germany). The DLRA is supplied with two substrates to allow the subsequent 
measurement of the activities of both luciferases in the same lysate. The reaction of 
the firefly luciferase gives a stable luminescent signal when 100 µl Luciferase Assay 
Reagent II is added to the 20 µl cell lysate. After the appropriate measurement of the 
signal, it is quenched by the Stop & Glo reagent which contains a different substrate 
for the Renilla luciferase. Activity was measured by a 2-second pre-measurement 
delay and a continuous measurement for 10 seconds. Triplicates were used in all 
experimental conditions.   
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2.3. Molecular biology methods 
2.3.1. RNA and DNA isolation, analysis and modification 
2.3.1.1. RNA isolation  
RNA work was routinely preceded by the cleaning of the lab surfaces and pipettes as 
well as the illumination of pipettes with UV light to avoid RNAse contamination. 
RNA was extracted by the Isolate RNA Mini Kit (Bioline, London, UK) according to 
the manufacturer`s instructions. RNA concentration was measured by a NanoVue 
spectrophotometer (GE Healthcare) at 260 nm and purity was tested with the 
260 nm/280 nm ratio. RNA was kept at -80
o
C until further analysis.  
2.3.1.2. DNA digestion and Reverse Transcription (RT) 
DNA contamination was removed by DNAse digestion (RQ1 RNase-Free DNase, 
Promega, Southampton, UK) in accordance with the manufacturer`s instructions. 
Half µg of digested RNA was subjected to a two-step RT reaction. First the RNA 
was incubated with 100 pmol oligodT18 and 0.5 mM dNTP (when in the final 20 µl, 
Fermentas, St. Leon-Rot, Germany) in 14.5 µl (completed with DEPC-treated water) 
at 65
o
C for 5 minutes and then chilled on ice. Next, 200 units of RevertAid Premium 
Reverse Transcriptase, 20 u Thermo Scientific RiboLock RNase Inhibitor and 1x 
RT-buffer (Fermentas) was added. Tubes were incubated at 50
o
C for 30 minutes, at 
60
o
C for 10 minutes and the reaction was terminated by heating up the samples to 
85
o
C for 5 minutes.  
2.3.1.3. Conventional (semi-quantitative) Polymerase Chain 
Reaction (PCR) 
One µl of the RT sample was subjected to PCR analysis with the addition of 
1.25 units GoTaq polymerase, 1× buffer, 1.5 mM MgCl2 (Promega), 0.2 mM dNTPs 
(Fermentas) and 250 nM of each primer. Cycling profile was: 95
o
C for 15 s, 60
o
C for 
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30 s and 72
o
C for 1 min, preceded by a 2-minute enzyme activation at 95
o
C. Primers 
used throughout the thesis for PCR analysis are listed in Table 2.5.  
 
Table 2.5.: Primer sequences used for RT-PCR. FW: forward, RW: reverse. 
2.3.1.4. Quantitative PCR (qPCR) 
Gene-expression levels were accurately measured by qPCR relative to the level of 
the large ribosomal protein P0 (RLP0) mRNA with Brilliant III Ultra-Fast SYBR 
Green mix (Agilent Technologies, Cheshire, UK). Each reaction contained cDNA 
product of 5 ng RNA, 250 nM of each primer, 1x qPCR mix and RNAse free 
ultrapure water in 20 µl. PCR was conducted in a Rotor-Gene Q PCR machine 
(Qiagen, Crawley, UK). Parameters were: 95
o
C for 3 min., and then 40 cycles of 
95
o
C for 5 s and 60
o
C for 20 s. PCR product was analysed by adding a melting curve 
at the end of the qPCR program (temperature gradient between 50
o
C and 99
o
C). 
Expression levels were calculated by the ΔΔCt method (Livak and Schmittgen 2001). 
Primer Sequence
RARα FW 5`-CACTTTTGCAGAGCGCGGTGCGG-3`
RARα RW 5`-GCGTTTGCTGGTGATGAAGACGTGGC-3`
RARβ FW 5`-GGAAGGAGAAGGCAGTGACTCTGTGG-3`
RARβ RW 5`-CGGTGCTGCCATTCGGCCTGG-3`
RARγ FW 5`-GCGGAGTCAGTGTGCGGTTTGGG-3`
RARγ RW 5`-GGTCTCGGGGATGGAGCACCGC-3`
RPL0 FW 5`-GAGTGATGTGCAGCTGATAAAGACTGG-3`
RPL0 RW 5`-CTGCTCTGTGATGTCGAGCACTTCAG-3`
PLCɳ2 FW 5`-GGCTACACTCTGACCTCCAAGATCC-3`
PLCɳ2 RW 5`-GGAAGCATGGTGGCATCTTCGCTGC-3`
21a FW 5`-GGCCCCTACTCAAGAGAGGTCAGG-3`
21b FW 5`-CCTGCCAGCCGGAGGGTGC-3`
21c RW 5`-GCATGCCAGGTGTAGAGAGCATGGG-3`
22 RW 5`-GGCACTCGCAGGTCTCAATCCC-3`
23 RW 5`-CTGGGAGCTGGTCACTTTGGCTCC-3`
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2.3.1.4. Agarose Gel Electrophoresis 
PCR products were analysed on agarose gels composed of 1% or 2% (w/v) agarose, 
melted in Tris-acetate/EDTA-buffer (TAE-buffer, from 40 mM Tris acetate and 
1 mM EDTA). SyberSafe dye was added to the melted agarose which enables the 
detection of DNA in the gel. Gel was left to set and then was transferred into an 
electrophoresis tank containing TAE-buffer. Samples were prepared with a gel 
loading dye and Hyperladder I DNA-ladder was also loaded at least in one lane 
(Bioline). Gels were run at 150 V for as long as required for the separation of bands. 
DNA was visualised in a Gel Doc XR+ Imager and analysed using an Image Lab 2.0 
software (Bio-Rad Laboratories, Inc.). 
2.3.1.5. Purification of DNA-bands from agarose gels 
DNA was visualised by a Blue Light Transilluminator (Life Technologies) and DNA 
bands were excised by sterile blades. DNA was purified by the QIAquick Gel 
Extraction Kit (Qiagen) from the gel block according to the manufacturer`s protocol. 
Purified DNA was eluted in 30 µl of sterile water.  
2.3.1.6. Digestion with restriction endonucleases 
Digestion of DNA by restriction enzymes was used as a diagnostic tool to detect the 
presence of the correct insert in vectors or to generate compatible overhanging DNA 
ends for cloning. All enzymes were obtained from New England Biolabs (NEB, 
Ipswich, MA, USA) and were supplied with their compatible buffer. As a general 
protocol, 1 µg of DNA was mixed with 2 units of enzyme, 2 µg BSA and 1x buffer 
in a final volume of 20 µl completed with sterile water. Double digestion was 
conducted in a buffer which was optimal for both enzymes. When needed, restriction 
enzyme was inactivated by incubating the reaction at 65 
o
C for 20 minutes.  
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2.3.1.7. Molecular cloning 
The human LIMK1 plasmid fused to a c-myc tag on the C-terminus and cloned into 
pcDNA3.1 was kindly provided by Prof. Michael Olson (Beatson Institute, Glasgow, 
UK). The 75–1238 residues of mouse PLCη2 (isoform a; NP_780765) cloned into 
pcDNA3.1 was a gift from Prof. Kiyoko Fukami (Tokyo University of Pharmacy and 
Life Science, Japan). The mCherry-conjugated PLCδ1 PH domain in pmCherry-C1 
vector (Clonetech, Saint-Germain-en-Laye, France) was provided by Dr. Alexander 
Gray (College of Life Sciences, University of Dundee, UK). GFP-tagged constructs 
(GFP-PLCη2, GFP-ΔPH-PLCη2 and GFP-PH- PLCη2) were cloned by the insertion 
of sequences into pcDNA3.1/NT-GFP-TOPO vector (Life Technologies) using the 
TA-cloning method according to the manufacturer`s instructions. Briefly, desired 
insert sequences were amplified by Taq polymerase which encompasses a terminal 
transferase activity linking a single deoxyadenosine to the 3` ends of PCR products. 
Reactions were run on agarose gels and DNA was gel purified as described before. 
One µl of the purified DNA was mixed with a ligation mixture containing 1 µl salt 
solution, 1 µl vector (10 ng) and 2 µl sterile water. Mixture was incubated for 5-
30 minutes. During this time, PCR products are integrated by joining to the 
overhanging 3´ deoxythymidine residues in the vector.  
PH-lacking PLCη2 (ΔPH-PLCη2) was cloned into pcDNA3.1 (Life Technologies) 
vector by directional cloning in accordance with the manufacturer`s instructions. 
Briefly, sequence encoding residues 228–1238 of PLCη2 was amplified by a forward 
primer providing the addition of the CACC sequence and the start codon (ATG) onto 
the 5` end and a reverse primer linking a stop codon at the 3` end. PCR was 
conducted by a proofreading DNA polymerase (Velocity DNA polymerase, Bioline) 
according to the manufacturer`s protocol. Reactions were analysed on agarose gels 
and gel purified as described before. One µl of the purified DNA was mixed with a 
ligation mixture containing 1 µl salt solution, 1 µl vector (10 ng) and 3 µl sterile 
water. Mixture was incubated for 5-30 minutes. The amplified sequence integrates 
into the plasmid by annealing to the GTGG 3` overhang on the reverse strand.  
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The GST-tagged PLCη PH domains were generated by inserting sequences 
corresponding to residues 14-137 and 115-238 of PLCη1 and PLCη2, respectively 
into the bacterial expression vector, pGEX6 using EcoRI and NotI restriction sites. 
Cloning was conducted by Dr. Alan Stewart.  
Ligation mixtures were transformed into E. coli in all cases as in section 2.3.1.9. The 
full-length sequences of the inserts were verified by sequencing, conducted at the 
Dundee Sequencing Service, Dundee, UK. 
2.3.1.8. Site-directed mutagenesis 
Point-mutations in PLCη2-sequence integral to plasmids pcDNA3.1 and 
pcDNA/NT-GFP were generated by QuikChange II XL Site-Directed Mutagenesis 
Kit (Agilent Technologies) according to the manufacturer`s instructions. The kit 
contains a proofreading DNA polymerase (PfuTurbo) and buffer composition 
allowing the enzyme to amplify the whole plasmid with primers containing the 
desired mutation during PCR cycles. Amplification is followed by a digestion of the 
parental plasmid DNA by DpnI restriction enzyme which targets methylated DNA. 
Mutations were verified by sequencing as previously.  
2.3.1.9. Transformation of vectors into E. coli 
One to four µl of the ligation mixture was transformed into 50 µl Alpha-select 
chemically competent cells (Bioline) by heat shock according to the manufacturer`s 
protocol. This was followed by the addition of SOC medium (Bioline) and its 
subsequent incubation at 37
o
C for 1 hour and shaking at 210 rpm. The whole mixture 
was spread on agar plates contaning the appropriate antibiotic resistance (100 μg/ml 
ampicillin). Plates were incubated at 37
o
C overnight and positive clones were 
isolated the next day. Stocks of the transformed bacteria were made by mixing 
800 µl of an overnight culture with 200 µl glycerol in cryovials. Tubes were stored at 
-80
o
C. 
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2.3.1.10. Isolation of plasmid DNA 
Single-cell derived colonies or a small portion of glycerol stocks were used as the 
source to grow E.coli in 5 ml terrific broth (TB, Sigma-Aldrich) overnight (for 
miniprep) or in 1 ml Luria broth (LB, Sigma-Aldrich) for 6-8 hours from which 
100 µl was transferred into 200 ml LB for overnight incubation (for maxiprep). 
Cultures were shaken at 220 rpm and 37
o
C. Plasmids were isolated by the Plasmid 
MiniPrep Kit I for diagnostic procedures, or by the Endofree Plasmid Maxi Kit for 
transfection of mammalian cells according to the manufacturer`s instructions 
(Biomiga, San Diego, CA, USA). Plasmid DNA was stored at -20
o
C.  
2.3.2. Protein analysis 
2.3.2.1. Western-blot analysis 
Cells in a 6-well plate were washed two times with PBS and were scraped in 50-
100 µl RIPA buffer (150 mM NaCl, 2 mM EDTA, 1% IGEPAL CA-630, 0.1% SDS 
in 50 mM TrisHCl, pH 7.4 with protease inhibitor, Roche, Burgess Hill, UK) 
depending on the cell density. During this procedure plate was kept on ice. Cell 
lysates were spun at 14,000 rpm in a JA-18.1 rotor (Beckman-Coulter) for 
10 minutes to remove cell debris. To generate membrane enriched fractions, cells 
were scraped in RIPA buffer free of NP-40 and SDS. This was homogenised and 
spun at 14.000 rpm (JA-18.1) for 10 minutes. Pellet was washed once with the 
modified RIPA buffer, centrifugated and was resuspended in complete RIPA buffer.  
When it was required, protein concentration was measured by the BCA protein assay 
kit (Thermo Fisher Scientific) according to the manufacturer`s protocol. Protein 
samples were prepared with gel running buffer (final concentrations: 50 mM Tris–
HCl, 10% glycerol, 2% SDS and 0.1 M DTT, 0.01% bromophenol blue, pH 6.8). 
Samples were incubated at 95
o
C for 10 minutes before loaded onto NuPAGE precast 
polyacrylamide gradient gels (4–12% Bis–Tris). The Hyperpage prestained protein 
marker was used as a reference for protein mass (Bioline). Samples were separated at 
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150 V for 1 hour to 1.5 hours in a MES buffer system (SDS-PAGE, Life 
Technologies). 
Proteins were transferred onto PVDF membranes (GE Healthcare) in NuPage 
transfer buffer (Life Technologies, supplemented with 0.01% SDS and 11% 
methanol) at 30 V for 75 minutes. Before and following the transfer, membranes 
were treated with methanol for 2×5 minutes. Blots were incubated in blocking buffer 
(5% non-fat milk in TBS, for 1 hour) and in 1% non-fat milk and 0.5% Tween-20 in 
TBS for 1.5 hours containing primary antibody. Primary antibodies used in the thesis 
were: goat polyclonal anti-PLCη2 antibody (1:250 dilution; Santa Cruz 
Biotechnology, Heidelberg, Germany), rabbit polyclonal anti-PLCη2 antibody 
(1:5000 dilution; custom), mouse polyclonal anti-LIMK1 or rabbit anti-phospho-
LIMK1 (Thr508) antibodies (1:1,000 dilution; Abcam), rabbit anti-CREB or anti-
phospho-CREB (Ser133) antibodies (1:1,000 dilution; Cell Signaling Technology, 
Danvers, MA, USA) and mouse monoclonal anti-β-actin antibody (1:10,000 dilution; 
Sigma-Aldrich). The incubation was followed by three washing steps with TBST 
(TBS containing 0.5% Tween). Secondary antibodies were diluted in blocking buffer 
containing 0.5% Tween (1:10,000 dilution) which was added to the blots for 
1.5 hours at room temperature. Blots were then washed 3 times in TBST for 
15 minutes each. Two types of species-specific secondary antibodies were used. 
Alkaline phosphatase (AP)-linked secondary antibodies (anti-mouse, anti-rabbit and 
anti-goat) were used in combination with a colorimetric detection whereby the AP 
catalysed the diversion of the substrate (Western Blue Stabilized Substrate, Promega) 
into a purple product which was detected after drying the membrane. Otherwise, 
blots were incubated with horseradish peroxidase-conjugated antibodies (1:10,000 
dilution; Thermo Fisher Scientific) and antibody-binding was detected by the 
SuperSignal West Dura chemiluminescent substrate (Thermo Fisher Scientific) with 
an LAS-3000 phosphoimager (Fujifilm, Düsseldorf, Germany). Densitometry was 
performed using ImageJ software (NIH, Bethesda, MD, USA). 
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2.3.2.2. Purification of GST-tagged PH domains 
The pGex6 plasmids containing PLCη1 and PLCη2 PH domains were transformed 
into chemically competent E.coli strain BL21 (kindly provided by Dr. Jo Parish, 
College of Medical and Dental Sciences, University of Birmingham) by heat shock 
and plated as described earlier. A single colony from each was transferred into 5 ml 
LB and was incubated overnight at 37
o
C with shaking at 250 rpm. From this culture, 
2 ml was transferred into 100 ml LB and was incubated until the OD600 reached 0.7-
0.9 (approx. 2.5-3 hours). At this point, IPTG was added in a final concentration of 
0.1 mM and protein expression was induced for an additional 2.5 hours. Bacteria 
were harvested in 50 ml centrifugation tubes at 2,500 rpm for 10 minutes at 4
o
C in a 
JS.4.2 rotor. Pellets were resuspended in 10 ml GST-binding buffer containing 
25 mM Tris pH 7.5, 150 mM NaCl, 1mM EDTA and protease inhibitor cocktail 
(Roche). Triton X100 was mixed in a final 0.5% to lyse the cells and the tubes were 
transferred to -80
o
C for 2 hours. Cells were then thawed and sonicated. Remaining 
cell debris was removed by high-speed centrifugation at 10,000 rpm in a JA-20 rotor 
(Beckman Coulter). Supernatants were collected into a 50 ml tube and 500 µl of 50% 
glutathione-linked agarose beads (in GST binding buffer) were added. This was 
incubated for 2 hours at 4
o
C with mixing. Beads were collected at 1,000 rpm for 1 
minute and were washed with 20 ml GST-binding buffer. This was repeated once. 
The agarose slurry was then transferred into 1.5 ml microcentrifuge tubes, beads 
were pelleted by a quick spin and the remaining of the liquid phase was discarded. 
Proteins were eluted by 500 µl Elution buffer containing 10 mM reduced glutathione, 
50 mM Tris-HCl and 5 % glycerol, pH 8.0 which was incubated for 15 minutes. 
Elution was repeated but eluates were not pooled. Purities of eluates were tested by 
SDS-PAGE followed by staining the whole protein content of the gel. This latter 
included the incubation of the gel with excess amounts of Coomassie staining 
(0.003% Coomassie brilliant blue-R, 50% methanol and 10% acetic acid) for 
30 minutes followed by two washes in ultrapure water and repeated incubation in de-
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stain solution (40% methanol and 10% glacial acetic acid in ultrapure water). Gel 
was photographed in the Gel Doc XR+ Imager (Bio-Rad Laboratories, Inc.). 
2.3.2.3. Förster resonance energy transfer (FRET)-based detection of 
protein-lipid interactions 
The assay was conducted by Dr. Alexander Gray (College of Life Sciences, 
University of Dundee, UK) similarly as described before (Gray et al. 2003). Briefly, 
PLCη-PH domains (14 μl of 0.62 mg/ml) were mixed with 4 μl APC-streptavidin 
(2 mg/ml, Prozyme Ltd. Hayward, CA, US), 80 μl Eu-anti-GST (80 μg/ml) (Perkin-
Elmer) in 2.5 ml assay buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM 
MgCl2, 5 mM DTT, 0.05% Chaps). The assay was conducted in a 96-well format as 
follows: 25 μl of the assay mixture were added to the same volume of biotinylated 
lipids (elevating concentrations of 0-50 pmol in final volume) and the association of 
biotinylated phosphoinositide/PH domain complexes were measured in an LJL 
Analyst microplate reader. In addition displacement of GST-PLCη2 PH was also 
measured with the addition of elevating concentrations of phosphoinositides. 
PI(4,5)P2-PH domain sensor complexes were developed by mixing 4 μl (2 mg/ml) 
Streptavidin APC, 200 pmol biotin PI(4,5)P2, 14 μl (0.62 mg/ml) PH domain and 
50 μl Eu-anti GST (80 μg/ml) in 2.5 ml assay buffer. Complexes were dissociated by 
the addition of serially diluted non-biotinylated phosphoinositides.  
2.3.2.4. Detection of protein-lipid interactions by lipid-adsorbed 
membranes (PIP strips) 
Membranes pre-adsorbed with phospholipids; lysophosphatidic acid, 
lysophosphocholine, phosphatidylinositol, phosphatidylinositol 3-phosphate, 
phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, 
phosphatidylethanolamine, phosphatidylcholine, sphingosine 1-phosphate, 
phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate, 
phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol trisphosphate, 
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phosphatidic acid and phosphatidylserine were obtained from Echelon Biosciences 
Inc. and were processed according to the manufacturer`s instructions. Briefly, 
membranes were blocked and then incubated by the addition of purified GST-PH 
domains in the concentration of 0.5 µg/mL in 3% BSA and 0.1% Tween-20 in 
phosphate-buffered saline (PBS). This was followed by two incubation steps with a 
monoclonal mouse-anti-GST (Sigma-Aldrich) and anti-mouse HRP-linked secondary 
antibodies diluted in the same buffer, respectively. Antibody-binding was detected 
by the SuperSignal West Dura chemiluminescent substrate in the LAS-3000 
phosphoimager.  
2.3.2.5. Identification of protein-protein interactions by bacterial 
two-hybrid screen 
The BacterioMatch II Two-Hybrid System (Agilent) was used to identify interaction 
partners for PLCη2 C-terminal domain in accordance with the manufacturer`s 
instructions. The cDNA corresponding to the C-terminal domain of PLCη2 splice 
variant 21a/22/23 (residues 967-1070) was cloned into the pBT bait vector (work 
was conducted by Dr. Alan J. Stewart). This was co-transfected into the reporter 
E.coli strain with a human pancreas cDNA library encoded by the pTRG plasmid 
(cloned by Dr Kevin Morgan, MRC Human Reproductive Sciences Unit, Edinburgh, 
UK). When an interaction occurs between the C-terminal domain and the protein 
encoded by the pTRG vector, it allows the expression of the His3 and Aad3 genes in 
the reporter E. coli strain. That permits the bacteria to grow in the presence of 3-
aminotriazole (3-AT, an inhibitor of histidine synthesis) or streptomycin, which are 
used for selection of interaction partners. The pBT and pTRG plasmids were co-
transformed into reporter cells according to the manufacturer’s protocol. 
Transformed cells were spread onto plates containing 5 mM 3-AT and growing 
colonies were transferred onto dual-selective plates containing 5 mM 3-AT and 
12.5 μg/ml streptomycin. The plasmids were isolated from a single colony-derived 
culture, and sequenced to identify the interaction partner using NCBI-BLAST.  
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2.3.2.6. Myc-tag co-immunoprecipitation (pull-down) 
Experiment was conducted by using the Pierce Mammalian c-Myc Tag IP/Co-IP Kit 
(Thermo Fisher Scientific) in accordance with the manufacturer`s instructions. 
Vectors, expressing PLCη2 and myc-tagged LIMK1 were transfected into COS-7 
cells by electroporation as previously. As controls, cells transfected with only one of 
the constructs were used. Transfected cells were seeded onto 6-well plates. After two 
days, cells were washed twice with TBS and lysed with the Mammalian Protein 
Extraction Reagent of the kit, by adding 200 µl to each well of 5 wells. One well of 
cells was scraped and collected in RIPA buffer for the subsequent detection of the 
expression levels of transfected proteins by Western blot. Other wells were pooled 
together, prepared as suggested by the protocol and protein concentration was 
measured by the BCA protein assay kit (Thermo Fisher Scientific). From each 
transfection, 500 µg of protein was added to 5 µg antibody-linked agarose slurry. 
This was incubated overnight and protein complexes were purified and eluted the 
next day according to the manufacturer`s instructions. Proteins were detected by 
Western blot. 
2.4. Statistical analysis 
Experiments were repeated independently at least three times and all assays were 
performed in triplicate. Data are presented as mean values ± the standard error of the 
mean (SEM). Three levels of statistical significance were used according to the 
confidence values: p<0.05, p<0.01 or p<0.001, which were indicated by asterisks in 
figures. Analyses were performed using the SigmaPlot software (Systat Software Inc, 
Chicago, IL, USA) with one-way ANOVA followed by the Holm-Sidak post hoc test 
or Student`s t-test depending on the type of the experiment. 
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3.1. Introduction 
Following the identification of PLCη2 the general attention was focused on the 
characterisation of its enzyme activity. Nakahara et al. generated GST-tagged PLCη2 
using a baculovirus/Sf9 cell expression system in parallel with GST-PLCδ1 
(Nakahara et al. 2005). These proteins were treated with various amounts of Ca
2+
 in a 
reaction mixture containing reconstituted membranes composed of 
phosphatidylethanolamine, PI(4,5)P2 and [
3
H]PI(4,5)P2. The reaction was followed 
by the measurement of [
3
H]I(1,4,5)P3 accumulation. Although the threshold for Ca
2+
 
activation of recombinant PLCη2 was 10-fold lower than that of PLCδ1, its maximal 
rate of PI(4,5)P2 hydrolysis was measured at much smaller values (~10-fold) (at any 
concentrations of Ca
2+
) (Nakahara et al. 2005). Reduced enzymatic activity of 
PLCη2 might be due to the lack of essential factors that are required for effective 
hydrolysis and are normally found in the cell. One of those factors might be the 
presence of membranes with physiological phospholipid content that might be 
required for the efficient docking of the enzyme. A primary aim of this Chapter is to 
therefore study the activation of the enzyme in a cellular context. The overexpression 
of PLCη2 in COS-7 cells offered an excellent tool for this purpose. 
PH domains of PLCs are important for membrane targeting and possess different 
sensitivities towards phospholipids (Singh and Murray 2003). This latter feature 
might be of unique importance in determining subcellular localisation of PLCη2. In 
this Chapter, the importance of the PH domain for membrane binding as well as its 
lipid-binding specificity is assessed. A secondary, Ca
2+
-dependent binding of the 
membrane by the C2 domain is crucial for optimal phospholipase activity in PLCδ1 
(Grobler et al. 1996). The importance of the C2 domain in PLCη2 was therefore also 
examined by site-directed mutagenesis.  
PLCζ was previously demonstrated to contain a functional EF-hand which is unique 
among PLCs. This domain provides the structural background for sensing Ca
2+
 in the 
nanomolar levels. The sperm-specific PLCζ uses this exceptional feature to evoke 
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Ca
2+
 transients upon its transfer to the oocyte during fertilisation (Kouchi et al. 2005; 
Nomikos et al. 2011a). High Ca
2+
-sensitivity of PLCηs inspired the examination of 
the molecular properties of its EF-hand and to evaluate the Ca
2+
-binding properties 
of this domain also by site directed mutagenesis studies. 
3.2 Characterisation of PLCη2 Ca2+-activation 
3.2.1. PLCη2 is activated by monensin 
PLCη2 was expressed in COS-7 cells as described in Materials and Methods. This 
particular cell line was selected for two main reasons. Firstly, COS-7 cells are often 
used as mammalian cellular models for expression studies due to their high 
transfection rate by electroporation (Parham et al. 1998). In addition, COS-7 cells 
possess no endogenous PLCη2 expression and therefore adequately report the 
differences upon their transfection with the PLCη2-encoding vector (Stewart et al. 
2007). Numerous agents were used known to increase intracellular Ca
2+
 levels 
through different mechanisms (monensin, ionomycin, A23187, thapsigargin and 
bafilomycin, Figure 3.1.). Empty vector transfected cells were used as controls in all 
experiments. Monensin is a Na
+
/H
+
 antiporter which was previously shown to 
activate Na
+
/Ca
2+
 exchangers to remove the excess Na
+
 from the cell and 
consequently increase intracellular Ca
2+
 level (Wang et al. 1999). Ca
2+
 transients 
evoked by this mechanism greatly stimulated PI(4,5)P2 hydrolysis in PLCη2-
expressing cells (~6-fold, p<0.001, one-way ANOVA, Figure 3.1a) at maximal 
monensin-concentration (70µM). Treatment of a 10-fold lower concentration also 
resulted in a significant, ~2.8-fold upregulation of phospholipid turnover (p<0.01, 
one-way ANOVA). A slight increase (less than 55% of the untreated control) in 
PI(4,5)P2 hydrolysis was observed in empty vector transfected cells possibly due to 
the activation of the endogenous PLC-pool. Next the effects of the Ca
2+
-ionophores, 
ionomycin and A23187, were investigated (Figure 3.1b and 3.1c). Unexpectedly, 
none of the agents significantly increased PI(4,5)P2 hydrolysis in PLCη2 expressing 
cells relative to the empty vector containing cells (one-way ANOVA). A small 
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difference between PLCη2 and empty vector transfected cells was observed when 5 
µM A23187 was used, however as stated above this was not significant. Potency of 
these drugs to stimulate PLC-activity is implicated by the dose-dependent activation 
of endogenous PLCs in the empty vector transfected cells.  
 
Figure 3.1.: The effects of various Ca
2+
-mobilising agents on PI(4,5)P2 hydrolysis in 
COS-7 cells transfected with PLCη2. Cells were treated with monensin (0-70 µM, 
A), ionomycin (0-1 µM, B), A23187 (0-5 µM), thapsigargin (0-5 µM, D) or 
bafilomycin (0-500 nM, E) for 3 hours. Empty vector transfected cells were used to 
detect the activity of the endogenous PLCs of COS-7 cells. All agents stimulated 
phospholipid-turnover in a dose-dependent manner in the control cells. However, 
only the Na
+
/H
+
 antiporter monensin induced a significant elevation in PLCη2-
transfected cells compared to the activity in the control cells. A representative 
western blot shows (F) that PLCη2 is only expressed in transfected cells. Blot was 
probed with PLCη2 (PLCη2-AB) and β-actin antibodies (β-actin-AB). Error bars 
represent ± S.E.M. (one-way ANOVA, p<0.05:*, p<0.01:**, p<0.001:***, n=3). 
Figure is reproduced with permission from Elsevier (Popovics et al. 2011). 
The highest concentration of ionomycin (1 µM) induced a ~65% increase whereas 
5 µM A23187 elevated PI(4,5)P2 hydrolysis by 3-fold in empty vector transfected 
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cells. Thapsigargin is a well-defined inhibitor of SERCA which prevents the Ca
2+
-
uptake to the ER/SR leading to its Ca
2+
-depletion (Sagara and Inesi 1991). Although 
thapsigargin increased basal PLC activity to some extent (~30% at 5 µM), PLCη2-
expressing cells showed no significantly different rate of [
3
H]inositol phosphate 
accumulation. Bafilomycin (A1) is a potent stimulator of lysosomal Ca
2+ 
release. 
This is directed by its inhibitory effect on the vacuolar H
+
-pump leading to increased 
pH. Alkalinisation mobilises Ca
2+
 previously bound to proteins of the lysosome and 
the consequent increase in free lysosomal Ca
2+
 triggers a transient Ca
2+
-release from 
the organelle (Camacho et al. 2008). However, bafilomycin had no significant 
stimulatory effect upon PLCη2 activity in the transfected COS-7 cells. The lack of 
the effects of the Ca
2+ 
ionophores ionomycin and A23187 on PLCη2 activity raises 
the possibility that it is not directly activated by the monensin-induced Ca
2+
 rise – 
rather it could be induced by non-direct, Ca
2+
-dependent processes. The following 
experiments were designed to provide evidence that the monensin-induced changes 
in PLCη2 activity are clearly Ca2+-dependent.  
3.2.2. Monensin-induced activation of PLCη2 is directed by Ca2+ 
Monensin-induced activation of PLCη2 was further investigated by applying various 
agents that affect PLC activity or intracellular Ca
2+
 level (U73122, EGTA, SKF-
96365 and CPG-3757) during the treatment of the maximal concentration of 
monensin (70 µM). Firstly, the non-PLC specific inhibitor, U73122 was used to 
verify that the stimulation of inositol phosphate release is dependent on PLC activity 
in both empty vector and PLCη2-transfected cells. This inhibitor strongly reduced 
the phospholipid turnover in both conditions in a dose-dependent manner (Figure 
3.2a, p<0.01 and p<0.001 at 1 and 10 µM, one-way ANOVA).  
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Figure 3.2.: Inhibition of monensin-induced PI(4,5)P2 hydrolysis in PLCη2-
transfected COS-7 cells by various inhibitors. Cells were treated simultaneously with 
70 µM monensin and elevating concentrations of the inhibitors: U73122 (0-10 µM, 
A), EGTA (0-2.5 mM, B), SKF-96365 (0-10 µM, C) and CPG-3757 (0-5 µM, D). In 
one experiment two inhibitors were administered simultaneously (SKF-96365 and 
CPG-3757, E). Black bars show the endogenous phospholipase activity in empty 
vector- and white bars in PLCη2-transfected cells. Error bars indicate ±S.E.M. 
Statistical significance of inhibition is shown relative to monensin-induced PLCη2 
transfected cells (one-way ANOVA, p<0.05:*, p<0.01:**, p<0.001:***). Figure is 
reproduced with permission from Elsevier (Popovics et al. 2011). 
In the following experiment, to demonstrate that the action of monensin is clearly 
dependent on Ca
2+
, a specific chelator (EGTA) was used. EGTA decreased the 
monensin-induced stimulation of PI(4,5)P2 hydrolysis in a concentration-dependent 
manner to reach the control level at the highest dose (2.5 mM, p<0.001, one-way 
ANOVA, Figure 3.2.b). A non-selective Ca
2+
-channel inhibitor, SKF-96365 (Merritt 
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et al. 1990) also abolished the monensin-induced PLCη2 activity further indicating 
the Ca
2+
-dependence of this process. However, it has to be mentioned that in certain 
conditions SKF-96365 may inhibit off-target proteins and might affect the transport 
of other ions than Ca
2+
 (Rae et al. 2012). Interestingly, a selective inhibitor of the 
NCXmito, CPG-37157 (Cox et al. 1993) reduced inositol-turnover in PLCη2-
transfected cells to a similar extent (~40%, p<0.01, one-way ANOVA) to the 
maximal concentration of SKF-96365 (10 µM, p<0.001, one-way ANOVA). When 
the maximal concentration of SKF-96365 and CPG-37157 (10 µM and 5 µM, 
respectively) was applied simultaneously, only a slight additional reduction was 
administered in the [
3
H]inositol phosphate accumulation of the PLCη2-transfected 
cells (~50% total inhibition, p<0.001, one-way ANOVA). This suggests that a 
substantial extent of SKF-96365-inhibition is derived from its action on the NCXmito. 
Moreover, this leads to the observation that mitochondrial Ca
2+
-release –either 
directly or indirectly- is involved in the activation of PLCη2. 
3.2.3. PLCη2 is activated by physiological levels of Ca2+ in 
permeabilised COS-7 cells 
To determine the sensitivity of PLCη2 towards Ca2+, PLCη2-expressing COS-7 cells 
were permeabilised and were incubated for two hours in the presence of various free 
Ca
2+
 concentrations (with 10-fold dilution steps from 10
-3
 to 10
-9
M Ca
2+
). This was 
followed by the measurement of [
3
H]inositol phosphate release (Figure 3.3.). Empty 
vector-transfected cells were used as controls. PLCη2 activity displayed a strong 
increase between 0.1 and 1 μM free Ca2+. Maximal stimulation was acquired at 10-5 
M Ca
2+
. Endogenous PLC activity registered in empty vector-transfected cells only 
exhibited a slight elevation and reached maximal activation at 10
-4 
M Ca
2+
. This is 
consistent with the previous finding which examined the Ca
2+
-sensitivity of PLCη2 
and determined its maximal activity to be at ten-fold less Ca
2+
 concentration than that 
of PLCδ1 (Nakahara et al., 2005). It is noteworthy that above 10-4 M Ca2+ the activity 
of PLCη2 declines which event might suggest the presence of an inhibitory 
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mechanism and could have an important role in the regulation of PLCη2. This assay 
set up is used in further experiments to show alterations in Ca
2+
-sensitivity of PLCη2 
mutants. 
 
Figure 3.3.: Measurement of [
3
H]inositol phosphate release in permeabilised COS-7 
cells transfected with empty vector (dotted line) or PLCη2 (solid line) in the presence 
of various concentrations of free Ca
2+
. Results are expressed ± S.E.M, n=3.  
3.2.4.: Localisation of PLCη2 in COS-7 cells 
In section 3.2.2., monensin-induced PLCη2 activation was linked to mitochondrial 
Ca
2+
-release. This suggests that PLCη2 is localised to membranes which are in 
communicating distance from these organelles. To reveal the cellular localisation of 
PLCη2, two experiments were conducted. Firstly, an N-terminally tagged GFP-
construct of PLCη2 was generated by TA-cloning using the 1/NT-GFP-TOPO vector 
as described in Chapter 2. Cellular localisation of the GFP-fused PLCη2 was 
assessed in transfected COS-7 cells. Two days after transfection, cells were treated 
with a mitochondrial-specific fluorescent dye, mitotracker (Red CMXRos, Life 
Technologies) according to the manufacturer`s instructions. Upon entering the cell, 
the dye undergoes oxidation, accumulates in the mitochondria and reacts with thiol 
protein groups. These steps provide the chemical background for the development of 
fluorescence which is retained after fixation (Macho et al. 1996). Distribution of the 
GFP-PLCη2 protein was somewhat variable, usually manifesting as punctate staining 
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throughout the cell indicating its association to organelle membranes. Unexpectedly, 
it only partially co-localised with the mitochondrial staining (Pearson coefficient: 
0.4433, S.E.M.=0.0387, Figure 3.4., co-localisation is indicated by yellow colour on 
the merged image).  
 
Figure 3.4.: GFP-PLCη2 (green) possesses a low co-localisation rate with the 
mitochondria (red) in COS-7 cells. Transfected cells were treated with a 
mitochondrial marker (mitotracker) before fixation. Nuclei were stained with DAPI 
(blue). Images show little co-localisation of GFP-PLCη2 with mitochondria. This is 
supported by the co-localisation coefficient (0.4433, S.E.M.=0.0387, Pearson 
coefficient) calculated from 3 images. Images are representative and bars correspond 
to 5 µm. Images were taken by a Leica confocal system (TCP SP2). 
For the detection of PLCη2 intracellular localisation, the protein was tagged on its N-
terminus by GFP just before the PH-domain. Disturbance in target-binding and 
consequently in enzyme activity is a possible outcome when protein structure is 
altered by a fluorescent protein tag. Enzyme integrity of GFP-PLCη2 was assessed 
by measuring monensin-induced [
3
H]inositol-phosphate accumulation in transfected 
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COS-7 cells that was compared to wild-type PLCη2-expressing cells (Figure 3.5.). 
The GFP-tag highly reduced the PLC-activity which only reached a 2.3-fold 
elevation at maximal monensin concentration (70 μM).  
 
Figure 3.5.: Measurement of monensin-induced accumulation of [
3
H]inositol 
phosphate in COS-7 cells transfected with constructs encoding wild-type and GFP-
PLCη2. Empty vector transfected cells were used to detect the activity of the 
endogenous PLC activity. PLCη2 tagged with GFP on its N-terminus showed 
reduced activity compared to the untagged wild-type protein. Results are expressed ± 
S.E.M., n=3. 
To exclude possibility that the GFP-tag altered the targeting-specificity of the 
protein, exogenously expressed untagged-PLCη2 was labelled by immunostaining 
(Figure 3.6.). Untagged-PLCη2-overexpressing COS-7 cells were again treated with 
mitotracker red, fixed, permabilised and probed with a rabbit antibody against 
PLCη2, and an anti-rabbit Dylight-488 secondary antibody. The green staining only 
occurred in certain cells which were considered transfected. Surprisingly, PLCη2 
was highly co-localised with the mitochondrial dye (Pearson coefficient: 0.7921, 
S.E.M.=0.0629). On the other hand, PLCη2 expressing cells underwent a structural 
change and abnormal condensation of the mitochondria at the perinuclear region was 
observed. The origin of the altered morphology is unknown, however the 
mitochondrial localisation of PLCη2 uncovers why it was specifically activated by 
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mitochondrial Ca
2+
-release. It is also intriguing that the number of mitochondria 
seems to be substantially increased in PLCη2-transfected cells. This could be due to 
the presence of PLCη2 which might have altered basal Ca2+ concentrations and has 
led to increased mitochondrial fissure. 
 
Figure 3.6.: Exogenously introduced PLCη2 exhibits a high co-localisation rate with 
mitochondria and induce morphological changes in COS-7 cells. PLCη2 was 
transfected into COS-7 cells by electroporation. Cells were treated with mitotracker 
before fixation to label mitochondria (red) and PLCη2 was immunostained by a 
specific primary antibody and an anti-rabbit Dylight-488 secondary antibody (green). 
Nuclei were stained with DAPI (blue). Images show high co-localisation rate of 
PLCη2 with mitochondria. This is supported by the co-localisation coefficient 
(0.7921, S.E.M.=0.0629, Pearson coefficient) calculated from 3 images. Images are 
representative and bars correspond to 10 µm. Images were taken by a Leica confocal 
system (TCP SP2). 
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3.3. Investigation of the PLCη2 PH domain 
3.3.1. PLCη2 PH domain is required for membrane-binding 
Membrane-targeting of PLC enzymes (with the exception of PLCζ) is directed by the 
N-terminal PH domain (section 1.2.3.2.). To ascertain whether PLCη2 is able to 
associate with the membranes in the absence of the PH domain, a deletion mutant of 
PLCη2 lacking this domain (residues 228–1238, ΔPH-PLCη2) was inserted into 
1/NT-GFP-TOPO vector as described in Chapter 2. Wild-type and ΔPH-PLCη2 were 
then overexpressed in COS-7 cells and the distribution of each protein (as visualised 
by the GFP-tag) was examined by confocal microscopy (Figure 3.7.).  
 
Figure 3.7.: Localisation of GFP-PLCη2 and its PH domain lacking deletion mutant 
(GFP-ΔPH) in COS-7 cells. The two GFP-fused constructs (shown in green) were 
transfected by electroporation and fixed after 2 days. Nuclei were stained with DAPI 
(blue). GFP-PLCη2 was localised to the plasma membrane and exhibited a punctate 
staining throughout the cell indicating its presence on extra- and intracellular 
membranes. GFP-ΔPH-PLCη2 has lost its ability to bind membranes revealed by its 
diffused staining in the cytosol and the nucleoplasm. Bars correspond to 10 µm. 
Images were taken by a Leica confocal system (TCP SP2). Figure is reproduced with 
permission from Elsevier (Popovics et al. 2011). 
The GFP-PLCη2 protein localised to cellular membranes with punctate staining 
throughout the cell body only lacking in the nucleus. A similar study by Nakahara et 
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al. using HeLa S3 cells found that GFP-PLCη2 predominantly localises at the plasma 
membrane (Nakahara et al., 2005). This suggests that PLCη2 might exhibit a cell-
specific localisation pattern that may be directed by the alterations in phospholipid-
composition of membranes in these cells. The GFP-ΔPH-PLCη2 protein exhibited 
diffuse staining throughout the cytosol indicating its inability to associate with 
cellular membranes. This is consistent with the findings of the above mentioned 
study (Nakahara et al., 2005), which similarly highlighted the importance of the PH 
domain in membrane binding.  
 
Figure 3.8.: Membrane-binding ability of PLCη2 is reduced in its PH-lacking 
mutant as it was shown by western blot from membrane enriched fractions. A: 
Western blots showing the protein levels of wild-type and ΔPH-PLCη2 in whole cell 
lysates (wcl) and in membrane-enriched fractions (mef) of transfected COS-7 cells. 
To collect membranes, cells were scraped and homogenised in RIPA buffer (lacking 
IGEPAL and SDS) and the homogenate was centrifugated at 14,000 g for 10 min. 
The pellet was washed and resuspended in complete RIPA buffer. Blots were also 
probed with antibodies specific to β-actin and the α1 subunit of Na+/K+-ATPase to 
show equal loading. B: Protein levels were calculated relative to wild-type PLCη2 
after their normalisation to β-actin Na+/K+-ATPase levels. Results are expressed ± 
S.E.M, n=3. Figure is reproduced with permission from Elsevier (Popovics et al. 
2011). 
The abilities of PLCη2 and ΔPH-PLCη2 proteins to bind to cellular membranes were 
also assessed by Western blotting. Both proteins were transfected into COS-7 cells 
which were lysed after 2 days and protein levels were detected by Western blot 
(Figure 3.8a). Firstly, the expression of the two proteins in whole cell-lysates was 
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calculated relative to β-actin levels. Membrane enriched cell lysates were also 
produced from the same transfected cells by an altered preparation of cell lysates (see 
Chapter 2 for more information on preparation). In these samples the level of PLCη2 
and ΔPH-PLCη2 were detected and expressed relative to the expression of the 
membrane marker Na
+
/K
+
 ATPase. Figure 3.7b demonstrates the relative levels of 
PLCη2 and ΔPH-PLCη2 after their normalisation with their levels in whole cell 
membranes. This indicates that ΔPH level is ~75% reduced compared to wild type 
PLCη2 providing further support of the importance of this domain for membrane-
binding. 
3.3.2. Membrane association of PLCη2 is essential for its activity 
To assess whether the PH domain-dependent membrane association is essential for 
the enzymatic activity of PLCη2, monensin-induced activation was studied in COS-7 
cells transfected with empty vector, wild type or ΔPH-PLCη2 constructs (Figure 
3.9.). PI(4,5)P2 hydrolysis is reduced to the control level (vector) in ΔPH-PLCη2-
expressing cells indicative of very little or no enzyme activity.  
 
Figure 3.9.: Measurement of monensin-induced accumulation of [
3
H]inositol 
phosphate in COS-7 cells transfected with constructs encoding wild-type and ΔPH-
PLCη2. Empty vector transfected cells were used to detect the activity of the 
endogenous PLC activity. PLCη2 lacking the PH domain possessed no additional 
activity compared the level of the vector-transfected cells. Protein expression levels 
are shown on the previous figure. Results are expressed ± S.E.M., n=3. Figure is 
reproduced with permission from Elsevier (Popovics et al. 2011). 
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In a separate experiment, activation of the wild-type and ΔPH-PLCη2 at various 
concentrations of free Ca
2+
 were assessed in COS-7 cells as previously (Figure 
3.10.). This revealed that Ca
2+
 was unable to activate the PH-lacking protein. 
Collectively these results show that membrane attachment of PLCη2 by the PH 
domain is crucial for its enzymatic activity. 
 
Figure 3.10.: Measurement of PI(4,5)P2 hydrolysis in wild-type and ΔPH PLCη2-
expressing permeabilised COS-7 cells in the presence of various free Ca
2+
 
concentrations. Empty vector transfected cells were used to detect the activity of 
endogenous PLCs. PLC-activity in ΔPH PLCη2-transfected cells was similar to the 
control level indicating that this construct is defective in PI(4,5)P2 cleavage. Results 
are expressed ± S.E.M., n=3. Figure is reproduced with permission from Elsevier 
(Popovics et al. 2011). 
3.3.3. Purification of GST-tagged PH domains of PLCη1 and PLCη2 
A further step towards understanding the properties of PLCη PH domains is to 
evaluate their phospholipid binding selectivity. When the mouse sequences of 
PLCη1 and PLCη2 PH domains (residues corresponding to 14-137 and 115-238, 
respectively) are aligned (Figure 3.11.) a high degree of similarity can be observed 
between these sequences. This suggests that their phospholipid-binding specificities 
may be similar.  
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Figure 3.11.: ClustalW alignment of protein sequences corresponding to the PH 
domains of PLCη1 and PLCη2. The high rate of conserved residues suggests that the 
two PH domains possess similar phospholipid-binding properties. Symbols used to 
express the rate of similarity: “*” identity, “:” high similarity, “.” weak similarity. 
Colour coding corresponds to the clustal color scheme.  
 
Figure 3.12.: Polyacrylamide gel demonstrating the purity of GST-PH-PLCη in the 
elution buffer. Bacterial cell lysates, first wash (from multiple washes) and the 1. and 
2. elutions were separated on a 4-12% polyacrylamide gradient. The first elution was 
used in subsequent experiments. Recombinant PH domains were detected at 
approximately 40 kDa.  
For the subsequent analysis, PLCη PH domains (encoding residues 14-137 and 115-
238 of PLCη1 and PLCη2, respectively) were cloned into the bacterial expression 
vector, pGEX6 by using EcoRI and NotI restriction sites from the full-length cDNA 
containing pcDNA3.1. (conducted by Dr. Alan Stewart). This vector has the 
CHAPTER 3. BIOCHEMICAL CHARACTERISATION OF PLCη2  
 
94 
 
advantage of tagging the inserted PH domains with GST (Glutathione S-transferase). 
Sequence verified plasmids were transformed into E. coli strain BL21. Expression of 
PH domains was induced by IPTG. Cells were pelleted, lysed and recombinant 
proteins were purified on glutathione-conjugated agarose beads. Purity of eluates was 
tested by PAGE followed by Coomassie staining (Figure 3.12.). Protein mass was 
calculated by an online software (www.bioinformatics.org/sms/prot_mw.html) and 
was estimated to be: 41.36 kDa for GST-PLCη1-PH, and 41.22 for GST-PLCη2-PH. 
Expressed proteins were identified according to their weights. Samples from the first 
elution were at least 90% pure and were subjected for further examination. 
3.3.4. Determination of the specificity of PLCη PH domains towards 
phosphoinositides by a FRET-based assay 
The following experiment was conducted by Dr. Alexander Gray (University of 
Dundee, Dundee, UK) from the materials which were produced in the previous 
section. Purified GST-PLCη2 PH domains were subjected to a Förster resonance 
energy transfer (FRET) assay which aimed to measure the dose-dependent binding of 
the PH domains to various phospholipids. Simplified description of this experimental 
approach is described in Figure 3.13. FRET signal is generated when a sensor 
complex is formed by the interaction of the PH domain and the biotinylated lipid.  
By using the above described FRET approach, first the ability of both PH domains to 
form sensor complexes with biotinylated phosphatidylinositol 3,4,5-trisphosphate 
(PI(3,4,5)P3), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), phosphatidylinositol 
3,4-bisphosphate (PI(3,4)P2), phosphatidylinositol 3-phosphate (PI(3)P) and 
phosphatidylinositol 4-phosphate (PI(4)P) was examined (Figure 3.14). PLCη PH 
domains possessed the highest sensitivity towards PI(3,4,5)P3 with EC50: 0.7611 
pmol for PLCη1 and 0.7761 pmol for PLCη2. In addition, PI(4,5)P2 also associated 
with PH domains with slightly lower affinity (3.0576 pmol for PLCη1 and 3.1131 
pmol for PLCη2). None of the other biotinylated-lipids were able to form FRET-
active complexes.  
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Figure 3.13.: Principles of detecting PH domain-phospholipid interactions by FRET. 
In the reaction, GST-PH domains associate with the Eu-tagged anti-GST antibody 
and with the preferred phospholipid. The allophycocyanin (APC) also binds 
biotinylated phospholipids through its streptavidin tag. FRET-signal (upon excitation 
at 340 nm) is generated when the Eu chelate and the APC gets to a close distance 
which is achieved when PH domain-phospholipid interactions are formed. Figure 
was taken with permission from Elsevier (Gray et al. 2003). 
 
Figure 3.14.: Measurement of the association of PLCη1 and PLCη2 PH domains 
with biotinylated phosphoinositides by using TR-FRET detection. Both PLCη1 and 
PLCη2 PH domains exhibited the highest affinity towards PI(3,4,5)P3 (EC50: 0.7611 
pmol for PLCη1 and 0.7761 pmol for PLCη2) but also bound to PI(4,5)P2 at slightly 
higher biotin lipid concentration (3.0576 pmol for PLCη1 and 3.1131 for PLCη2). 
TR-FRET was conducted as described in Materials and Methods. Biotinylated lipids 
used to build sensor complexes were as follows: PI(3,4,5)P3, PI(4,5)P2, PI(3,4)P2, 
PI(3)P and PI(4)P. EC50 values were calculated by the SigmaPlot software. Data are 
expressed as mean ± S.D., n=3. 
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As a parallel approach, the ability of non-biotinylated phosphoinositides to dissociate 
already formed sensor complexes formed by PLCη-PH and biotinylated PI(4,5)P2 
was also assessed (Figure 3.15.). Apart from the phosphoinositides used in the 
previous experiment, inositol phosphates were also included such as I(1,3,4,5)P4 
(inositol 1,3,4,5-tetrakisphosphate), I(1,3,4)P3 (inositol 1,3,4-trisphosphate), 
I(1,4,5)P3 (inositol 1,4,5-trisphosphate). IC50 values are summarised in Table 3.1. 
Almost all lipids tested were able to displace biotinylated PI(4,5)P2 in the complex. 
PI(3,4,5)P3 was the strongest competitor with IC50 values 35.70 pmol and 41.60 pmol 
for PLCη1 and PLCη2, respectively. This was followed by PI(4,5)P2 (EC50 
130.60 pmol and 198.40 pmol for PLCη1 and PLCη2, respectively). The list of the 
rest of the phospholipids arranged by their potency to compete with the PLCη2-
PI(4,5)P2-binding contained some differences for the two PLCη PH domains. For 
PLCη1-PH the order was: PI(3,4)P2 (442.10 pmol), 1,3,4,5 IP4 (671.70 pmol), PI(3)P 
(1051.80 pmol), 1,4,5 I(1,4,5)P3 (1066.10 pmol). However, when PLCη2-PH was 
subjected to the assay it was I(1,3,4,5)P4 (301.10 pmol), I(1,4,5)P3 (542.90 pmol), 
PI(3,4)P2 (919.80 pmol) and PI(3)P (2256.40 pmol). This might indicate that the PH 
domain of PLCη2 is more vulnerable to dissociation from its membrane-binding 
state (achieved by binding PI(3,4,5)P3 or PI(4,5)P2). This process is recognised as a 
negative feedback of PH domains possessing proteins (Jia et al. 2007; Lomasney et 
al. 1996). Only PI(1,3,4)P3 was unable to compete with the PLCη-PH-PI(4,5)P2 
complexes.  
These results collectively indicate the major role of PI(3,4,5)P3-binding as a regulator 
for the localisation of PLCη-PHs. Although there were slight differences in the 
potency for competition of inositol phosphates it seems that their role in negatively 
regulating the association of PLCη-PH complexes with PI(3,4,5)P3 or PI(4,5)P2 is 
negligible. In the case of the PLCδ1, the enzymatic activity is greatly reduced by the 
addition of I(1,4,5)P3 to PI(4,5)P2 (main target of this PH domain) in a ratio of 1:10 
suggesting an important regulatory mechanism. However, in the previous 
experiments, it was revealed that there is at least a 10-fold difference in the 
sensitivities of PH-PLCηs towards PI(3,4,5)P3 and I(1,4,5)P3 or its derivatives. When 
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the PH domains of PLCηs were aligned with that of PLCδ1 an interesting structural 
detail was revealed (Figure 3.16.). Conserved residues of the inositol-binding loop, 
which projects from the β-structure of the PH domains were identified in all three 
proteins. However, the first two residues of this loop which were shown to be 
important for the binding of inositol phosphates are excised in PLCηs (Ferguson et 
al. 1995). This deletion might be the causative of the altered lipid-binding properties 
of the PH domains in the PLCη enzyme family.  
 
Figure 3.15.: FRET measurement of the dissociation of biotinylated PI(4,5)P2-PLCη 
PH domain sensor complexes by unbiotinylated phosphoinositides. PH domains were 
pre-incubated with PI(4,5)P2 (200 pmol/reaction) before the addition of serially 
diluted lipids:  PI(3,4,5)P3, PI(4,5)P2, PI(3,4)P2, PI(3)P, I(1,3,4,5)P4, I(1,3,4) or 
I(1,4,5)P3. The strongest competitor of the PI(4,5)P2-PLCη PH domain complex was 
PI(3,4,5)P3 for both PLCηs followed by PI(4,5)P2. Only I(1,3,4)P3 was unable to 
dissociate the sensor complex.  
 
Table 3.1.: Half-maximal inhibitory values (IC50) calculated from the FRET-assay 
measuring the dissociation of the PI(4,5)P2-PLCη PH domain sensor complexes by 
unbiotinylated phosphoinositides. Values were calculated by SigmaPlot software and 
are shown both in pmoles/sample and in µM concentrations.  
PLCɳ1 PLCɳ2 PLCɳ1 PLCɳ2
PI(3,4,5)P3 35.70 41.60 0.71 0.83
PI(4,5)P2 130.60 198.40 2.61 3.97
PI(3,4)P2 442.10 919.80 8.84 18.40
PI(3)P 1051.80 2256.40 21.04 45.13
1,3,4,5 IP4 671.70 301.10 13.43 6.02
1,3,4 IP3 <10000 <10000 <200 <200
1,4,5 IP3 1066.10 542.90 21.32 10.86
IC50 (pmol) IC50 (µM)
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Figure 3.16.: Unique structure of PLCη PH domains suggested by their alignment 
with PLCδ1. I(1,4,5)P3-binding residues were previously identified from the crystal 
structure of the PLCδ1-PH-I(1,4,5)P3 complex (residues are indicated by black 
triangles, Ferguson et al., 1995). The sequence of an elongated loop which contains 4 
from the above mentioned I(1,4,5)P3-binding residues is bordered with a black box. 
Sequence alignment revealed that the first two residues of this loop which bind 
I(1,4,5)P3 in PLCδ1 are absent in PLCηs. This might represent the structural basis for 
the inability of I(1,4,5)P3 to effectively compete with the PI(1,4,5)P2-PLCη complex 
as revealed in the FRET assay. Structure of the PLCδ1 PH domain was taken with 
permission from Elsevier (Ferguson et al. 1995). Alignment was produced by the 
author of this thesis. 
3.3.5.: Detection of PLCη PH domain-phospholipid interactions by 
lipid-absorbed membranes   
Phospholipid-protein interactions may also be detected by comercially available 
lipid-absorbed membranes known as PIP-strips. The advantage of this method that it 
provides a wider array of lipids containing others than just phosphinositols. 
Membranes containing the following lipids were used: lysophosphatidic acid (LPA), 
lysophosphocholine (LPC), (PI), PI(3)P, PI(4)P, PI(5)P, PE, PC, sphingosine 1-
phosphate (S(1)P), PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, PI(3,4,5)P3, PA and PS. 
Membranes were incubated with purified GST-PLCη1-PH or GST-PLCη2-PH, a 
mouse anti-GST antibody and horseradish peroxidase-conjugated anti-mouse 
antibody. Antibody complexes were visualised by an enhanced chemiluminescent 
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substrate (ECL, Figure 3.17.). The binding of PH-PLCη1 and PH-PLCη2 to 
PI(3,4,5)P3 was confirmed by this method, however, it was unable to detect their 
association to PI(4,5)P2. Additionally, in contrast to the FRET-analysis binding of 
both PH domains to PI(3)P and PI(4)P was detected. Strong associations of PH 
domains to phosphatidylserine were also observed. This phospholipid has been 
previously shown to localise to the plasma-, endosomal- and lysosomal membranes 
(Yeung et al. 2008).  
 
Figure 3.17.: Investigation of PLCη PH domain phospholipid selectivity by lipid-
protein overlay assay. GST-tagged PLCη PH domains were probed with hydrophobic 
membranes spotted with 15 phospholipids. These were as follows: LPA: 
lysophosphatidic acid, LPC: lysophosphocholine, PI: phosphatidylinositol, PI(3)P: 
phosphatidylinositol 3-phosphate, PI(4)P: phosphatidylinositol 4-phosphate, PI(5)P: 
phosphatidylinositol 5-phosphate, PE: phosphatidylethanolamine, PC: 
phosphatidylcholine, S(1)P: sphingosine 1-phosphate, PI(3,4)P2: phosphatidylinositol 
3,4-bisphosphate, PI(3,5)P2: phosphatidylinositol 3,5-bisphosphate, PI(4,5)P2: 
phosphatidylinositol 4,5-bisphosphate, PI(3,4,5)P3: phosphatidylinositol 3,4,5-
trisphosphate, PA: phosphatidic acid, PS: phosphatidylserine. Both PH domains 
showed strong binding to PS. In addition the binding of PI(3,4,5)P3, PI(3)P and 
PI(5)P was also registered.  
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The quality of these membranes and their ability to show phospholipid-protein 
interactions were poor in these experiments. Moreover, a repeat of this experiment 
did not provide any detectable results (data not shown). However, strong binding of 
PS by the PH domains may be significant and worthwhile following up in future 
experiments. 
3.3.6.: Localisation of PH-PLCη2 in Neuro-2a cells in relation to the 
distribution of PI(3,4,5)P3 and PI(4,5)P2 
Previous experiments investigated the phospholipid-binding properties of PLCη PH 
domains, however, in an artificially constituted environment. A further step towards 
understanding the role of the interactions between PLCη2 PH domain and 
phospholipids is to study their role in the regulation of cellular localisation. Inspired 
by this, a GFP-tagged construct of the PH domain of PLCη2 in pcDNA3.1 was 
produced by TA-cloning (performed by Mohammed Arastoo, Ph.D. student). This 
was cotransfected with the PI(4,5)P2-specific PH domain of PLCδ1 (Watt et al. 2002) 
tagged with the fluorophore, mCherry. Alternatively, a specific antibody was used to 
detect the cellular localisation of PI(3,4,5)P3. In this study, Neuro-2a cells were used 
which are derived from murine neuroblastoma cells (Klebe and Ruddle 1969). GFP-
PH-PLCη2 exhibited limited co-localisation with mCherry-PH-PLCδ1 on the plasma 
membrane and the cytosol (Pearson coefficient: 0.0953, S.E.M.=0.033555, n=2) but 
the highest extent of the GFP-PH-PLCη2 was restricted to the nucleus similarly to 
the PI(3,4,5)P3-immunostaining (Pearson coefficient: 0.7475, S.E.M=0.0355, 
n=2,Figure 3.18.). Cellular distribution of PLCη2 in neuron-like cells will be further 
assessed in Chapter 4.  
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Figure 3.18.: Localisation of GFP-PH-PLCη2 (green) in Neuro-2a cells in relation to 
PI(4,5)P2 and PI(3,4,5)P3 (both shown in red). Nuclei are stained with DAPI (blue). 
GFP-PH-PLCη2 was transfected by lipofectamine and cells were fixed the next day. 
PI(4,5)P2 was labelled with the cotransfection of mCherry-PH-PLCδ1 whereas 
PI(3,4,5)P3 was immunostained with a specific antibody. GFP-PH-PLCη2 possessed 
a high co-localisation rate with PI(3,4,5)P3 in the nucleus (0.7475, S.E.M=0.0355, 
n=2, Pearson coefficient). In contrast, PLCη2 colocalised less markedly with 
mCherry-PH-PLCδ1 (0.0953, S.E.M.=0.033555, n=2, Pearson coefficient). Images 
are representative and were taken from a deconvoluted Z-stack. Bars correspond to 
10 µm. 
3.4. An EF-hand directs the Ca
2+
-sensitivity of PLCη2 – the 
description of a novel EF-hand structure 
EF-hand-related sequences in other PLCs have been implicated in Ca
2+
-binding and 
enzyme activation (Yamamoto et al 1999; Nomikos et al. 2005). Accordingly, these 
domains are distinguished as EF-hand like domains in other PLCs (described in 
section 1.2.3.2.3.). On the other hand, PLCζ possesses a unique functional EF-hand 
which is responsible for its high Ca
2+
-sensitivity compared to other PLCs (Nomikos 
et al. 2005). As revealed from the Ca
2+
-permeabilisation experiment, PLCη2 also 
exhibits a high sensitivity towards Ca
2+
 which might indicate that this PLC also 
carries an active EF-hand domain. To investigate this possibility, PLCη2 sequence 
was aligned with proteins with known functional paired EF-hand-loops (Figure 
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3.19.). Ca
2+
-binding loops are formed by 12 residues in canonical EF-hands which is 
true for the first loop, however, insertion of a residue in the second loop resulted in a 
loop consisting of 13-residues. This insertion is expected to be at either H296 or 
Q297 (at poitions 5 or 6) which assumption is based on the conservity of the other 
residues in the loop and is highlighted by the alignment with other EF-hand-
containing proteins (Figure 3.19b). In the alignment calbindin D9K is also included 
which contains a non-canonical first loop containing two insertions (alanine between 
the 1. and 2. and a proline between 5. and 6.) however this insertion does not prevent 
the coordination of the Ca
2+ 
(Kordel et al. 1993). 
 
Figure 3.19.: Coordination of Ca
2+
 in EF-hands (A) and the alignment of these 
domains from PLCη enzymes and other proteins  (B). Ligands in positions Y, -Y, Z, 
-Z1 and -Z2 are arranged as a pentagon whereas ligands X and -X are placed in an 
axial position to the others that allows the formation of a pentagonal bipyramid 
structure. The sequences of murine and human PLCη2 (MmPLCη2 and HsPLCη2) 
are compared with the human forms of PLCη1 (HsPLCη1), calmodulin EF-hand 
domain 1 (HsCaMEF1), human calmodulin EF-hand domain 2 (HsCaMEF2), human 
troponin C type 2 (HsTropCII), human neuronal calcium sensor-1 (HsNCS-1), 
calcineurin B (HsCalcinB) and human calbindin D9K (HsCalD9K). The putative 
Ca
2+
-coordinating residues X, Y, Z, -Y ,-X and -Z are indicated based on the 
conserved residues. Residues which were mutated in the following experiments are 
bold. Figure is created by Dr. Alan Stewart. 
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To assess the role of the EF-loops in PLCη2, mutations in both loops were generated 
by site-directed mutagenesis. Aspartic acids in the first position of both loops are 
highly conserved in EF-hand-containing proteins and usually supply the “X” ligands 
for coordination of the Ca
2+
 in a pentagonal bipyramid structure (Figure 3.19.). Thus, 
these residues were the first targets of the mutagenesis studies and were both 
changed to alanine (D256A and D292A). Subsequently, three more similar mutations 
were generated in the second loop changing residues in positions 5, 6 and 13 to 
alanines (H296A, Q297A and E304A). Either H296 or Q297 has been inserted into 
the 12-residue loop and led to the constitution of this novel EF-loop. Hence, the 
mutation of these residues may provide information on how this insertion affects 
Ca
2+
-binding properties of the domain. In addition, E304 provides a bidentate ligand 
in canonical EF-hands and its mutation is expected to greatly impair the Ca
2+
-
dependent conformational changes in the EF-loop. Wild type (wt) and mutated 
PLCη2 proteins were overexpressessed in COS-7 cells to study the role of the EF-
hand in monensin-induced activation and Ca
2+
-sensitivity in permeabilised cells. 
Transfection of these constructs were conducted in two sets: one containing the 
vector, wt, D256A and D292A and one set with vector, wt, H296A, Q297A and 
E304A. Expression levels of recombinant proteins were detected by Western-blotting 
from cell lysates (Figure 3.20.).  
 
Figure 3.20.: Western-blot showing that wild-type (wt) and mutants of PLCη2 are 
expressed in transfected COS-7 cells. Transfections were conducted in two series: 
one containing vector, wt, D256A and D292A and one containing vector, wt, 
H296A, Q297A and E304A. Equal amounts of protein lysates were subjected to 
SDS-PAGE and transferred onto PVDF membranes. Blots were probed with PLCη2- 
and β-actin-specific antibodies. β-actin serves as a loading control. 
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Only small variability was found in the transfection efficiencies. However, all 
experiments were repeated at least three times to ensure that differences in enzyme 
activities are not the consequences of altered expression levels.  
Monensin treatment stimulated inositol phosphate accumulation by 4-5 fold in both 
experiments (Figure 3.21 and 3.22). Mutation of the D256A residue blocked the 
ability of the enzyme to respond to monensin. In contrast, mutation of the same 
aspartate in the second loop (D292A) only resulted in a 20% decrease in monensin-
induced activation compared to the wild type construct. These results clearly 
demonstrate the importance of the first loop for activation, however, the involvement 
of the second loop is not certain.  
 
Figure 3.21.: Measurement of monensin-induced accumulation of [
3
H]-labelled 
inositol phosphate in COS-7 cells transfected with constructs encoding wild-type or 
mutant PLCη2 (D256A and D292A). Cells transfected with the vector were used as 
controls. The D256A mutant exhibited no activity above the control level whereas 
mutation of the D292A residue only resulted in a slight decrease in PI(4,5)P2 
hydrolysis. Results are representative of multiple experiments and expressed as ± 
S.E.M.  
To further evaluate the role of the second EF-loop in Ca
2+
-dependent activation of 
the enzyme, other putative Ca
2+
-binding residues were mutated as stated above. 
Surprisingly, these mutations did not affect the monensin-stimulated enzyme activity 
(Figure 3.22.). These results indicate that only the first EF-loop possess regulatory 
role on the enzyme activity probably via a structural change triggered upon Ca
2+
-
binding. 
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Figure 3.22.: Measurement of monensin-induced accumulation of [
3
H]-labelled 
inositol phosphate in COS-7 cells transfected with constructs encoding wild-type or 
mutant PLCη2 (H296A, Q297A and E304A). Cells transfected with the vector were 
used as controls. None of the mutations of the second EF-loop inhibited 
phospholipase activity. Results are representative of multiple experiments and 
expressed as ± S.E.M. 
 
Figure 3.23.: Measurement of the accumulation of [
3
H]-labelled inositol phosphates 
in permeabilised COS-7 cells transfected with constructs encoding wild-type or 
mutant PLCη2 (D256A: A and D292A: B) in the presence of various free Ca2+-
concentrations. Cells transfected with the vector were used as controls. Whereas 
D256A exhibited 10-fold less sensitivity for Ca
2+
, the D292A mutant mirrored the 
activation of the wild-type enzyme. Experiments were performed simultaneously. 
The activities of the mutants are shown with solid lines. The wild-type enzymatic 
activity and the endogenous level in control cells are also indicated by dashed and 
dotted lines, respectively. Results are representative of multiple experiments and 
expressed as ± S.E.M. 
Ca
2+
 sensitivity of the EF-hand mutants were also assessed in permeabilised COS-7 
cells in the presence of various free Ca
2+
 concentrations. Results for each mutant are 
shown separately by indicating the level of the empty vector- and wild-type-
transfected cells. Experiments were conducted in two groups similarly to the 
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monensin-treated cells. Interestingly, the first activation of D256A mutant was only 
acquired at a ten-fold higher Ca
2+
-concentration (10 µM) compared to wild-type. In 
contrast, the D292A mutant exhibited the same activation curve as the wild-type 
PLCη2 (Figure 3.23.). It is noteworthy that the D292A mutant displayed different 
activation when monensin or purely Ca
2+
-was administered. Although the nature of 
these experiments greatly differ, these results also raise the possibility that monensin 
activation of PLCη2 is not only directly derived from its effect on Ca2+-release. In 
FRTL-5 cells, monensin elevated intracellular pH and altered iodide transport 
(Smallridge et al. 1992). Thus, it is possible that monensin has a complex effect on 
cellular physiology and these changes collectively lead to the potentiation of PLCη2 
activity.   
 
Figure 3.24.: Measurement of the accumulation of [
3
H]-labelled inositol phosphates 
in permeabilised COS-7 cells transfected with constructs encoding wild-type or 
mutant PLCη2 (H296A: A Q297A: B and E304A: C) in the presence of various free 
Ca
2+
-concentrations. Cells transfected with the vector were used as controls. All 
mutants possessed similar Ca
2+
-sensitivities to the wild-type enzyme, however their 
activity was slightly decreased at 10 and 100 µM Ca
2+
-concentrations. Experiments 
were performed simultaneously. The activities of the mutants are shown with solid 
lines. The wild-type enzymatic activity and the endogenous level in control cells are 
also indicated by dashed and dotted lines, respectively. Results are representative of 
multiple experiments and expressed as ± S.E.M. 
Further mutations in the second EF-loop (H296A, Q297A and E304A) did not alter 
the sensitivity of the enzyme towards Ca
2+
 but resulted in a decrease in enzyme 
activity at 10 and 100 µM Ca
2+
-concentrations (Figure 3.24.). This might indicate 
that for maximal activation the functionality of the second loop is also required. 
Although monensin-activation was unaffected by the mutations, it is possible that 70 
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μM monensin treatment has similar intracellular effects as when the cells are 
permeabilised in the presence of 10
-6
 M Ca
2+
. This could result in the inability of the 
monensin-activation to show mutation induced differences in enzyme activity when 
they are coupled to higher Ca
2+
 concentrations. Or otherwise, the complexity of 
monensin actions did not allow the differences to be revealed.  
Collectively, these results indicate that Ca
2+
-binding to the first EF-loop in PLCη2 
triggers a conformational change of the protein that translates to the catalytic site 
leading to increased enzymatic activity. Whether the second loop binds Ca
2+
 or not, 
remains uncertain. However, it was revealed that it does not contribute to the 
activation of PLCη2 by Ca2+ in the range of 100 nM-1 µM, which is the 
concentration window particular for PLCη enzymes. Hopefully in the future more 
structural data will be acquired by the purification and crystallisation of the domain 
in which the Ca
2+
-binding mechanism could be further investigated. Nevertheless, 
PLCη2- (and certainly PLCη1) EF-hand represents a novel type of this domain 
containing a canonical and a non-canonical Ca
2+
-binding loopfrom which the 
canonical first loop directs the unique Ca
2+
 sensitivity of the enzyme. .  
3.5.: Ca
2+
-regulated membrane association of the C2 domain is 
essential for PLCη2 enzyme activity 
All PLC isozymes contain a C2 domain of which only the Ca
2+
-bound structure of 
PLCδ1 has been solved to date by X-ray crystallography. Metal binding sites of this 
domain have been identified by using Ca
2+
, or its analogues Ba
2+
 and La
3+
 in the 
buffer used for crystallography. This revealed that two or three Ca
2+
 may associate to 
the three membrane-facing loops of PLCδ1-doman. Upon binding, the Ca2+ ions may 
form a bridge between the C2 domain and phospholipid headgroups or alter 
electrostatic features of the protein surface to enhance its association with the 
membrane. Coordination of the Ca
2+
 is mostly achieved by aspartic acid residues 
(Essen et al. 1997a). In Figure 3.25., murine sequence of C2 domain from PLCη2 is 
aligned with that of PLCη1, PLCδ1 and synaptotagmin 1 (Syt1). Synaptotagmin 
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contains two C2 domains and also represents a structurally altered subtype of C2 
domain formed by circular permutation (Essen et al. 1996). Sequence alignment 
revealed the existence of 5 conserved aspartates in PLCη2 C2 domain. Residues 
D861 and D920 were chosen as targets for site directed mutagenesis to study the role 
of Ca
2+
-dependent membrane association of the C2 domain for PLCη2 enzyme 
activity. These residues were replaced by alanines (D861A and D920A). In addition, 
it was found that the residue corresponding to D861 is an asparagine in PLCδ1. In 
order to detect if this natural mutation has important functions in PLCη2 enzymatic 
activity, an additional construct was generated with D861N mutation.  
 
Figure 3.25.: Alignment of murine sequences corresponding to the C2 domains of 
PLCη2, PLCη1, PLCδ1 and synaptotagmin-I (Syt-1). Synaptotagmin-I contains two 
C2 domains (C2A and C2B). Five conserved aspartic acid residues which are 
implicated in Ca
2+
-dependent membrane binding of this domain are shown in bold. 
The alignment revealed that the first aspartate is altered to an asparagine in PLCδ1. 
For further analysis, the first and the third aspartate was mutated to alanine (D861A 
and D920A) or asparagine (D861N). Figure is reproduced with permission from 
Elsevier (Popovics et al. 2011). 
Constructs encoding wild-type and mutant PLCη2 proteins were transfected into 
COS-7 cells by electroporation to study the effect of mutations on monensin-induced 
activation and Ca
2+
-sensitivity. As shown in Figure 3.26., constructs were 
successfully transfected and expressed in these cells with similar protein levels.  
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Figure 3.26.: Western blot showing equal protein levels of wild-type (WT) and 
mutant PLCη2 (D861A, D861N and D920A) in whole cell lysates from transfected 
COS-7 cells. Equal amounts of protein lysates were subjected to SDS-PAGE and 
transferred onto PVDF membranes. Blots were also probed with an antibody specific 
to β-actin as a loading control. Figure material is collected from the same membrane 
by joining two fragments indicated by a vertical line. Figure is reproduced with 
permission from Elsevier (Popovics et al. 2011). 
 
Figure 3.27.: Monensin-induced accumulation of [
3
H] inositol phosphate in COS-7 
cells transfected with wild-type PLCη2 or D861A, D861N and D920A mutants. 
Empty vector transfected cells were used to detect the activity of the endogenous 
PLC-pool. From the mutations generated in the C2 domain of PLCη2 only D920A 
showed no activity above the level of the control indicative of its defect in PI(4,5)P2-
hydrolysing. In addition, the D861N mutation also resulted in the reduction of the 
enzyme activity. Data shown is representative of multiple experiments. Results are 
expressed ± S.E.M., n=3. Figure is reproduced with permission from Elsevier 
(Popovics et al. 2011). 
Monensin (0-70 µM) induced the expected elevation in the wild-type enzyme 
activity and slightly stimulated endogenous PLCs (Figure 3.27.). The D861A 
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mutation only yielded a ~23% decrease (after adjusting for basal PLC activity) 
compared to the wild-type PLCη2 activity. However, the mutation of the same 
residue to asparagine (D861N) resulted in a ~55% reduction (after adjusting for basal 
PLC activity). The D920A mutant activity was similar to that of the control level 
with all monensin concentrations tested.  
 
 
Figure 3.28.: Measurement of the accumulation of [
3
H]-labelled inositol phosphates 
in permeabilised COS-7 cells transfected with constructs encoding wild-type or 
mutant PLCη2 (D861A, D861N and D920) in the presence of various free Ca2+-
concentrations. Cells transfected with the vector were used as controls. Endogenous 
PLC-activity is indicated with a solid line on the first diagram and then with dashed 
lines on the rest. The D861A mutant activity was similar to that of the wild-type. In 
contrast, the D861N and D920A mutants exhibited much reduced activity compared 
to the wild-type PLCη2. This reduction affected the whole activation curve and did 
not change the sensitivity of the enzymes towards Ca
2+
. Results are representative of 
multiple experiments and were expressed as ± S.E.M. Figure is reproduced with 
permission from Elsevier (Popovics et al. 2011). 
Ca
2+
-sensitivities of wild-type and C2 domain mutant PLCη2 enzymatic activities 
were investigated by permeabilisation of COS-7 cells in the presence of elevating 
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Ca
2+
-concentrations (Figure 3.28.). Wild-type PLCη2 activity exhibited an increase 
at concentrations between 0.1 and 1 μM free Ca2+ as was expected. The D861A 
mutant displayed activation curve similar to that of the wild-type. In contrast, the 
D861N and D920A mutants demonstrated much less activation by Ca
2+
 (~78% and 
85%, respectively at 10 µM Ca
2+
 after adjusting for basal PLC activity). None of the 
mutants were differentially sensitive towards Ca
2+
 compared with the wild-type 
enzyme. This suggests, that the association of the C2 domain with the membrane (in 
the presence of Ca
2+
) is a crucial step for the effective hydrolysis of PI(4,5)P2, 
however, it is not responsible for the activation of the enzyme by the submicromolar 
Ca
2+
 concentrations.  
 
Figure 3.29.: Mutations in the C2 domain did not alter the membrane-binding 
properties of PLCη2 in COS-7 cells. Vectors encoding GFP-tagged wild-type (WT) 
and mutant PLCη2 (D861A, D861N and D920A) were transfected into COS-7 cells 
by electroporation and cells were fixed after 2 days of expression. All constructs 
localised to intra- and extracellular membranes. Image of the wild-type GFP-PLCη2 
is taken from Figure 3.4. Bars correspond to 10 µm. Images were taken by a Leica 
confocal system (TCP SP2). 
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The subcellular membrane targeting of some PLCδ isoforms are regulated by the 
selectivity of their C2 domain to phosphatidylserine (Ananthanarayanan et al. 2002). 
To evaluate if the C2 domain of PLCη2 affects the cellular localisation of the full-
length protein the previously introduced mutations were also generated in the GFP-
PLCη2 construct, respectively. GFP-D861A, -D861N and –D920A were expressed 
in COS-7 cells as previously the wild-type GFP-PLCη2 (Figure 3.29.). All GFP-
constructs exhibited similar cellular localisation to the wild-type construct with 
punctuate distribution inside the cell and limited appearance on the plasma 
membrane. This suggests that the C2 domain has little or no participation in the 
membrane-targeting of the full-length PLCη2 which mechanism is probably under 
the absolute control of the PH domain.  
 
Figure 3.30.: Western blot showing the protein levels of wild-type and mutant 
PLCη2 (D861A, D861N and D920A) in membrane-enriched fractions of transfected 
COS-7 cells. Cells were scraped and homogenised in RIPA buffer (lacking IGEPAL 
and SDS) and the homogenate was centrifugated at 14,000 g for 10 min. The pellet 
was washed and resuspended in complete RIPA buffer. Equal amounts of protein 
lysates were subjected to SDS-PAGE and transferred onto PVDF membranes. Blots 
were also probed with an antibody specific to the α1 subunit of Na+/K+-ATPase (a 
marker for the plasma membrane) as a loading control. Figure material is collected 
from the same membrane by joining two fragments indicated by a vertical line. The 
blot is representative of three independent experiments. 
The C2 domain directs the secondary attachment of the whole protein to the 
membrane which might increase the affinity of this association. This theory was 
investigated by the assessment of wild-type and mutant PLCη2 protein levels in 
membrane-enriched fractions from wild-type and mutant PLCη2-transfected COS-7 
cells (WT, D861A, D861N and D920A, Figure 3.30.). Protein levels, however, were 
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similar, indicative of the high affinity of the PH domain to the membrane rather than 
the C2 domain in this process.  
3.6.: Discussion 
3.6.1. The initial characterisation 
The data presented within this Chapter provides information as to how the PH 
domain, C2 domain and EF-hand regulate the enzyme activity of PLCη2. The first 
step in the initial characterisation was the identification of a Ca
2+
-mobilising agent as 
a specific trigger for PLCη2 activity in a cellular environment (COS-7 cells). 
Unexpectedly, only monensin induced a significant elevation in PLCη2 activity of all 
Ca
2+
-mobilising agents tested (ionomycin, A23187, thapsigargin and bafilomycin). 
Kim et al. also demonstrated that ionomycin stimulation of the endogenous PLC-
activity was retained after PLCη2 knock-down in Neuro-2a cells (Kim et al. 2011). 
Ca
2+
 ionophores ionomycin and A23187 might have been incapable of inducing the 
special spatial and/or temporal distribution of Ca
2+
 which was developed by 
monensin. It was demonstrated earlier that monensin is able to increase intracellular 
Ca
2+
 level by 2.3-fold in FRTL-5 thyroid cells by reversing the NCXs and this was 
coupled to increased PLC activity. This seems to confirm that the effect of monensin 
on PLCη2 is due to the elevated Ca2+ levels. Although, in this case the Ca2+-
ionophores (ionomycin and A23187) should have had at least some effect on PLCη2 
activity. To better understand the nature of Ca
2+
 dynamics following monensin 
stimulation Ca
2+
-chelation and non-specific inhibition of Ca
2+
 channels were used. In 
the presence of EGTA, PLCη2 activity was reduced to the control level. The 
compound SKF-96365, which is a non-specific inhibitor of the voltage- and receptor-
operated Ca
2+
-entry (Merritt et al. 1990; Singh et al. 2010) also greatly reduced 
PLCη2 activity in transfected cells. These agents further demonstrated that the action 
of monensin on PLCη2 is clearly Ca2+-dependent. Depending on the localisation of 
PLCη2, its activation might be controlled by Ca2+release from a specific store. A 
specific inhibitor of the mitochondrial Na
+
/Ca
2+
-exchanger (CPG-3757) greatly 
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interfered with the monensin-induced activity of PLCη2. This suggests that the 
monensin-induced Ca
2+
 release from mitochondria – either directly or indirectly- 
influenced PLCη2 activity. At least some of the inhibition of SKF-96365 on 
monensin-induced Ca
2+
-release was likely derived from its action on the Na
+
/Ca
2+
-
exchanger. This was shown by the co-administration of SKF-96365 and CPG-3757 
which resulted in only a slight additional inhibition. Collectively these results show 
that monensin is an activator of PLCη2 and in this activation mitochondrial Ca2+ 
release is likely to play an important role. However, it is plausible that monensin has 
no direct effect and other factors might transmit its effect on PLCη2 activity via an 
unknown mechanism. 
The cellular distribution of the GFP-tagged PLCη2 protein highlighted that this 
enzyme may be present on both plasma- and organelle membranes. However this 
construct did not provide sufficient evidence that PLCη2 would primarily localise on 
mitochondrial membranes as was suggested by previous results. Interestingly, 
localisation of the same construct was found to be predominant on the plasma 
membrane in HeLa S3 cells (Nakahara et al. 2005). Immunostaining of the 
overexpressed PLCη2 yielded in a somewhat contradictory result placing the 
majority of PLCη2 onto the mitochondria. Moreover, mitochondrial labelling 
highlighted a morphological change in the intracellular structure of transfected COS-
7 cells. One possibility is that PLCη2 may act as a link between mitochondrial 
membranes directed by the homodimerisation of the molecule. PLCβ was previously 
found to compose dimers via its C-terminal extension (Singer et al. 2002). If PLCη2 
is also able to form such structures, the dimer-partners may attack different 
membranes with their PH domains and the overexpression of PLCη2 may lead to the 
development of extended PLC-membrane complexes. In PLCη2-transfected COS-7 
cells a considerably higher level of mitochondrial-staining was observed compared to 
untransfected cells. This suggests that the rate of mitochondrial fissure was elevated 
in transfected cells that might be caused by the high levels of PLCη2. Similar 
structural changes are detected when hFis1, a protein involved in mitochondrial 
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fissure is overexpressed in HeLa cells (Frieden et al. 2004). The greater number of 
mitochondria and the high localisation of the overexpressed untagged PLCη2 on 
mitochondria-related membranes might partially explain why mitochondrial Ca
2+
 
release possessed such a great effect on PLCη2 activity. ηηIn addition, the future 
assessment of the effect of PLCη2 on mitochondrial fissure might be of great 
importance and should be followed up in the future. Elevated mitochondrial fissure 
may be a hallmark of degenerative diseases such as Alzheimer`s Disease (Wang et 
al. 2009) so it is plausible that imbalanced PLCη2 activity also contribute to the 
development of age-related cell abnormalities.Nakahara et al. identified the first time 
that PLCη2 possesses a unique sensitivity towards Ca2+ in vitro. According to this 
study, PLCη2 is activated by a 10-fold lower Ca2+ concentration (1 µM) than PLCδ1. 
Unfortunately, results of this assay were not convincing due to the low level of 
activation and the high variance in values (Nakahara et al. 2005). My aim was to 
study Ca
2+
-sensitivity of PLCη2 in a cellular model providing the physiological 
environment necessary for the activation of the enzyme. Permeabilised COS-7 cells 
offered the desired tool whereby the Ca
2+
-sensitivity of wild-type and mutant PLCη2 
proteins were quantitatively determined. PLCη2 enzyme activity displayed the 
greatest increase between 100 nM and 1 µM [Ca
2+
]. This renders the enzyme 10-fold 
less sensitive to Ca
2+ 
than the sperm-specific PLCζ, although 10-fold more than 
PLCδ1 (Kouchi et al. 2005; Nakahara et al. 2005).  
3.6.2. Targeting mechanism of the PH domain 
PLC enzymes are typically distributed in the cytoplasm and are recruited to the 
membranes upon agonist-induced stimulation (Suh et al. 2008). In PLCδ1, the Ca2+-
dependent binding of the PH domain to PI(4,5)P2 is directed via its EFL-domain by 
an unknown mechanism (Yamamoto et al. 1999). In contrast, PLCη2 does not 
require extracellular stimuli for membrane-association indicated by the punctuate 
staining of GFP- PLCη2 in unstimulated COS-7 cells. Considering this and the high 
Ca
2+
-sensitivity of the enzyme, PLCη2 has been proposed as the “primarily reacting 
PLC” (Popovics and Stewart 2012b). This is supported by the finding of Kim et al. 
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showing that the closely related isoform, PLCη1, is an amplifier of the external 
stimuli which lowers the threshold for PLCβ1 activation (Kim et al. 2011).  
The unique membrane-binding dynamics of PLCη2 is likely to depend merely on its 
specific PH domain. In the absence of this domain the protein lost the ability of 
membrane-binding. Similar results were obtained by Nakahara et al. in HeLa S3 cells 
with a few differences. In their experiments the full-length GFP-PLCη2 distribution 
was concentrated to the plasma membrane with a small extent remaining cytosolic 
(Nakahara et al. 2005). Moreover, without the PH domain PLCη2 loses its ability to 
associate with the membrane. Using a FRET-based method the lipid-specificities of 
both PLCη1 and PLCη2 PH domains were assessed. Both domains exhibited a high 
selectivity towards PI(3,4,5)P3, followed by the PLC enzyme substrate PI(4,5)P2 with 
approximately 4-5-fold lower EC50 values. The PLCγ1 PH domain also possesses 
specific affinity for PI(3,4,5)P3 but almost no binding to PI(4,5)P2. This allows the 
protein to be activated by the PI3K-pathway which is known to elevate PI(3,4,5)P3 
levels (Falasca et al. 1998). PLCδ1-PH is highly specific to PI(4,5)P2 and this 
facilitated its usage as a marker for this phospholipid (Watt et al. 2002). The PLCη 
PH domain may participate in membrane-binding even in the absence of its preferred 
lipid, PI(3,4,5)P3 by associating to PI(4,5)P2. The association of PLCδ1-PH domain 
to membranes is regulated by the cleavage product of PI(4,5)P2 hydrolysis, 
I(1,4,5)P3. It is also bound to the PLCδ1-PH domain although as I(1,4,5)P3 is 
released to the cytosol it liberates the associated PLCδ from the membrane by this 
mechanism. This represents a negative feedback mechanism on PLCδ. The PLCη PH 
domains showed approximately 10-fold lower IC50 toward I(1,4,5)P3 than for 
PI(3,4,5)P3. For the dissociation of PLCδ1 from the membrane by the physiologically 
released I(1,4,5)P3, it was determined that its PH domain is 20-fold more sensitive to 
I(1,4,5)P3 than PI(4,5)P2 levels (Hirose et al. 1999). In the light of these findings, it is 
improbable, that the PLCη PH domain-PI(3,4,5)P3 association is under the control of 
I(1,4,5)P3.  
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The study of PH domain lipid-selectivity by the PIP-strip method provided more 
insight into this process. One interesting outcome was the high level of binding of the 
PLCη-PH domains to phosphatidylserine. This is not exceptional among PH domain 
containing proteins; in 3-phosphoinositide dependent kinase-1 (PDK1) a specific PS-
binding groove was identified which is different from its phosphoinositide-binding 
site. Two mutations of this groove (R466A/K467A) prevented agonist-induced 
translocation of PDK1 to the membrane (Lucas and Cho 2011). PH domain of 
evectin-2 has a high specificity towards PS which directs the localisation of the 
protein to the ER (Uchida et al. 2011). In PLCδ1, PS-content of the cell membrane 
inhibits the association of its PH domain which is driven by electrostatic interactions 
(Uekama et al. 2007). PS-binding of PLCη-PH domains might be unique in the PLC 
family, although binding-properties should be assessed in the future by a quantitative 
method such as the FRET-assay used in this Chapter. 
3.6.3. Identification of a novel EF-hand in PLCη2 
An EF-hand-domain with two Ca
2+
-binding loops was identified in PLCη proteins 
based on the alignment of its sequence with other proteins with similar domains. This 
revealed that PLCη EF-loops are asymmetrical; whereas EF-loop 1 is similar to 
canonical EF-hand conserved amino acid composition possessing 12-residue, the 
second loop contains a one-residue insertion. This was mapped between position 4 
and 5 (H296) or 5 and 6 (Q297). The distorted EF-loop 2 might still be able to co-
ordinate Ca
2+
.For example, the extracellular Ca
2+
-binding protein, BM-
40/osteonectin contains an amino acid insertion in its first EF-loop and it is still able 
to develop the pentagonal bipyramid Ca
2+
-binding structure (Hohenester et al. 1996).  
To assess the participation of each loop in Ca
2+
-activation, mutations were generated, 
changing key residues to alanine in both loops. The aspartic acid in position 1 of the 
loops provides a carboxylate group as the first ligand for coordination of the Ca
2+
 in 
canonical EF-hands (Gifford et al. 2007). The corresponding residue in each of the 
EF-loops was mutated (D256A and D292A) and the activities of each were 
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examined. The D256A mutant transfected cells were unaffected by monensin 
treatment and exhibited a 10-fold decrease in its threshold for activation by Ca
2+
. In 
contrast, the D292A mutation did not induce any visible change in Ca
2+
 sensitivity 
and only slightly decreased the stimulatory action of monensin. Further mutations 
were generated in the second loop in order to reveal if Ca
2+
-coordination by other 
residues may affect the catalytic activity. These were the hypothesised insertions 
(H296A and Q297A) and the glutamic acid in the 12 position, which provides a 
bidentate ligand in the canonical EF-hand structure (E304A) (Gifford et al. 2007). 
None of these mutations affected monensin-induced activity and Ca
2+
-sensitivity of 
PLCη2. Although, it is worth mentioning that all three mutants exhibited reduced 
activity at 10 µM and 100 µM Ca
2+
 concentrations. Collectively, these results 
suggest that the allosteric changes upon Ca
2+
-binding of the first EF-loop is alone 
responsible for the activation of the catalytic domain whereas the second loop might 
only possess a little regulatory role on this process. Activity of the wild-type PLCη2 
declines at high Ca
2+
-levels (100 nM and 1 mM). This suggests the existence of a 
negative feedback by high [Ca
2+
] which might be directed by the second EF-loop. 
Nevertheless, further studies are required to ascertain exactly how the PLCη2 EF-
hand domain translates Ca
2+
 binding into the regulation of enzymatic activity.   
3.6.4.: C2 domain supports the secondary membrane-docking of 
PLCη2 
Putative Ca
2+
-binding residues of PLCη2 C2 domain were identified following 
alignment of its sequence with C2 domain sequences from PLCη1, PLCδ1 and 
synaptotagmin. In these proteins, similarly to other Ca
2+
-binding domains, ligands 
for Ca
2+
-coordination are predominantly provided by aspartic acids of the C2 domain 
(Sutton et al. 1995; Ananthanarayanan et al. 2002). Accordingly, conserved residues 
D861 and D920 in PLCη2 were selected for mutation. At position D861 in PLCδ1 
(N647), Ca
2+
-coordination is directed by an asparagine. This residue is responsible 
for the selectivity of the C2 domain towards phosphatidylserine and regulates the 
intracellular localisation of the domain when it is expressed without other domains as 
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a GFP-tagged protein (Ananthanarayanan et al. 2002). To assess the role of this 
variation, the D861 residue was mutated to both alanine and asparagine in PLCη2, 
respectively. 
Measurement of PLC-activity in transfected cells following monensin stimulation 
revealed that the lack of Ca
2+
-coordination by the D861 residue has little effect on 
this process (23% reduction). However, the D861N mutation decreased monensin-
induced activation to a much greater extent (55% reduction). As described before, 
this latter residue directs lipid sensitivity in PLCδ1 and therefore it might occur that 
the substitution of the D861 residue with an asparagine in PLCη2 mimicked the 
lipid-binding specificity of the C2 domain in a way that was deleterious for 
enzymatic cleavage (Ananthanarayanan et al. 2002). Nevertheless, inability of the 
D861A mutation to induce great changes in enzyme activity suggests that lack of 
Ca
2+
-coordination by the first conserved aspartate of PLCη2 C2-domain might be 
compensated by the other Ca
2+
-binding residues in the domain. Conversely, mutation 
of the D920 residue greatly reduced the enzyme activity in both assays implicating 
its specific role in providing ligand to Ca
2+
. Similar results were obtained by the 
permeabilisation of transfected COS-7 cells showing that D861A and D920A 
mutants were comparatively unresponsive to Ca
2+
. In addition, there was no change 
in Ca
2+
-sensitivity in any of the C2 domain mutants providing more evidence on the 
unique involvement of the EF-hand in this process. In conclusion, the D920A mutant 
revealed that the secondary membrane association of the C2 domain is essential for 
regular enzymatic activity of PLCη2. 
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Table 3.2.: Summary of mutations generated in PLCη2 and their effects on enzyme 
activity. 
3.6.5.: Conclusion 
The main conclusions of this Chapter are presented in Figure 3.30. Enzymatic 
activity of the catalytic site is assisted by a two-point membrane-association of 
PLCη2. Firstly, PH domain selects the membrane subtype based on its lipid 
composition and secondly, the C2 domain also associates with the membrane 
possibly via a Ca
2+
-bridge. This highlights that the intracellular localisation of 
PLCη2 is primarily controlled by the PH domain. As determined in this Chapter, it 
depends on the presence of two molecules, PI(3,4,5)P3 and PI(4,5)P2 in membranes, 
respectively. In addition, the activation of the membrane-docked protein by 
submicromolar Ca
2+
concentration is directed by the EF-hand. This allows the 
enzyme to react to small changes in Ca
2+
 levels and amplify these signals by 
PLCη2 domains mutations
effect of 
monensin (70 μM)
effect of Ca2+-
permeabilisation
PH-domain ΔPH deleterious deleterious
D256A deleterious
10-fold decrease 
in Ca2+-
sensitivity
D292A ~20 % decrease
no difference 
from WT
D296A
no difference 
from WT
~20 % decrease 
at 10 μM
Q297A
no difference 
from WT
~20 % decrease 
at 10 μM
E304A
no difference 
from WT
~30 % decrease 
at 10 μM
D861A ~20 % decrease
no difference 
from WT
D861N ~60 % decrease
~80 % decrease 
at 10 μM
D920A deleterious
~90 % decrease 
at 10 μM
EF-hand
C2-domain
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releasing more Ca
2+
 from I(1,4,5)P3-sensitive stores. These findings describe the 
basic regulation of PLCη2. The following Chapter investigates the PLCη2 from a 
new, physiological aspect to determine its role in differentiating neurons.  
 
Figure 3.30.: Illustration of the role of PLCη2 domains in supporting enzymatic 
cleavage. PH domain directs the primary association of PLCη2 to membranes. The 
EF-hand directs the activation of PI(4,5)P2 hydrolysis upon Ca
2+
-binding. A 
secondary, Ca
2+
-associated binding of the membrane is also crucial for normal 
enzymatic function which is regulated by the C2 domain. Stimulation of the activity 
leads to the generation of diacilglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). 
Figure is reproduced with permission from Elsevier (Popovics et al. 2011).
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4.1. Introduction 
Although some of the biochemical properties of PLCη2 have been characterised, its 
functional role and the answer to the question “why do we need another PLC?” is yet 
to be revealed. Hypothetical functions have been proposed by us and others largely 
based on high expression of PLCη2 in the brain and in neuroendocrine cells 
(Cockcroft 2006; Stewart et al. 2007; Popovics and Stewart 2012b). PLCη2 is 
expressed throughout the cerebral cortex but its highest levels are found in the 
hippocampus, habenula, olfactory bulb and cerebellum (Nakahara et al. 2005; 
Kanemaru et al. 2010). Its presence seems to be restricted to neurons suggested by its 
lack from astrocyte-enriched primary cultures (Nakahara et al. 2005). In the first part 
of this Chapter, the tissue specific expression of PLCη2 is examined through the use 
of in situ hybridisation data available within the Allen Brain Atlas (Lein et al. 2007, 
http://mouse.brain-map.org). Depending on the cellular localisation of the enzyme, it 
may be involved in various functions of the neuron. Unfortunately, until now the 
cellular localisation of PLCη2 had only been assessed in non-neuronal cells (COS-7 
and HEK 293 cells) (Nakahara et al. 2005; Popovics et al. 2011). Therefore, one aim 
of this Chapter is to assess its distribution in neuronal cells. 
Interestingly, PLCη2 levels gradually increase after birth (Nakahara et al. 2005). 
Changes in its level during intrauterine development have not previously been 
assessed. Data stored within the Allen Brain Database show a tendency for PLCη2 to 
elevate during both intrauterine and postnatal development 
(http://developinghumanbrain.org) indicating that it might possess an important role 
for neuronal differentiation or maturation. Here, the role of PLCη2 in neuronal 
differentiation is examined. For this study, a well-defined mouse neuroblastoma cell 
line (Neuro-2a) was selected as a model of neuronal differentiation that was isolated 
from a spontaneous tumour of murine neural crest cells (Klebe and Ruddle 1969). 
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4.2. Results 
4.2.1. The distribution of PLCη2 in the mouse brain  
The expression of PLCη2 in different areas of the mouse brain had been 
characterised earlier by in situ hybridisation, LacZ reporter knock-in or by western 
blot (Nakahara et al. 2005; Kanemaru et al. 2010). Additional information on PLCη2 
expression is stored within the Allen Brain Atlas which was created by a non-profit 
medical research organisation known as the Allen Institute for Brain Science (AIBS). 
Their first large scale project was to map the expression of approx. 20,000 genes in 
the mouse brain by in situ hybridisation (Lein et al. 2007). The expression of these 
genes were detected, quantified and the data was collected into a database which is 
suitable for multi-level comparisons of gene expression patterns. To facilitate the 
correct localisation of gene expressions, a comprehensive atlas of the mouse brain 
was also produced. All data was collected from 8-week-old adult C57BL/6J male 
mice. In this Chapter, the database was used to reveal PLCη2 mRNA expression 
patterns of different brain regions and to compare it to the existing literature. The 
anatomical terminology used is identical to the atlas provided by the AIBS. After the 
digitalisation of gene expression levels, a so-called heat map was produced for all in 
situ hybridised brain slice. On these maps the level of gene expression is shown by 
different colours as follows: blue: low, green: medium, red: high expression level. 
PLCη2 is expressed throughout the cerebral cortex and its highest levels are found in 
the olfactory bulb, hippocampus and cerebellum (Figure 4.1.). This is consistent with 
previous findings (Nakahara et al. 2005; Kanemaru et al. 2010).  
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Figure 4.1: The expression of PLCη2 mRNA in the mouse brain detected by in situ 
hybridisation. A: heat map representing the expression level of PLCη2 (blue: low, 
green: medium, red: high expression level), B: colorimetric detection of In situ 
hybridisation by digoxigenin labelled PLCη2 RNA probe;; C: Reference atlas of the 
mouse brain. Data was collected from 8 week old adult C57BL/6J male mice. Main 
anatomical structures: MOB: main olfactory bulb, AOB: accessory olfactory bulb, 
OT: olfactory tubercule, ACB: nucleus accumbens, CP: caudoputamen, CTX: 
cerebral cortex, TH: thalamus, HY: hypothalamus, HPF: hippocampal formation, 
MB: midbrain (SC: superior colliculus, IC: inferior colliculus, MRN: midbrain 
reticular nucleus, VTA: ventral tegmental area), CBX: cerebellar cortex, P: pons and 
MY: medulla. Pictures were taken with permission from AIBS (Lein et al. 2007). 
Magnification of a cerebellar folium (Figure 4.2.) revealed the cell layer-specific 
localisation of PLCη2. PLCη2 expression is absent in the Purkinje- but pronounced 
in the granular layer. The most frequent cell type of this latter layer is the granule cell 
that is also present in the olfactory bulb and dentate gyrus of the hippocampus. In the 
cerebellum, granule cells receive input from the mossy fibers and their axon is 
terminated in the molecular layer to form synapses with the Purkinje cell arborisation 
(Nieuwenhuys 2007). PLC activity is particularly important in these cells as it 
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transforms the ligand-dependent activation of muscarinic, metabotropic 
glutamatergic, histaminergic and α-adrenergic receptors into downstream cellular 
responses (del Rio et al. 1999). 
 
Figure 4.2: PLCη2 is highly abundant in the cerebellum. A small section of a 
cerebellar folium is shown with the indication of the different layers: molecular layer 
(mol. lay.), Purkinje layer (pur. lay.) and granular layer (gran. lay.). PLCη2-positive 
cells are predominantly found in the granular layer. A similar tissue section with 
Nissl staining (staining of the cell nuclei) is used as reference. In situ hybridisation 
was performed using a digoxigenin-labelled PLCη2 RNA probe. Data was collected 
from 8 week old adult C57BL/6J male mice. Pictures were taken with permission 
from AIBS (Lein et al. 2007). 
The hippocampal formation is composed of two main structural entity; the Ammon`s 
horn (CA1-CA3 regions) and the dentate gyrus with the main cell types being 
pyramidal and granule cells, respectively. Whereas cells in the CA1-CA3 contain 
high amounts of PLCη2 mRNA, only a couple were PLCη2 positive in the dentate 
gyrus (Figure 4.3a). In the study by Nakahara et al., the presence of PLCη2 mRNA 
in the dentate gyrus granule cells was also detected by in situ hybridisation. 
Unfortunately, this study did not specify the age of the mice or the mouse lineage 
(Nakahara et al. 2005). In a separate report, Kanemaru et al showed only a weak 
expression of the gene in the CA1-CA3 region in PLCη2/ LacZ reporter transgenic 
CHAPTER 4. THE ROLE OF PLCη2 IN NEURONAL PHYSIOLOGY  
 
129 
 
mouse and the in situ hybridisation conducted by the same study showed no staining 
in the dentate gyrus (Kanemaru et al. 2010). Variations in gene expression levels are 
likely to be the result of different ages of the animals. It is also possible considering 
that the hippocampal formation is highly involved in learning and memory 
formation, the difference observed might be related to the environmental enrichment 
of the different animals. The subgranular zone of the dentate gyrus is one of the 
major origins of neurogenesis in the adult brain (Eriksson et al. 1998). Here, granule 
cells are produced throughout life by a long maturation process (Ehninger and 
Kempermann 2008). The number of new born neurons is associated with the quality 
of the environment. For instance, exercise has a stimulatory action whereas stress 
possesses an inhibitory effect on adult neurogenesis (van Praag et al. 1999; Karten et 
al. 2005). PLCη2 expression in the dentate gyrus is restricted to small numbers of 
cells suggesting that it might encompass a specific temporal expression pattern 
during the maturation of granule cells.  
Increased expression of PLCη2 was found in the medial habenula (MH), pineal gland 
(PIN,) and the suprachiasmatic nucleus (SCH, part of the hypothalamus, Figure 4.3). 
These structures are functionally interlinked by their involvement in the generation 
and organisation of circadian information. The major intrinsic rhythm generator is 
the SCH, which receives inputs from melanopsin containing cells of the retina to 
acquire information of the current phase of the day and night cycle (Hattar et al. 
2006). The habenula and the SCH innervate the PIN and consequently regulate its 
melatonin secretion (Teclemariam-Mesbah et al. 1999). Interestingly, not only the 
intracranial structures of the circadian system but also the retina contain elevated 
PLCη2 levels (Zhou et al. 2005; Kanemaru et al. 2010). Suggested by these findings, 
PLCη2 might have a specific role in the physiology of the regions collectively 
known as the circadian system. 
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Figure 4.3.: High expression levels of PLCη2 were found in the hippocampus, 
medial habenula (A), suprachiasmatic nucleus (B) and pineal gland (C). Reference 
atlases were included for pictures A and B. Abbreviations of the anatomic structures 
are: Hippocampal formation (HPF): Ammon`s horn (CA1, CA2 and CA3) and 
dentate gyrus (DG). Epithalamus: medial habenula (MH), lateral habenula (LH) and 
pineal gland (PIN), the suprachiasmatic nucleus (SCH) as part of the hypothalamus 
(HY), found above the optic chiasm (och). PLCη2 only appears in the polymorph 
layer (po) of the dentate gyrus and it is almost absent in the granule cell layer (sg). In 
addition, PLCη2 is highly abundant in the CA1-CA3 regions, MH, SCH and PIN. In 
situ hybridisation was performed using a digoxigenin labelled PLCη2 RNA probe. 
Data was collected from 8 week old adult C57BL/6J male mice. Pictures were taken 
with permission from AIBS (Lein et al. 2007). 
High mRNA levels of PLCη2 were also detected in the main olfactory bulb (MOB), 
pyriform cortex (PIR) and in the olfactory tubercule (OT). These regions are part of 
the system which processes olfactory information (Figure 4.4). The granule layer of 
the MOB and the cell-dense groups of the OT (isles of Calleja) are mainly composed 
of granule cells (Millhouse 1987). Hence, the presence of PLCη2 in this cell type 
was again shown but in regions associated with different functions. In addition, 
PLCη2 might specifically be involved in the procession of olfactory information. 
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Figure 4.4.: Increased PLCη2 mRNA levels are found in the main olfactory bulb 
(MOB), pyriform cortex (PIR) and the olfactory tubercule (OT). Layers of the main 
olfactory bulb are magnified and labelled as: mitral layer, inner plexiform layer and 
granule layer. The in situ hybridisation was performed using a digoxigenin labelled 
PLCη2 RNA probe. Data was collected from 8 week old adult C57BL/6J male mice. 
Main anatomical structures are: MOB: main olfactory bulb, AOB: accessory 
olfactory bulb, ACB: nucleus accumbens, OT: olfactory tubercule, PIR: piriform 
cortex, SI: substantia innominata, isl: isles of Calleja, lot: lateral olfactory tract. 
Pictures were taken with permission from AIBS (Lein et al. 2007). 
4.2.2. Different splice variants of PLCη2 are expressed in Neuro-2a 
cells and in mouse brain 
Splicing of the exons in PLCη2 C-terminal domain provides the mechanism for the 
generation of 5 different splice variants with large variations in their mass (from 
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119.2 kDa to 181.4 kDa of the mouse protein, Zhou et al. 2005). The terminology of 
the variants indicates their exon composition (Figure 4.5). The splice variant specific 
sequences are selected from 3 exons: 21, 22 and 23, however, exon 21 is excised at 3 
different sites on its C-terminal end serving as the origin for more variation between 
spliceforms. The expression of the spliceforms is tissue-specific; among the five 
different splice variants of PLCη2, two (21b/22/23 and 21c/22/23) are expressed in 
the brain and 4 in the retina (Zhou et al. 2005).  
 
Figure 4.5: Exon composition of the C-terminus in different splice variants of 
PLCη2. Coloured blocks represent exons: 21a, 21b, 21c, 22 and 23. Stop codons are 
indicated by arrows. Black lines symbolise protein segments encoded by maturated 
mRNA of the different spliceforms. Figure was produced by the author of this thesis. 
Both PLCη1 and PLCη2 have been shown to be expressed in Neuro-2a cells 
although only with methods which did not discriminate between splice variants (Kim 
et al. 2011). Zhou et al employed splice variant-specific primers in an RT-PCR to 
detect differences between PLCη2 variant-composition of mouse tissues (Zhou et al. 
2005). Unfortunately, the authors did not specify the PCR conditions for this 
experiment and when it was repeated in our lab the primers were not able to amplify 
PCR products in any of the conditions tested (data not shown). Therefore, new 
primers were designed (Table 4.1 contains the sizes of PCR products and the primer 
sequences are found in Chapter 2, Table 2.5.). 
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Table 4.1.: Detection of PLCη2 spliceforms by using specific primers. Various 
combinations of forward and reverse primers determine the amplification of splice-
variant specific PCR products (see Materials and Methods for primer sequences). 
The Table reports the expected sizes (bp) of all potential PCR products. Two 
products of the 21bFW/23RW primer combination were undiscriminated due to the 
small differences in their sizes (287 bp and 314 bp). The smallest product of the 
21aFW/22RW primer combination (66 bp) was not detectable. 
 
Figure 4.6.: Detection of PLCη2 splice variants in Neuro-2a cells (A) and in mouse 
brain (B) by RT-PCR. Lanes: 1: 21aFW/23RW, 2: 21bFW/23RW, 3: 21aFW/22RW, 
4: 21bFW/22RW, 5: 21bFW/21cRW, 6: PLCη2 (not spliceform specific), 7: RPLP0 
(loading marker). Sizes of PCR products are found in Table 4.1. (A non-specific 
band is found in Lane 4 close to the 600 bp marker. In Lane 5 of Figure A, only non-
specific products were amplified probably due to the lack of the 21c/22/23 variant in 
Neuro-2a cells). Summary of results is found in Table 4.2. 
With these primers, cDNAs from both Neuro-2a cells and whole mouse brain were 
tested for splice-variant composition (Figure 4.6.). In Neuro-2a cell cDNA, the 
presences of 21a/23 and 21a/22/23 variants were confirmed. The 21b/22/23- and 
21c/22/23- specific primers of the same sample only resulted in a product once (out 
of 4 and 3, respectively) therefore it was treated as false positive. In contrast, mainly 
primer composition 21a/23 21a/22/23 21b/23 21b/22/23 21c/22/23
21aFW/23RW 214 241 718 740 1567
21bFW/23RW 287 not separated 314 not separated 1136
21aFW/22RW 66-not detectable 570 1392
21bFW/22RW 139 961
21bFW/21cRW 163
size of PCR products (bp)
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the 21b/22/23 and 21c/22/23 variants were detected in brain as previously found by 
Zhou et al (Zhou et al. 2005).  
 
Table 4.2.: Splice variant-specific PCR products detected in Neuro-2a cells and in 
mouse brain. Mainly the 21a/23 and 21a/22/23 spliceforms were detected in Neuro-
2a cells (abbreviated as N2A), whereas in brain the 21b/22/23 and 21c/22/23 forms 
were predominant.  
RT-PCR results were supported by employing a western blot on Neuro-2a cell-
lysates with a PLCη2 specific antibody (Figure 4.7.). It is apparent from the blot, that 
the 21a/22/23 spliceform is the predominant variant as detected at its expected 
protein mass (119.2 kDa). An additional band, which possibly corresponds to the 
21a/23 variant (164.3 kDa), was also detected. This latter finding might be important 
as it is one of the two splice variants which contain the PDZ-binding motif at the C-
terminal end. However, as the 21a/22/23 spliceform is the dominant in Neuro-2a 
cells, the expression of this variant will be assessed in further experiments and will 
be referred to as PLCη2. 
 
Figure 4.7.: Immunoblot of Neuro-2a cell lysates demonstrating the expression of 
the 21a/23 and 21a/22/23 splice variants of PLCη2. Bands corresponding to the 
21a/23 and the 21a/22/23 splice variant have been detected at their expected sizes 
(164.3 kDa and 119.2 kDa, respectively). Whole cell lysate from Neuro-2a cells was 
separated on a 4-12% SDS-polyacrylamide gel. 
primer composition 21a/23 21a/22/23 21b/23 21b/22/23 21c/22/23
21aFW/23RW N2A N2A brain
21bFW/23RW brain? brain? N2A
21aFW/22RW brain
21bFW/22RW N2A,brain brain
21bFW/21cRW brain
detected bands
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4.2.3.: PLCη2 level gradually elevates during retinoic acid induced 
differentiation of Neuro-2a cells 
Neuro-2a cells were previously described as neuronal stem cells being highly 
susceptible to differentiation initiating molecules. Zeng and Zhou et al. employed the 
combination of retinoic acid treatment (20 µM), reduced serum (2% FBS) and low 
cell plating density (100cells/mm
2
) (Zeng and Zhou 2008). Following this protocol, 
Neuro-2a cells were differentiated in 4 days. During this time, cells changed their 
stem-cell like morphology to possess extended neurites and an enlarged cell body 
(Figure 4.8.a). This 4-day model was used to examine PLCη2 protein levels during 
neuronal differentiation. Short-term treatment (4 hours) of retinoic acid already 
resulted in a significant increase in PLCη2 protein level (76%, t-test, p<0.01). 
Moreover, PLCη2 levels gradually increased throughout the differentiation process. 
At day 4, PLCη2 level was ~10-fold higher compared to its basal expression on day 
0 (t-test, p<0.01, Figure 4.8.b,c).  
As a first step towards investigating the specific role of PLCη2 in neuronal 
differentiation, the cellular localisation of the endogenous protein was investigated in 
undifferentiated and differentiated Neuro-2a cells by immunocytochemistry (Figure 
4.9.). This was conducted with a PLCη2-specific antibody as described in Chapter 2. 
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Figure 4.8.: PLCη2 protein levels increase during retinoic acid-stimulated 
differentiation of Neuro-2a cells. A) Bright field images showing Neuro-2a cells 
differentiated with 20µM retinoic acid for 4 hrs, or for 1 to 4 days. Bars correspond 
to 100 µm. B) Western blot showing PLCη2 protein levels during differentiation 
(Day 0, 4 hrs, Day 1-4). The protein levels of β-actin were used as a loading control. 
The blot shown is representative of 3 independent experiments. Protein samples were 
separated on a 4-12% polyacrylamide gradient. C) Quantification of PLCη2 protein 
levels during Neuro-2a cell differentiation. Densitometry was conducted by using the 
ImageJ analysis software. PLCη2 protein expression was normalised to the β-actin 
protein level and the basal expression on Day 0 was defined 1. Error bars represent ± 
S.E.M. (t-test, p<0.05:*, p<0.01:**, p<0.001:***, n=3).  
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Figure 4.9.: Cellular localisation of endogenous PLCη2 (green) in undifferentiated 
(A) and differentiated (B) Neuro-2a cells counterstained with the nuclear marker, 
DAPI (blue). A) In undifferentiated Neuro-2a cells PLCη2 is localised to the nucleus, 
perinuclear area and plasma membrane (perinuclear and extracellular membrane 
localisation are indicated by arrows). B) In differentiated Neuro-2a cells, PLCη2 is 
also highly abundant in the nucleus and the perinuclear area. In the neurite, PLCη2 
staining is displayed as local accumulations in bulge-like structures (indicated by 
arrows). Neuro-2a cells were seeded onto coverslips and fixed the next day 
(undifferentiated cells) or differentiated for 4 days with 20 µM retinoic acid 
(differentiated cells). Images are representative and were taken from a deconvoluted 
Z-stack by a DeltaVision deconvolution microscope (Applied Precision). Bars 
correspond to 10 µm.  
In undifferentiated cells, PLCη2 was localised mainly in the nucleus but was also 
found in the perinuclear area and on the cell membranes (Figure 4.9.a). In 
CHAPTER 4. THE ROLE OF PLCη2 IN NEURONAL PHYSIOLOGY  
 
138 
 
differentiated cells, a similar pattern was observed (Figure 4.9.b). In addition, PLCη2 
also localised to the neurite where it concentrated to small bulge-like structures. 
Detection of PLCη2 in the nucleus was unexpected based on earlier findings. In non-
neuronal cells the GFP-tagged enzyme was mainly detected at the cellular membrane 
(HEK-293) or on intracellular membranes (COS-7 cells in Chapter 3) but its 
transport to the nucleus was not indicated (Nakahara et al. 2005). Therefore the 
nuclear transport of PLCη2 in these cells might be facilitated by an unknown 
mechanism which would consequently involve the enzyme in the regulation of 
nuclear Ca
2+
 dynamics in neurons. Although the presence of a nuclear localisation 
signal was not yet characterised on PLCη2 these results highlight the importance of 
such investigation in the future.  
Furthermore, PLCη2 was also observed in the neurites, often as small concentrated 
areas in bulge-like structures. These varicosities are likely to be the structures 
involved in axonal transport of packed ER tubules and mitochondria that has been 
described in regenerating neurons (Koenig et al. 1985; Hollenbeck and Bray 1987). 
The movement of these structures is Ca
2+
 dependent and therefore PLCη2 activity 
may contribute to the regulation of this process (Koenig et al. 1985).  
Cellular localisation of PLCη2 was also assessed in Neuro-2a cells transfected with 
the GFP-tagged PLCη2 construct used in Chapter 3 (Figure 4.10.). Neuro-2a cells 
were transiently transfected by Lipofectamine and were fixed the next day 
(undifferentiated cells) or were treated with 20 µM retinoic acid for 2 days before 
fixation.  
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Figure 4.10.: Cellular localisation of GFP-tagged PLCη2 (green) in undifferentiated 
(A) and differentiated Neuro-2a cells (B) counterstained with the nuclear marker, 
DAPI (blue). A) GFP-PLCη2 is highly abundant in the nucleus but it is also present 
on the plasma membrane and in the cytoplasm (plasma membrane localisation is 
indicated by an arrow). B) In differentiated cells, GFP-PLCη2 is mainly localised to 
the nucleus, perinuclear region and the intra- and extracellular membranes. At the 
nerve ending PLCη2 is predominantly localised to the extracellular membrane. 
Neuro-2a cells were seeded onto coverslips, transfected with GFP-PLCη2 the next 
day and fixed after 24 hrs (undifferentiated cells) or transfected and differentiated for 
2 days with 20 µM retinoic acid before fixation (differentiated cells). Images are 
representative and were taken from a Z-stack. Images were taken by: A) DeltaVision 
deconvolution microscope (Applied Precision) B) Leica confocal microscope. Bars 
correspond to 10 µm.  
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The advantage of the GFP-tag is that it provides a better signal-to-noise ratio, 
however, it always has to be taken into account that a protein which is 
overexpressessed might display altered cellular distribution than the endogenous 
protein. There is always a chance that the surplus GFP-tagged protein might 
associate to membranes which normally do not attract PLCη2. However, the cellular 
distribution GFP-PLCη2 largely mirrored the localisation of the endogenous PLCη2, 
although, a large pool of PLCη2 was found in the cytosol. This might be due to the 
excess amounts of PLCη2 produced by the overexpression of the protein. The main 
proportion of the GFP signal was found in the nucleus in both undifferentiated and 
differentiated cells. Apart from this, GFP-PLCη2 was also observed on extra- and 
intracellular membranes. In addition, the enhanced signal of GFP highlighted the 
localisation of PLCη2 in nerve endings where it was detected in the synaptic 
membrane and on tubular like intracellular structures.  
 
Figure 4.11.: Endogenous PLCη2 (green) is partially colocalised with mitochondria 
(red) in non-differentiated and differentiated Neuro-2a cells. Co-localisation 
coefficient was 0.5875 in undifferentiated cells (S.E.M.: 0.0509, n=3, Pearson 
coefficient)  indicating a tendency of PLCη2 to associate with mitochondrial 
membranes. In undifferentiated cells the co-localisation level was below 0.5 possibly 
due to the increased presence of PLCη2 in the nucleus. Cells were seeded onto 
coverslips and fixed the next day (undifferentiated cells) or differentiated for 4 days 
with 20 µM retinoic acid (differentiated cells). Mitochondria are stained with 
MitoTracker Red. Images are representative and were taken from a deconvoluted Z-
stack by a DeltaVision deconvolution microscope (Applied Precision). Bars 
correspond to 10 μm. 
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As earlier shown in Chapter 3., transfected PLCη2 in COS-7 cells has a high co-
localisation rate with mitochondria. To ascertain whether this occurs in an 
endogenous PLCη2 model such as Neuro-2a cells, non-differentiated and 4-day 
differentiated cells were subjected to MitoTracker Red treatment that was followed 
by the fluorescent labelling of endogenous PLCη2 (Figure 4.11.). Deconvoluted 
images show a partial co-localisation of PLCη2 with mitochondrial membranes 
although the co-localisation coefficient was just above 0.5 (Pearson coefficient). 
Although this could be due to the presence of PLCη2 in the nucleus as mitochondrial 
staining should never occur inside these organelle. 
4.2.4. The physiological level of PLCη2 is essential for the retinoic 
acid-induced differentiation of Neuro-2a cells  
The finding that PLCη2 expression is upregulated during the differentiation of 
Neuro-2a cells (Figure 4.8.) strongly supports the idea that PLCη2 is a key molecule  
for neuritogenesis. Therefore, the next aim was to investigate of its importance for 
Neuro-2a cell differentiation. PLCη2 knock-down cell lines were generated by the 
stable transfection of shRNA targeting the expression of PLCη2. Four shRNA 
constructs in psi-H1 vector (Genecopoeia) were transfected by electroporation and 
stable clones were selected using puromycin. Single-cell-derived clones were tested 
with Western blot to select two cell lines with the highest knock-down efficiency 
(shRNAPLCη2-1 and shRNAPLCη2-2, Figure 4.12.a). A control cell line was 
produced by the stable transfection of scrambled control shRNA. The protein level of 
PLCη2 21a/22/23 variant was calculated based on the densitometry of two western 
blots and was normalised to β-actin levels (Figure 4.12.). According to this, PLCη2 
expression was decreased to 33% and 61% in shRNAPLCη2-1 and shRNAPLCη2-2 
cell lines, respectively. 
Previously, a role for PLCη1 was proposed in the enhancement of GPCR-induced 
PLC activity in Neuro-2a cells. In this study, PLCη1 and PLCη2 knock-down cells 
were treated with the Ca
2+
 ionophore, ionomycin, followed by the measurement of 
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inositol-turnover. Interestingly, only the downregulation of PLCη1 level was 
effective in reducing the Ca
2+
-induced phospholipase activity in this experiment. 
Unfortunately, Kim et al. did not demonstrate the level of PLCη2 reduction in knock-
down cells and therefore it might not be appropriate to compare the participation of 
the two enzymes in this Ca
2+
-dependent process (Kim et al. 2011). 
 
Figure 4.12.: PLCη2 protein level was downregulated by the stable transfection of 
shRNA in Neuro-2a cells. A) Representative immunoblot showing the expression of 
PLCη2 splice variants 21a/23 (164.3 kDa) and the 21a/22/23 (119.2 kDa). The whole 
cell lysate from Neuro-2a cells was separated on a 4-12% SDS-polyacrylamide gel. 
B) Calculation of PLCη2 (21a/22/23) knock-down efficiency by densitometry on 2 
western blots. PLCη2 levels were normalised to β-actin levels and the level of 
shRNAcontrol was determined as 100%.  
To ascertain whether PLCη2 is involved in this process, an inositol phosphate (IP) 
release assay was employed with the three cell lines to determine phospholipid 
turnover in response to Ca
2+
. The only Ca
2+
-mobilising agent which effectively 
increased the activity of PLCη2 in transfected COS-7 cells was the Na+ ionophore 
monensin (Chapter 3) although this might have been due to the specific cellular 
localisation of the enzyme in these cells. In Neuro-2a cells, the distribution of PLCη2 
is certainly altered and our aim was to find an agent which is more likely to increase 
the overall PLC activity in these cells. Although, the treatment of the Ca
2+
 ionophore 
A23187 was unsuccessful to increase inositol phosphate level above the control level 
in PLCη2-expressing COS-7 cells, it stimulated the endogenous PLC activity 3-fold 
in the control cells. As this agent was found to be a potent stimulator of PLC activity, 
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it was used to treat the Neuro-2a cell lines in the IP release assays. Unfortunately, 
monensin treatments were not efficient in the elevation of endogenous PLC activity 
in these cells (data not shown) therefore this agent was not used in the following 
experiments. Preliminary experiments implied that the cell content of a 12-well plate 
that was previously used with the COS-7 cells would not provide enough material to 
effectively count IP-levels in Neuro-2a cells and therefore experimental conditions 
have been altered. Cells were grown and treated with 1 μCi/ml myo-D-[3H]inositol in 
14 cm diameter dishes. On the day of the IP assay cells were trypsinised, sorted into 
tubes (500.000 cells/tube) and were pre-incubated with 10 mM LiCl containing 
buffer A for 1 hour. Subsequently, 5 µM A23187 was introduced to the cells for 3 
hours and the stimulation was stopped by adding formic acid to a final concentration 
of 10 mM. This was followed by the conduction of the IP assay. Interestingly, the 
Ca
2+
 induced release of IPs was significantly reduced in both knock-down cell lines 
from 154% (shRNAcontrol) to 110% (shRNAPLCη2-1, one-way ANOVA, p<0.01) 
and 118% (shRNAPLCη2-2, one-way ANOVA, p<0.01, Figure 4.13.). This supports 
the idea that PLCη2 is activated by Ca2+-transients in Neuro-2a cells and might be 
also crucial for the synergistic activation of other PLCs similarly to PLCη1 (Kim et 
al. 2011). 
Next the effect of PLCη2 knock-down on the differentiation process of Neuro-2a 
cells was investigated. Control and knock-down cells were differentiated as 
described previously for 4 days and bright images were taken with a x10 objective on 
each day to follow the morphological changes during the whole process. 
Representative images of 4-day differentiated cells from each cell line are shown in 
Figure 4.14a. Differentiation was significantly inhibited in the knock-down cells to 
an extent which largely mirrored the reduction in PLCη2 levels of the two cell lines. 
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Figure 4.13: Calcium induced phospholipid turnover is significantly reduced in 
PLCη2 knock-down cells. ShRNAcontrol and PLCη2 knock-down Neuro-2a cells 
were incubated with myo-D-[
3
H]inositol for 24 hours. Subsequently cells (500.000 
cells/tube) were pretreated with 10 mM LiCl for an hour, treated with 5 µM A23187 
(Ca
2+
 -ionophore) in 10 mM LiCl containing buffer A for 3 hours and were subjected 
to inositol -phosphate release assay. The activity of the untreated shRNA control was 
defined as 1. Error bars represent ± S.E.M. (one-way ANOVA, p<0.01, n=3).  
The shRNAPLCη2-1 cells showed very little neurite outgrowth whereas the 
shRNAPLCη2-2 cells possessed longer neurites. To quantitatively evaluate these 
results the rate of differentiation for each day was calculated from three independent 
experiments (Figure 4.14.b). A cell was defined differentiated upon possessing at 
least one neurite that was longer than twice the diameter of the cell body. Two 
images were analysed in each experimental group (at least 75 cells in each group). 
ImageJ software was used to accurately measure cell body and neurite lengths. 
Significant differences between the differentiation rates of shRNAcontrol and knock-
down cell lines were detected already on day 1 of treatment (one-way ANOVA, 
P<0.05) which difference gradually increased during the 4 days (Figure 4.14b). On 
day 4 the differentiation rate of shRNAcontrol cells was 73%, whereas only 8% and 
22% of the shRNAPLCη2-1 and shRNAPLCη2-2 cells were defined as 
differentiated, respectively (one-way ANOVA, p<0.001 and p<0.01, respectively). 
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Figure 4.14.: The retinoic acid-induced differentiation of Neuro-2a cells is reduced 
in PLCη2 knock-down cells. A) Bright field images showing control and PLCη2 
knock-down cells (shRNAPLCη2-1, shRNAPLCη2-2) after 4 days of retinoic acid 
treatment. Bars correspond to 100 µm. B) Differentiation rate of control and PLCη2 
knock-down cells. A cell was defined differentiated when it possessed at least one 
neurite with a length longer than twice the cell body diameter. The results are 
calculated from 3 independent experiments and at least 75 cells were measured in 
each group. Error bars represent ± S.E.M. (one-way ANOVA, p<0.05: *, p<0.01: **, 
p<0.001: ***, n=3).  
Total neurite outgrowth was calculated based on a previously described stereological 
approach (description is provided in Chapter 2) (Ronn et al. 2000; Lucocq 2008). 
Results were calculated from three independent experiments and four micrographs 
were analysed in each experimental group (at least 180 cells in each group, Figure 
4.15.). As it was expected, the control cells showed gradual increase in neuronal 
outgrowth expanding the basal 14.7 µm to 243.3 µm (total neurite length/cell) on day 
4. In contrast, neuronal outgrowth was largely deteriorated in PLCη2 knock-down 
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cells. From the basal 18.4 µm, the shRNAPLCη2-1 cells reached 34.9 µm on the first 
day, but remained on this level throughout the whole differentiation process (35.7 
µm on day 4, one-way ANOVA, p<0.001 compared to control). Although the 
spontaneous neuritogenesis (basal level) was lower in shRNAPLCη2-2 cells (8.8 
µm), it was increased to 39.6 µm on the first day. On day 4, the total length of 
neurites/cell in these cells was 51.5 µm on average (one-way ANOVA, p<0.001 
compared to control, Figure 4.15.).  
 
Figure 4.13.: Retinoic acid-induced neuronal outgrowth is significantly reduced in 
PLCη2 knock-down cells. The rate of neuronal outgrowth is determined as the total 
length of neurites/cell and was determined by using a stereological approach (Ronn 
et al. 2000; Lucocq 2008). The results are calculated from 3 independent 
experiments. Four images and at least 180 cells were measured in each group. Error 
bars represent ± S.E.M. (one-way ANOVA, p<0.01: **, p<0.001: ***, n=3).  
4.2.5. PLCη2 is involved in the regulation of retinoic acid receptor 
signalling 
As suggested by the previous experiments, it appears that PLCη2 plays an important 
role in the differentiation of Neuro-2a cells. However, the exact mechanism is far 
from being understood. PLCη2 is mainly found in the nuclei of Neuro-2a cells. This 
raises the possibility that it might be involved in the regulation of the local Ca
2+
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dynamics in the nucleus which might consequently affect transcriptional activity. 
Although transcriptional regulation as a function of PLCη2 has not been proposed 
before, its participation in this process would not be unique across the PLC family 
(Cocco et al. 2006). As the differentiation of Neuro-2a cells was induced by retinoic 
acid in previous experiments and its downstream signalling highly affects the 
expression of various genes, the detection of changes in RA-dependent changes in 
control and PLCη2 knock-down cells seems to be a good tool for further 
investigating the physiological role of PLCη2. 
Retinoic acid signalling is processed by its nuclear receptor (RAR), which is able to 
regulate the expression of various genes upon ligand-induced stimulation. In 
addition, RAR undergoes heterodimerisation with the retinoid X receptor (RXR) 
after ligand-binding which enables the efficient binding to gene promoters (Lane and 
Bailey 2005). A short DNA sequence on the promoter, which is the target of the 
receptor-ligand complex, is termed as retinoic acid responsive element (RARE) 
(Lane and Bailey 2005). Three variants of retinoid receptors are known to exist such 
as RARα, RARβ and RARγ (Chambon 1996). The expressions of all three RAR 
variants were tested by RT-PCR (Figure 4.16). As several splice variants of these 
receptors exist, the primers used in this experiment were designed to be non-specific 
for variations. Mouse brain cDNA was used as a positive control and RPLP0 level as 
a loading control. After 35 PCR cycles, high levels of RARα mRNA were detected in 
both Neuro-2a and brain samples whereas the RARβ gene was only expressed in 
brain. The latter result was expected because RARβ gene expression is often 
downregulated in tumours and the Neuro-2a cell line was developed from a 
spontaneous tumour of the mice (Xu 2001). RARγ mRNA was undetectable in both 
Neuro-2a cells and the mouse brain. The expression of this gene in developing neural 
structures is almost completely absent and therefore it possibly has little significance 
for neuronal physiology (Ruberte et al. 1993). 
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Figure 4.16.: RT-PCR showing the expression of retinoid receptors in Neuro-2a 
cells and in mouse brain. PCR products corresponding to RARα, RARβ and the 
standard gene mRNA, RPLP0 are detected at their expected sizes (159 bp, 173 bp 
and 163 bp, respectively). RARγ transcript (169bp) couldn`t be detected possible due 
to the lack of its expression in Neuro-2a cells and in mouse brain. Amplification was 
stopped after 25 cycles for RPLP0 and after 35 cycles for receptor transcripts. In the 
marker lane the band corresponding to 200 bp is shown.  
As the only detected receptor variant in Neuro-2a cells was RARα, this was further 
investigated in the control and PLCη2 knock-down cells. RARα mRNA levels were 
measured by quantitative PCR (qPCR) and were calculated relative to RPLP0 levels 
(Figure 4.175). The results showed no significant difference in the mRNA level of 
RARα among these groups (one-way ANOVA). As the next purpose of the study 
was to investigate the rate of retinoid signalling downstream from this receptor, it 
was essential to determine if there was any difference in its basal levels in these cells. 
With the detection of equal retinoid receptor level in control and knock-down cells, 
differences measured in the retinoid signalling in further experiments will not be the 
causative of altered receptor numbers. 
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Figure 4.17.: Quantitative PCR showing the relative levels of RARα mRNA in 
control and knock-down Neuro-2a cell lines. The unstimulated stable cell lines did 
not show significant difference in the mRNA levels of RARα. Results were 
normalised to the expression of the ribosomal mRNA, RPLP0. The RARα level of 
the shRNAcontrol was defined 1. Error bars represent ± S.E.M. (one-way ANOVA, 
n=3).  
 
Figure 4.18.: Simple representation of luciferase reporter constructs designed for the 
detection of retinoic acid induced gene transcription. The retinoic acid (RA)-RAR-
RXR complex binds to the RARE sequence which induces the expression of the 
firefly luciferase gene. A control vector is co-transfected with the reporter construct 
which contains a Renilla luciferase under the control of a CMV (Cytomegalovirus) 
promoter. This provides an endogenous control to measure transfection efficiency 
and to normalise the expression of the firefly luciferase. Figure was produced by the 
author of this thesis. 
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A dual-luciferase reporter assay was employed to measure retinoic acid-induced 
transcriptional activity in the control and PLCη2 knock-down Neuro-2a cells as 
described in Chapter 2. Briefly, 2 vectors were co-transfected into Neuro-2a cells; 
one containing a firefly luciferase gene which is under the regulation of a RARE 
sequence (AGGTCACCAGGAGGTCA) and one vector encoding Renilla luciferase 
preceded by a constitutively active promoter (Figure 4.18., designed and synthetized 
at SABiosciences, Qiagen). This latter construct provided an internal reporter of the 
transfection efficiency.  
Control and PLCη2 knock-down cells were seeded into a 96-well plate 
(50.000 cells/well) and the plasmid mixture (100ng/well) was transfected the next 
day by Lipofectamine. Six hours after the transfection complexes were added, the 
culture medium was replaced with serum-free medium. The following day, 
transfected cells were either treated with 20 µM retinoic acid or with vehicle 
(DMSO) in serum-free medium for 4 hours. Cells were then lysed and the activities 
of both firefly and renilla luciferases were measured sequentially. In Figure 4.19., the 
activity of vehicle-treated cells represents the basal activity of retinoid signalling. 
Interestingly, both knock-down cell lines had reduced levels of basal retinoic acid 
signalling compared to the control cells. The luciferase activity was decreased to 
40% in shRNAPLCη2-1 (one-way ANOVA, p<0.001) whereas it was reduced to 
70% in shRNAPLCη2-2 cells (one-way ANOVA, p<0.01) when the luciferase 
activity of the control was defined as 100%. Interestingly, there was also a significant 
difference between shRNAPLCη2-1 and shRNAPLCη2-2 (one-way ANOVA, 
p<0.01) which might be the causative of different levels of PLCη2 in these cells. 
The luciferase activity of the retinoic acid stimulated cells was expressed as the fold 
change of the basal activity in each group (Figure 4.20.). Large elevation in 
luciferase activity was detected in the control cells in response to the retinoic acid-
stimulation (101-fold). In contrast, the shRNAPLCη2-1 and shRNAPLCη2-2 cells 
exhibited only 35- and 44-fold increase in activity, respectively (one-way ANOVA, 
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p<0.05). This indicates that PLCη2 possesses a high impact on both basal and 
stimulated retinoid signalling. 
 
Figure 4.19.: Basal retinoid receptor activity in control and PLCη2 knock-down cell 
lines as determined by a dual-luciferase assay. The basal activity was measured 1 day 
following the transfection of the reporter constructs. The results were normalised to 
the constitutively produced Renilla luciferase activity. The luciferase activity of the 
shRNAcontrol was defined as one. Error bars represent ± S.E.M. (one-way ANOVA, 
**: p<0.01, ***p<0.001, n=3).  
 
Figure 4.20.: Retinoic acid-stimulated signalling is suppressed in PLCη2 knock-
down cell lines as detected by dual-luciferase assay. Cells were treated with 20 µM 
retinoic acid for 4 hours one day after the transfection of the reporter constructs. The 
results were normalised to the constitutively produced Renilla luciferase activity 
which was transfected simultaneously with the firefly luciferase-encoding construct. 
The basal luciferase activities for all 3 cell lines were defined as one. Error bars 
represent ± S.E.M. (one-way ANOVA, p<0.05:*, n=3).  
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4.2.6. The interaction of PLCη2 and Lim domain kinase-1 and its 
consequences for neuronal outgrowth 
A bacterial two-hybrid (B2H) screen was previously carried out in our lab by Deana 
Finelli (B.Sc. honours student, 2011) to identify possible interacting partners of the 
C-terminal domains from different PLCη2 splice variants. The B2H screen consists 
of the co-transfection of the bait vector (pBT) containing the PLCη2 C-terminus and 
a cDNA library encoded by the target vector (pTRG) into a reporter E. coli strain 
(BacterioMatch II Two Hybrid System, Agilent Technologies, Figure 4.21.). The bait 
(PLCη2 C-terminus) is fused to a full-length bacteriophage λ lambda repressor 
protein whereas the target (pancreas cDNA library) is connected to the α-subunit of 
RNA polymerase (RNAP). When the proteins encoded by the co-transfected 
plasmids interact in one cell, the RNAP is tethered to the promoter region of the 
reporter gene which allows the transcription of two selection markers. The reporter 
strain is defective in the endogen synthesis of histidine. Although cells are able to 
grow on minimal medium due to the basal transcription activity of the reporter gene 
encoding an enzyme which catalyses an essential step of the histidine synthesis 
pathway (HIS3). The compound 3-AT is a competitive inhibitor of the HIS3 gene 
product and when it is added to the medium the bacteria may grow only upon 
possessing an interacting protein pair encoded by the pBT and pTRG vectors. The 
reporter gene also encodes a streptomycin resistance gene to provide a second 
selection for verifying interactions.  
CHAPTER 4. THE ROLE OF PLCη2 IN NEURONAL PHYSIOLOGY  
 
153 
 
  
Figure 4.21.: Simplified description of the 2-hybrid system. The cDNA encoding a 
protein which is screened for interaction partners is inserted into the bait vector 
(pBT) and this provides its fusion to the full-length bacteriophage λ lambda repressor 
protein (λcI). A cDNA library is also produced in the pTRG plasmid. This generates 
a fusion of the transcripts to the α-subunit of RNA polymerase (RNAP). The two 
vectors are co-transfected into the E. coli reporter strain. Upon interaction of the 
encoded proteins in one cell, the RNAP is tethered to the promoter region of the 
reporter gene which enables the transcription of genes important for histamine 
synthesis and streptomycin resistance. Figure is taken from the BacterioMatch II 
Two Hybrid System manual (Agilent Technologies). 
By using the B2H screen, Lim domain kinase-1 (LIMK1) was identified as a putative 
interaction partner of the C-terminus of the 21a/22/23 PLCη2 variant. This variant 
encodes the splice variant exhibiting the shortest amino acid sequence which is 
integral to all the other variants except for the last three amino acids (VRD; derived 
from the exon 22). This suggests that the putative interaction between PLCη2 and 
LIMK1 would not likely to be splice variant specific. LIMK1 is a Ser/Thr/Tyr 
kinase, which phosphorylates downstream substrates such as cofilin with its c-
terminal kinase domain (Arber et al. 1998). The other domains serve to regulate this 
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function (Manetti 2011). The target vector from the B2H screen only contained a 
partial sequence of LIMK1 (519-647, red line in Figure 4.22.). This encodes a 
fragment of the kinase domain which excludes the substrate binding site and the 
kinase active region.  
 
Figure 4.22.: Domain structure of the human LIMK1. The main domains are as 
follows: LIM1 (5-77 residues) and LIM2 (84-138 residues) constituted of zinc finger 
pairs, PDZ (163-255 residues) and the protein interaction site/protein kinase domain 
possessing the catalytic activity of the enzyme (345-624). Residues involved in 
substrate binding and phosphorylation activity are supplied by the kinase domain 
between 345-514 residues. An important phosphorylation site (Tyr508) is indicated 
by an arrow which is involved in the regulation of kinase activity. The sequence 
identified by the B2H screen is highlighted with a red line (519-647 residues). The 
structure was created based on an alignment in the Conserved Domain Database 
(NCBI) by the author of this thesis. 
In the study conducted by Deana Finelli, the interaction of PLCη2-LIMK1 was only 
verified with the 3-AT selection. To confirm this interaction, purified plasmids were 
separated by agarose gel electrophoresis and purified by gel extraction (Qiagen). 
Equal amounts (100ng-100ng) of the plasmids were retransformed to the reporter E. 
coli strain by heat-shock and after incubating the bacteria in minimal medium they 
were spread onto 3-AT plates containing selective antibiotics for the plasmids 
(tetracyclin and chloramphenicol). Next day, a mixture of the growing colonies was 
spread onto 3-AT, streptomycin, tetracyclin and chloramphenicol containing plates. 
Colonies were detected after an overnight incubation indicating the interaction of the 
bait and the target (Figure 4. 23).  
CHAPTER 4. THE ROLE OF PLCη2 IN NEURONAL PHYSIOLOGY  
 
155 
 
 
Figure 4.23.: E. coli reporter strain encompassing both PLCη2-pBT and LIMK1-
pTRG plasmids grow on selective plate containing streptomycin, 3-AT, tetracyclin 
and chloramphenicol. A mixture of colonies was transferred from the 3-AT selection 
plate and was incubated for 24 hours at 37
o
C. 
The B2H system is a useful method for identifying protein-protein interactions 
(Joung et al. 2000). However, to verify an interaction, an alternative method is often 
required. To provide more evidence on PLCη2-LIMK1 interaction, a pull-down 
experiment was carried out by using the c-Myc Tag IP/Co-IP Kit (Thermo 
Scientific). This consisted of the overexpression of the full-length LIMK1 labelled 
with a c-myc tag on its c-terminus (kind gift from Prof. Michael Olson, Beatson 
Institute, Glasgow) and PLCη2 in COS-7 cells. As controls, cells transfected with 
only one of the constructs were used. Two days following transfection, cells were 
lysed and 500 µg total protein containing lysates were incubated with 5 µg anti-c-
myc agarose overnight. Agarose beads were washed with TBST five times and the 
proteins were eluted. Both the input (cell lysates) and the output (eluted samples) of 
the pull-down were run on 4-12% polyacrylamide gels and proteins were identified 
by western blot with specific antibodies against the c-myc tag and PLCη2. The 
analysis of the cell lysates showed that PLCη2 and LIMK1 were efficiently 
transfected and expressed in COS-7 cells (Figure 4.24a). After conducting the pull-
down experiment, LIMK1 was bound onto the myc-tagged beads with high 
efficiency. However, the co-immunoprecipitation of PLCη2 was not detected 
(4.24b). Unfortunately, the pull-down experiment failed to confirm the interaction 
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between LIMK1 and PLCη2. This might be due to their weak or temporary 
interaction under the conditions employed. Unfortunately, the constitution of the 
lysis and the elution buffers is not provided by the supplier of the 
immunoprecipitation kit, therefore it is hard to estimate what contents should be 
adjusted for getting better results. Nevertheless, failure of the pull-down experiment 
to show interaction between these proteins does not provide definitive proof that 
these proteins do not interact in vivo. 
 
Figure 4.24.: Co-immunoprecipitation experiment failed to show the interaction 
between LIM kinase 1 and PLCη2. C-myc-LIMK1, PLCη2 or both constructs were 
transfected into COS-7 cells. The transfection efficiency was assessed by western 
blot for which β-actin level was used as a loading control (A). The output of the co-
immunoprecipitation experiment shows no interaction between LIMK1 and PLCη2 
(B). Samples were separated on a 4-12% SDS-polyacrylamide gel, electroblotted 
onto PVDF membrane which was probed with anti-PLCη2, anti-c-myc and anti-β-
actin antibodies, respectively. 
As previously discussed, the hypothetical PLCη2 binding site on LIMK1 was 
mapped based on the partial nature of the LIMK1 sequence identified from the B2H 
screen. According to this, PLCη2 binds to the C-terminal portion of the kinase 
domain not including the substrate binding site or the enzyme catalytic region 
(Figure 4.25.). The kinase domain of LIMK1 has been recently crystallised in 
complex with its inhibitor, staurosporine (Beltrami et al., unpublished, PDB: 3s95). 
Based on this structure, the possible interaction sites were modelled (Figure 4.25.). 
The main phosphorylation site of the kinase domain is the Thr508 residue targeted by 
two kinases, PAK (p21-activated kinase) and ROCK (rho-associated protein kinase) 
(Edwards et al. 1999; Ohashi et al. 2000). In addition, two other residues are 
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phosphorylated by protein kinase A (Ser 323 and Ser 596) (Nadella et al. 2009). The 
Thr508 residue is found next to the substrate binding site and it has been suggested to 
regulate the ability of the domain to target proteins for phosphorylation (Edwards 
and Gill 1999). In contrast, it is unknown how the phosphorylation of the Ser596 
residue might contribute to this process as it is found relatively far from the residues 
involved in kinase activity. Nevertheless, this C-terminal portion of the kinase 
domain has important regulatory function and it is likely that the binding of the C-
terminal of PLCη2 is involved in this process. 
 
Figure 4.25.: Structure of the kinase domain of human LIMK1. The partial sequence 
found in the target vector is shown in yellow. The substrate binding site and the 2 
phosphorylation sites (Thr508 and Ser596 in red) are indicated by arrows. The role 
of Ser596 residue in regulating kinase activity is not fully understood particularly as 
it is located relatively far from the functional region. The structure was modelled 
with Accelrys Discovery Studio 3.1 by the author of this thesis. 
For an actual interaction of proteins, the similar pattern of their cellular distribution 
is required. Thus, to provide more evidence on the interaction of PLCη2 and LIMK1 
it is essential to investigate their localisation in a cell model that contains these 
proteins endogenously. Both PLCη2 and LIMK1 is highly expressed in the brain and 
therefore the Neuro-2a cells are certainly good models for this purpose. Both 
undifferentiated and differentiated cells were stained for endogenous PLCη2 and 
LIMK1 by co-immunostaining (Figure 4.26.).  
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Figure 4.26.: Endogenous PLCη2 and LIMK1 co-localise in the nucleus of 
undifferentiated (A) and differentiated (B) Neuro-2a cells. Cells were seeded onto 
coverslips and fixed the next day (undifferentiated cells) or differentiated for 4 days 
with 20 µM retinoic acid (differentiated cells). PLCη2 possessed a high co-
localisation rate with LIMK1 in both undifferentiated (0.6762, S.E.M: 0.0305, 
Pearson coefficient) and differentiated cells (0.6794, S.E.M.: 0.0619, n=3, Pearson 
coefficient). Images are representative and were taken from a deconvoluted Z-stack. 
Bars correspond to 10 µm. 
Both LIMK1 and PLCη appeared to be abundant in the nucleus (Figure 4.26.). This 
is consistent with the previous finding that LIMK1 localised mainly to the nucleus in 
certain types of neurons (Bernard et al. 1994).  
The localisation of LIMK1 was also compared to transfected GFP-PLCη2 in 
undifferentiated and differentiated cells (Figure 4.27.). This provided similar results 
to the endogenous PLCη2-staining. LIMK1 and GFP-PLCη2 possessed a high co-
localisation rate in the nucleus of both differentiated and undifferentiated cells. 
Moreover, they were both detected in the neurites of the differentiated cells and 
exhibited similar patterns.  
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Figure 4.27.: GFP-tagged PLCη2 and LIMK1 co-localise in the nucleus of 
undifferentiated (A) and differentiated (B) Neuro-2a cells. Cells were seeded onto 
coverslips and transfected by GFP- PLCη2 the next day. Fixation was carried out the 
following day (undifferentiated cells) or cells were differentiated for 2 days with 20 
µM retinoic acid (differentiated cells) and fixed. A neurite is shown with a higher 
magnification to reveal co-localisation of PLCη2 and LIMK1. GFP-PLCη2 
possessed a high co-localisation rate with LIMK1 in both undifferentiated (0.7663, 
S.E.M: 0.0619, Pearson coefficient) and differentiated cells (0.8866, S.E.M.: 0.0300, 
n=3, Pearson coefficient). Images are representative and were taken from a 
deconvoluted Z-stack. Bars correspond to 10 µm.  
The consequences of the potential interaction between LIMK1 and PLCη2 are 
unclear. However the assessment of the overall effect of decreased PLCη2 levels in 
knock-down cells on LIMK1 activity might provide a better insight into whether 
these proteins cooperate during Neuro-2a cell differentiation. It is necessary to 
emphasize that the interaction of these proteins might be only important for their 
close position and PLCη2 might not regulate LIMK1 enzyme activity directly. 
LIMK1 activity is highly sensitive to changes in Ca
2+
-dynamics. During neuronal 
differentiation of Neuro-2a cells induced by a Ca
2+
-ionophore (ionomycin), LIMK1 
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is phosphorylated by Ca
2+
/Calmodulin kinase IV at Thr508 (Takemura et al. 2009). 
Earlier in this Chapter, it was shown that Ca
2+
 activated PLC activity is reduced in 
PLCη2 knock-down cells, consequently leading to decreased release of Ca2+ from 
I(1,4,5)P3 sensitive stores. To assess whether LIMK1 activity is affected by the 
PLCη2 knock-down, the level of its phosphorylation level at Thr508 was detected at 
different stages of retinoic acid-induced differentiation. The shRNAcontrol and 
shRNAPLCη2 cell lines were selected for this experiment to be treated with retinoic 
acid for 4 hours, 2 days and 4 days (Figure 4.28.).  
 
Figure 4.28.: Retinoic acid stimulated LIMK1 and CREB phosphorylation levels are 
reduced in PLCη2 knock-down cells. A) Immunoblot showing the phosphorylation 
levels for LIMK1 (at Thr508) and CREB (at Ser133) at different time points during 
retinoic acid induced differentiation of shRNAcontrol (Cont.) and shRNAPLCη2-1 
(PLCη2) cells (basal, 4 hours, 2 days, 4 days). The levels of total LIMK1 and CREB 
as well as β-actin loading control were also measured. The blot shown is 
representative of 3 independent experiments. The whole cell lysates from Neuro-2a 
cells were separated on a 4-12% SDS-polyacrylamide gel. B) Phosphorylation level 
of LIMK1 and CREB relative to total LIMK1 and CREB levels. The 
pLIMK1/LIMK1 and pCREB/CREB levels were calculated relative to the 
shRNAcontrol level in each treatment group. White bars: control level, black bars: 
shRNAPLCη2-1 levels. Error bars represent ± S.E.M. (t-test, p<0.05:*, p<0.001:*** 
n=3). 
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The retinoic acid–induced phosphorylation of LIMK1 was greatly reduced in the 
shRNAPLCη2-1 cells (Figure 4.28.). Phosphorylation of LIMK1-Thr508 (pT508) 
was undetectable in the untreated cells and therefore its level was not calculated. 
After 4 hour stimulation, the level of pThr508 was downregulated by 75.3 % (t-test, 
p<0.001) and remained low at Day 2 and 4 (89% and 46.7% reduction, t-test, 
p<0.001 and p<0.05, respectively) compared to the shRNAcontrol. The 
phosphorylation rate of a LIMK1 downstream effector was also tested. The 
transcription factor, CREB is mainly phosphorylated and consequently activated by 
the cAMP pathway (Montminy and Bilezikjian 1987). Although in differentiating 
neurons, CREB is also directly phosphorylated by LIMK1 to direct the transcription 
of essential genes of neuronal outgrowth (Yang et al. 2004). Basal level of the 
phosphorylation of CREB at Ser133 was detectable but was similar in the 
shRNAPLCη2-1 and shRNAcontrol cells (t-test). After 4 hours, CREB 
phosphorylation was reduced by 30% in knock-down cells compared to the control 
cells although this was not a significant effect (t-test). At two and four days of 
differentiation, pCREB levels were 69.4% and 41.7% lower in shRNAPLCη2-1 than 
in the control cells, respectively (t-test, p<0.001 and p<0.05). In conclusion, the lack 
of PLCη2 in Neuro-2a cells disrupted certain signalling pathways that led to the 
alterations in the  phosphorylation of LIMK1 and CREB, however, the exact 
mechanism is not quite clear at this point. Either the consequently reduced PLC 
activity-releated Ca
2+
-release or a direct action of PLCη2 on LIMK1 may lead to 
reduced phosphorylation of these proteins. Nevertheless, these results highlight the 
importance of PLCη2 in LIMK1 signalling.LIMK1 is also involved in the control of 
actin dynamics through the phosphorylation and the subsequent inactivation of 
cofillin and the actin depolymerising factor (ADF). When activated, cofillin and 
ADH depolymerise F-actin (polymerised form of actin) and release G-actin 
(depolymerised form). Hence, upon LIMK1 stimulation, the level of F-actin elevates 
(Arber et al. 1998; Yang et al. 1998). In the growth cone of the neuron, the 
cooperation of LIM kinases (1 and 2) and phosphatases of cofillin and ADH 
(slingshot proteins, SSHs) is required to maintain a balance in actin dynamics. 
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Neurite outgrowth is inhibited when either LIMK1 or the SSHs levels are disturbed 
by the addition of siRNA targeting the expression of these proteins (Endo et al. 
2007).  
The distribution of F-actin was detected in control and PLCη2 knock-down cells by 
tetramethylrhodamine isothiocyanate (TRITC)-linked phalloidin in 4-day 
differentiated cells (Figure 4.29.) (Barden et al. 1987). The shRNAcontrol cells 
contained elongated actin filaments along the neurites. In contrast, both 
shRNAPLCη2-1 and shRNAPLCη2-1 cells possessed multiple processes and 
punctate distribution of actin. This suggests a role for PLCη2 in regulating actin 
dynamics possibly via controlling LIMK1 activity. Multiple growth cones in knock-
down cells might be the result of imbalanced F-actin/G-actin ratio. The 
downregulation of LIM kinase activity in PC12 cells significantly reduced neuronal 
outgrowth. Although the authors did not mention, in these cells the number of 
processes was higher compared to the control cells as suggested by the presented 
images (Endo et al. 2007). Potentially, the phenotype of PLCη2 knock-down cells in 
our experiment is originated from the upregulation of cofillin activity and the 
consequently reduced polymerisation rate of actin.  
 
Figure 4.29.: The actin dynamics is disturbed in PLCη2 knock-down cells. The 
shRNAcontrol cells showed the morphology of differentiated neurons with elongated 
actin fibers. In shRNAPLCη2-1 and shRNAPLCη2-2 cells multiple projections were 
detected with limited outgrowth and the actin staining showed punctate distribution. 
Cells were permeabilised after fixation and incubated with TRITC-phalloidin for F-
actin staining. Slides were examined on a Zeiss Axioplan fluorescent microscope 
system. Bars correspond to 10 μm.  
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4.2.7. The localisation of PLCη2 in differentiated Neuro-2a cells is 
controlled by PI(3,4,5)P3 levels 
In Chapter 3, the PH domain of PLCη2 (and PLCη1) was shown to bind 
preferentially to PI(3,4,5)P3, however its association with PI(4,5)P2 was also 
observed. PI(3,4,5)P3 is involved in neuronal polarisation by its accumulation in 
growth cones which triggers the local activation of Akt and PKCζ activity (Menager 
et al. 2004; Khodosevich and Monyer 2010). As PI(3,4,5)P3 might be a critical factor 
in defining the cellular distribution of PLCη2, it might direct PLCη2 to growth cones 
to regulate local Ca
2+
 dynamics. Here, the co-localisation of PLCη2 and PI(3,4,5)P3 
was assessed in differentiated Neuro-2a cells (Figure 4.30.). As it was seen in 
undifferentiated cells in Chapter 3, PI(3,4,5)P3 accumulates in the nucleus and there 
it possessed high co-localisation rate with the endogenous PLCη2 or the transfected 
GFP-PLCη2 proteins. PI(3,4,5)P3 was also present on the cell membrane throughout 
the cell. Moreover, local elevations of PI(3,4,5)P3 at the nerve tip of the growing 
neurite were detected with similar distribution to PLCη2 (indicated by arrows in 
Figure 4.30a). 
As mentioned above, PLCη2 PH domain also associates with PI(4,5)P2 in vitro. In 
Chapter 3, PI(4,5)P2 was visualised in undifferentiated Neuro-2a cells by the 
transfection of a construct encoding the PH domain of PLCδ1 fused to an mCherry-
tag (Watt et al. 2002). Here, this plasmid was transfected similarly but the cells were 
differentiated for two days afterwards (Figure 4.31.). 
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Figure 4.30.: PI(3,4,5)P3 is co-localised with endogenous PLCη2 (A) and transfected 
GFP-PLCη2 (B) in differentiated Neuro-2a cells. Cells were seeded onto coverslips 
and were differentiated for 4 days (A) or GFP-PLCη2 was delivered by 
lipotransfection and then differentiation was conducted for 2 days with 20 µM 
retinoic acid. Fixed cells were immunostained with PLCη2 antibody (green) and 
PI(3,4,5)P3 antibody (red) or alternatively in GFP-PLCη2 transfected cells only 
PI(3,4,5)P3 antibody was used. Nuclei were stained with DAPI. Both endogenous 
PLCη2 and transfected GFP-tagged construct colocalised with PI(3,4,5)P3 (0,8415, 
S.E.M.: 0,0379 and 0.8032, S.E.M.: 0.313, respectively, n=3, Pearson coefficient). 
Images are representative and were taken from a deconvoluted Z-stack. Bars 
correspond to 10 µm.  
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Figure 4.31.: Localisation of endogenous PLCη2 (A) and GFP-PLCη2 (B) relative 
to the PI(4,5)P2 marker, mCherry-PH-PLCδ1 in differentiated Neuro-2a cells. PLCη2 
only co-localises with mCherry-PH-PLCδ1 on the plasma membrane and in the 
neurite in both experimental conditions. Neuro-2a cells were seeded onto coverslips 
and mCherry-PH-PLCδ1 alone or together with GFP-PLCη2 was delivered by 
lipotransfection. Cells were differentiated for 2 days with 20 µM retinoic acid. Fixed 
cells were immunostained with PLCη2 antibody (green) in the first experimental 
condition. Nuclei were stained with DAPI. Pictures were taken with a Leica confocal 
microscope. Bars correspond to 10 µm.  
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In differentiated Neuro-2a cells, PH-PLCδ1 was detected mainly on the plasma 
membrane where it showed limited co-localisation with the endogenous PLCη2 or 
the overexpressed GFP-PLCη2 proteins. The presence of PH-PLCδ1 was hardly 
detectable in the nucleus. This would suggest that when PLCη2 enters the nucleus it 
becomes inactive due to the lack of its substrate. However, it was previously shown 
that the nucleus also contains substantial amount of PI(4,5)P2 (Watt et al. 2002). In 
summary, the driving force of PLCη2 localisation is PI(3,4,5)P3 whereas local 
elevations in PI(4,5)P2 may also regulate the cellular pattern of PLCη2 in neurons. 
4.3. Discussion 
4.3.1. Implications of the specific pattern of PLCη2 in the brain  
In the first part of this Chapter, the tissue specific localisation of PLCη2 was 
described (Figure 4.1–4.4) based on the data provided by the Allen Brain Atlas (Lein 
et al. 2007). Apart from its known presence in the cerebral cortex, cerebellum, 
hippocampus, medial habenula and olfactory bulb, new structures have been 
identified to contain PLCη2 mRNA. High PLCη2 mRNA levels were found in the 
suprachiasmatic nucleus, pineal gland, pyriform cortex and the olfactory tubercule.  
In contrast to the CA1-CA3 region, the dentate gyrus of the hippocampal formation 
only contained a few PLCη2 positive cells. This region contains a subgranular zone 
which produces new granular cells throughout life (Eriksson et al. 1998). The small 
number of PLCη2-positive cells in the dentate gyrus suggests that these cells might 
represent neurons in a particular maturation state. As there are inconsistencies in the 
literature of PLCη2 being present in the DG or not (Nakahara et al. 2005; Kanemaru 
et al. 2010), it is important to assess whether it is due to the limitation of methods 
used or it is caused by altered ages and/or environment of the mice. Nevertheless, the 
presence of PLCη2 in the CA1-CA3 region of the hippocampal formation is 
unquestionable and implicates a possible role for PLCη2 in processes relating to 
learning and memory formation. Long-term potentiation (LTP) is the process of 
“learning” on the level of the cells, which is manifested as alterations in the 
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efficiency of synaptic transmission. It requires local elevations in Ca
2+
 levels in 
dendritic spines (Guthrie et al. 1991). High abundance of PLCη2 in hippocampal 
pyramidal cells suggests its role in regulating their Ca
2+ 
dynamics and participating 
in the process of LTP. The role of PLCη2 in memory formation should be assessed 
for which the generation of a knock-out mouse-line would be crucial. By using this 
model a series of learning tests could be performed as well as it would allow the 
local measurement of synaptic transmission in the hippocampus  
The piriform cortex and the olfactory tubercule receive projections from the olfactory 
bulb and process olfactory information and olfaction-associated learning (Wilson 
2003; Carriero et al. 2009). The piriform cortex is the centre of odour-related 
associative learning (Roman et al. 1993). In addition, LTP was also registered in the 
level of the main olfactory bulb mitral cell-granule cell synapse (Zhang et al. 2010). 
As PLCη2 is abundant in the above mentioned regions, it might possess a special 
role in the cellular physiology in these regions. 
Interestingly, PLCη2 is also specifically elevated in cerebellar granule cells. The 
traditional theory is that cerebellar learning is processed at the level of the granule 
cell parallel fiber-Purkinje cell synapse (Ito and Kano 1982). The stimulation of the 
parallel fiber induces a prolonged decrease in synaptic excitability of the Purkinje 
cell (long term depression, LTD). Hence the first theory of cerebellar learning was 
that it is operated by the inhibition of neuron firing. Since then, plasticity has been 
recorded on other synaptic levels of the cerebellum. High frequency stimulation of 
the mossy fiber induces the development of LTP on the level of the mossy fiber - 
granule cell contact that is directed by NMDA and metabotropic glutamate receptors. 
PLCη2 might participate in the subsequent development of Ca2+ signal and the 
activation of PKC (D'Angelo et al. 1999). 
PLCη2 is also abundant in regions associated with the circadian clock system. The 
retina expresses high amounts of PLCη2 and its levels gradually elevate after birth 
(Kanemaru et al. 2010). Another structure involved in the circadian system is the 
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pineal gland which is often photoreceptive in non-vertebrates and its melatonin 
secretion is regulated by the daily light/dark cycles (Oksche 1965). In vertebrates, the 
melatonin secretion is regulated by light-sensing neurons in the retina (Moore et al. 
1967). This group of neurons also innervate the main intrinsic clock generator, the 
suprachiasmatic nucleus and the habenula (Hattar et al. 2006). The connections of 
these regions can be complicated further yet they represent a functional cooperation 
to regulate the circadian clock. The special appearance of PLCη2 in these regions 
might indicate a role in the cellular physiology of the generation of the intrinsic 
rhythmicity. In the SCN, the efficacy of external stimuli on spontaneous firing of the 
neurons is inhibited by an IP3R antagonist (2-APB) (Hamada et al. 1999). It is 
generally thought that PLCβ4 directs PLC activity in these cells and contributes to 
the synchronisation of neurons (Ikeda et al. 2000). However, the cholinergic 
stimulation induced Ca
2+
 rise was unaffected by the absence of PLCβ4 hence the role 
of other PLCs have been indicated in this process (Ikeda et al. 2000). Consequently, 
PLCη2 might have a major role in directing Ca2+ dynamics in these cells. Hopefully, 
the characterisation of PLCη2 tissue distribution in the brain provides a basis for 
further experimental approaches in the future. 
 4.3.2. The gradual elevation in PLCη2 protein levels is essential for 
neuronal differentiation of Neuro-2a cells 
The role of PLCη2 in neuronal physiology and differentiation was assessed in Neuro-
2a cells. Interestingly, different splice variants were detected in these cells compared 
to whole mouse brain lysates (Figure 4.6., Table 4.2.) although currently we are 
unaware of the importance of the alternative splicing of the C-terminus in PLCη2. In 
the weakly expressed PLCη2 variant of Neuro-2a cells (21a/23), but not in any of the 
brain variants, a putative class II PDZ motif was identified (Zhou et al. 2005). A 
similar motif on the PLCβ3 C-terminus directs its binding to post-synaptic density 
proteins (Shank2 and Homer1b complex) to regulate mGlu receptor mediated Ca
2+
-
signals (Hwang et al. 2005b). Alternative splicing of the PLCη2 C-terminus might 
alter its cellular distribution via changing its ability to bind PDZ-domain containing 
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proteins. Further investigation is required to assess the specific roles of the 
spliceforms and to detect regional variations in their tissue distribution. 
The Neuro-2a cells represent an excellent tool to study neuronal differentiation and it 
has been used to describe the function of many proteins in this process (Pignatelli et 
al. 1999; Bryan et al. 2006; Zeng and Zhou 2008). Results of this Chapter revealed 
that PLCη2 protein expression substantially increases during the retinoic-acid 
induced differentiation of Neuro-2a cells. The role of PLCη2 in neuronal outgrowth 
was further indicated by the insufficiency of this process in PLCη2 knock-down 
cells. Both the rate of differentiation and the total neurite outgrowth was decreased 
by the downregulation of PLCη2 levels. This might be simply the causative of 
altered Ca
2+
-induced Ca
2+
 release of the IP3Rs suggested by the inositol phosphate 
response to a Ca
2+
-ionophore in our experiments. Differentiating neurons show 
spontaneous Ca
2+
 spikes and waves (Gu and Spitzer 1995) and due to the unique 
Ca
2+
 sensitivity of PLCη2 it might contribute to the generation of these signals and to 
their translation into downstream effects.  
The cellular localisation of PLCη2 was assessed in undifferentiated and 
differentiated Neuro-2a cells. Earlier studies demonstrated that PLCη2 was found 
mainly on the plasma membrane in COS-7 and HEK-293 cells (Chapter 3) 
(Nakahara et al. 2005). Moreover, the protein had little presence in the cytoplasm in 
these cells. Based on this, it was concluded earlier that PLCη2 might direct the early 
responses to external stimuli as it does not require activation-induced translocation to 
the membrane (Popovics et al. 2011). However in Neuro-2a cells, PLCη2 mainly 
appeared in the nucleus and in the perinuclear area and only a small proportion of the 
protein was present on the plasma membrane. Additionally, it also localised to nerve 
terminals suggesting its role in neurotransmission. Further studies are required to 
evaluate the distribution of PLCη2 in other cellular models or primary cells. 
Possibly, the hippocampal pyramidal cells or cerebellar granule cells would provide 
a better tool for this analysis based on their high PLCη2 content.  
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4.3.4. The role of PLCη2 in nuclear signalling 
Although it was unexpected to detect PLCη2 in the nucleus of Neuro-2a cells, it is 
not a unique feature across the PLC family. PLCβ isozymes are also abundant in the 
nucleus although their local role is just beginning to come to light. They are 
suggested to appear in nuclear speckles which are the locations of several 
transcription-regulating molecules (Martelli et al. 2005). PLCβ1 is directly involved 
in the regulation of promoter-binding of the transcription factors, c-Jun and AP1 in 
differentiating myogenic cells (Ramazzotti et al. 2008). PLCβ1 also stimulates 
protein kinase Cα- activity (PKCα) via the production of diacylglycerol (DAG). The 
activated PKCα phosphorylates lamin B1 and triggers the breakdown of the nuclear 
lamina preceding mitotic division in murine erythroleukemia cells (Fiume et al. 
2009). Interestingly, the presence of IP3Rs on the inner nuclear membrane as well as 
inside the nucleus was shown by immunocytochemistry and immunoelectron 
microscopy. In addition, IP3R-dependent Ca
2+
 transients in the nucleus have been 
observed and are implicated in the regulation of CREB-mediated signalling 
(Cardenas et al. 2005). The production of I(1,4,5)P3 is consequently associated with 
the decrease in PI(4,5)P2 levels. PI(4,5)P2 is involved in chromatin remodelling by 
linking the BAF (Brahma-related gene Associated Factors) protein complex to the 
chromatin (Zhao et al. 1998). PLCη2 might participate in the regulation of these 
processes in neurons based on its high level in the nuclei of these cells. 
In our experiment, PLCη2 knock-down had a substantial effect on basal and retinoic 
acid stimulated retinoid signalling. This effect might not be restricted to the RARE 
containing promoters and might appear as a general effect on phosphoinositide-
regulated gene expression. This might contribute to the decreased differentiation rate 
detected in PLCη2 knock-down cells as neuronal differentiation is always associated 
with a substantial change in gene expression profiles (Gurok et al. 2004). This might 
be further investigated by using luciferase reporters of different DNA regulatory 
elements in PLCη2 knock-down or overexpressing cells. 
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4.3.5. The role of PLCη2-LIMK1 interaction for neuronal outgrowth 
of Neuro-2a cells 
The interaction of PLCη2 with LIMK1 was identified with a bacterial two-hybrid 
screen, whereas the myc-tag co-immunoprecipitation experiment was unable to 
verify this. The latter experiment might have been unsuccessful due to the 
experimental conditions (ionic composition etc.) suggested in the description of the 
results. Moreover other limitation might be that the C-terminal tag on LIMK1 altered 
the binding properties of the protein. This interaction should be further investigated 
in the future by using differently tagged LIMK1-PLCη2 pairs in the pull-down 
experiments. 
Nevertheless, LIMK1 and PLCη2 have a high co-localisation rate in both 
undifferentiated and differentiated Neuro-2a cells suggesting that their distribution 
allows the interaction of the proteins. Western blot analysis revealed that retinoic-
acid stimulated LIMK1 and CREB phosphorylation is highly reduced in the PLCη2 
knock-down cells. This effect may originate from two possible biological roles of 
PLCη2. As both LIMK1 and CREB phosphorylation is affected by Ca2+ transients 
via the phosphorylation activity of Ca
2+
/Calmodulin kinase IV (Matthews et al. 1994; 
Takemura et al. 2009) PLCη2 may affect these proteins by modulating Ca2+ 
dynamics. Additionally, PLCη2 might exhibit a direct effect on LIMK1, which 
consequently influences CREB phosphorylation (Yang et al. 2004).  
The GFP-PLCη2 and the endogenous LIMK1 possessed similar localisation in the 
neurite of Neuro-2a cells. Their local interaction might affect the phosphorylation 
state of the LIMK1 substrate, cofillin and thereby increases the F-actin/G-actin ratio 
(Yang et al. 1998). This theory is supported by the disturbed organisation of actin 
skeleton seen in PLCη2 knock-down cells. 
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4.3.6. PLCη2 localisation is regulated by PI(3,4,5)P3 
In Chapter 3, the PH domains of both PLCη1 and PLCη2 were shown to possess a 
preference toward PI(3,4,5)P3 binding and the co-localisation of PLCη2 with 
PI(3,4,5)P3 was confirmed in undifferentiated Neuro-2a cells. In this Chapter, the 
localisation of endogenous PLCη2 and its transfected GFP-tagged variant was 
assessed in differentiated Neuro-2a cells relative to PI(3,4,5)P3 and PI(4,5)P2. PLCη2 
and PI(3,4,5)P3 co-localised mainly in the nucleus and also on the cellular membrane 
to some extent. PI(3,4,5)P3 is likely to be the main phospholipid binding partner of 
PLCη2 PH domain and may enhance the accumulation of PLCη2 in the nucleus. 
However, PLCη2 is not functional without its substrate, PI(4,5)P2 being present. For 
the detection of PI(4,5)P2 distribution in differentiated Neuro-2a cells, the mCherry-
tagged PH domain of PLCδ1 was transfected. PLCη2 and the mCherry-PH-PLCδ1 
co-localised partially on the plasma membrane. In addition, PI(4,5)P2 staining 
seemed to be lacking from the cell nucleus. The presence of PI(4,5)P2 in the nucleus 
was confirmed earlier by electron microscopy in different cell types (Watt et al. 
2002). Thus, the amount of PI(4,5)P2 might be low in the nucleus as it is only 
detectable by very sensitive methods. In conclusion, the localisation of PLCη2 is 
mainly dependent on PI(3,4,5)P3 distribution and its enzyme activity might be 
regulated by the amount of the accessible PI(4,5)P2 levels.  
4.3.7. Final conclusion 
In this Chapter, a series of experiments were conducted to acquire evidence on the 
involvement of PLCη2 in neuronal differentiation and physiology. PLCη2 is 
expressed in special regions of the brain which are implicated in learning, memory 
formation, hormonal secretion or the maintenance of the intrinsic clock. Hypothetical 
functions of PLCη2 were also suggested based on tissue distribution. PLCη2 was 
shown to behave uniquely in neuronal cells based on its different cellular distribution 
in neuroblastoma cells compared to previous cellular models. PLCη2 was essential 
for the retinoic acid-induced differentiation of Neuro-2a cells. This might be the 
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result of the multiple roles of PLCη2 in these cells such as provoking Ca2+ signals, 
interacting with LIMK1 and regulating gene transcription patterns as indicated in 
Figure 4.32. 
 
Figure 4.32.: PLCη2 activity contributes to neuronal differentiation on multiple 
levels. Upon activation of PLCη2, the level of PI(4,5)P2 decreases whereas the 
concentrations of the enzymatic products, I(1,4,5)P3 and DAG elevate. I(1,4,5)P3 
triggers Ca
2+
-release from the endoplasmic reticulum which activates LIMK1 and 
CREB through their phosphorylation by CamKIV. Alternatively, CREB might also 
be phosphorylated directly by LIMK. PLCη2 may also directly activate LIMK1 by 
an unknown mechanism. LIMK1 inhibits actin depolymerising activity of cofilin 
resulting in the assembly of actin filaments required for neuronal outgrowth. 
Activated CREB initiates the transcription of essential genes for differentiation. 
Changes in the nuclear DAG and PI(4,5)P2 levels may also affect the transcriptional 
activity through the activation of PKC or altering PI(4,5)P2-chromatin interactions. 
Abbreviations: PLCη2: Phospholipase C-η2, I(1,4,5)P3: Inositol 1,4,5-trisphosphate, 
PI(4,5)P2: Phosphatidylinositol 4,5-bisphosphate, DAG: diacylglycerol, CamKIV: 
Ca
2+
/Calmodulin-dependent protein kinase IV, LIMK1: Lim-domain kinase 1, 
CREB: cAMP response element-binding protein, PKC: Protein kinase C. Figure was 
produced by the author of this thesis.  
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The work described in this thesis reveals that PLCη enzymes represent a unique class 
of PLCs. The importance and properties of several of their structural domains (PH-, 
EF- and C2) were ascertained. Moreover, a physiological role for PLCη2 in neuronal 
differentiation was identified. Scientific findings often give rise to more questions 
than they answer, which is a key driving force for Science. This Chapter contains 
suggestions for future experiments inspired by the key findings of the thesis. 
5.1.: How does Ca
2+
 activate PLCη2? 
It was successfully demonstrated in this thesis that Ca
2+
-activation of PLCη2 is 
operated by the EF-hand domain which triggers an allosteric switch to regulate the 
catalytic domain. More work is required to determine the structure of this unique EF-
hand and to describe the structural changes of the whole protein upon Ca
2+
-binding. 
Purification of the EF-hand domain would provide the opportunity to determine the 
Ca
2+
-binding properties of this domain. This might be tested by Isothermal Titration 
Calorimetry (ITC) which is a quantitative technique that is used to detect the 
interactions between proteins and small molecules. The ITC detects interactions 
based on the very sensitive measurement of temperature changes generated by 
chemical interactions (Bounds et al. 2002). This way, we might gain a better 
understanding on how the non-canonical second EF-loop coordinates Ca
2+
 or what 
concentrations of the metal are required for this interaction. The extension of the 
study would be particularly challenging and include the purification and 
crystallisation of the whole PLCη2 protein with or without Ca2+ or its analogues Ba2+ 
and La
3+
 as in (Essen et al. 1997a). These structural studies are required to acquire a 
greater insight into the regulation of PLCη enzymes. 
5.2.: What are the characteristics of PLCη2 C2 domain 
phospholipid-binding? 
An interesting new feature of PLCη2 provided by the findings of the thesis is that 
association of the PLCη2 C2 domain with membranes is required for the 
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physiological activity of the enzyme. Moreover, one mutant of the domain (D861N) 
was suggested to alter the lipid-binding selectivity of the domain (Ananthanarayanan 
et al. 2002). C2 domains in various proteins exhibit a wide range of phospholipid 
specificity (Stahelin 2009). Implications of this process in PLCηs are hard to 
estimate as the membrane targeting mechanism is dictated by the PH domain. 
However, considering that the lipid specificity of the PLCη2 C2 domain is important 
for activity, further investigation of this feature might provide useful information. 
Lipid-specificity of the C2 domain may be determined by various techniques such as 
a slight modification of the FRET-assay or PIP-strip method employed in the thesis. 
In addition to the mutations generated in the C2 domain, a new mutant lacking the 
whole domain might be a relevant tool to assess the role of this structure in cellular 
localisation or membrane affinity. Determination of the structure of the whole 
protein (suggested in the previous section) would also provide valuable information 
as to how Ca
2+
 directs the association of the domain to the membrane. 
5.3. Cellular localisation – still in doubts 
The cellular distribution of PLCη2 is cell type-specific. Neuro-2a cells were 
excellent tool for the initial characterisation of cellular distribution in neurons and 
determine the role of PLCη2 in neuronal differentiation. However, further studies are 
required to assess PLCη2 cellular distribution in more accepted models such as in 
primary neurons and in tissue sections derived from different brain regions. A 
technique which provides the highest resolution of the cellular distribution for 
proteins is immuno-electron microscopy. By quantifying the organelle-specific 
distribution of the protein in a range of cells an overall picture may be provided 
about its abundance on different membranes (Lucocq 2008). Moreover, the presence 
of PLCη2 in nerve endings and in dendrites should be further assessed to evaluate its 
role in pre- and postsynaptic events.  
Phospholipid content of membranes undergoes a substantial change upon agonist 
induced stimulation suggested by the high number of molecules which are linked to 
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lipid metabolism. Though PLCη2 is predominantly membrane-bound in COS-7 cells, 
a limited rate of cytosolic staining was detected in Neuro-2a cells. This might 
represent a cytosolic pool of the protein which is translocated to the membrane upon 
extracellular stimulation. Moreover, the redistribution of the membrane-bound forms 
might be also provoked by this process. To investigate these possibilities, live cell 
imaging using GFP-tagged PLCη2 could be conducted during treatment with Ca2+-
ionophores or other drugs that influence intracellular Ca
2+
 dynamics. As the thesis 
provides evidence for the regulation of PLCη2 localisation by PI(3,4,5)P3 levels, 
cells might be treated by stimulators or inhibitors of the PI3K-pathway, such as 
insulin and wortmannin, respectively (Powis et al. 1994). The localisation of 
PI(4,5)P2 and PI(3,4,5)P3 may be simultaneously detected by fluorescently tagged 
PH domains of PLCδ1 and GRP1 (general receptor for phosphoinositides-1) 
(Venkateswarlu et al. 1998; Varnai and Balla 2008). With these experiments, a better 
understanding about how PLCη2 is shuttled between membranes or in and out the 
nucleus may be provided.  
5.4. PLCη2 levels throughout life and in disease 
A key question that remains to be answered is how PLCη2 levels changes during pre- 
and postnatal development or during ageing. According to the data presented in this 
thesis, PLCη2 level increases during neuronal differentiation of Neuro-2a cells. 
However, further assessment of this phenomenon is required to be conducted in a 
mammalian model organism. PLCη2-levels should be followed during 
embryogenesis to allow us to determine which stage of the embryo is when PLCη2 
gains an essential role for development. There might also be differences in its 
regional distribution during embryogenesis whose investigation might provide a 
better insight into its physiological role. Apart from its developmental role, PLCη2 
function has been linked to ageing and the progression of Alzheimer`s disease (AD) 
(Popovics and Stewart 2012a). However, further research is required to support this 
hypothesis. It has been shown that PLCη2 levels gradually increase after birth in the 
brain and in the retina (Nakahara et al. 2005; Kanemaru et al. 2010). Moreover, data 
CHAPTER 5. FUTURE EXPERIMENTS  
 
180 
 
provided by the Allen Brain Atlas highlights the same tendency of PLCη2 expression 
in man (http://developinghumanbrain.org). Protein levels of PLCη2 should be further 
assessed throughout life in mouse and in man to gain more evidence on this process. 
Elevated PLCη2 levels may disturb the physiological Ca2+ responses at later stages 
of life but may also severe the progression of AD that is known to be connected to 
distorted Ca
2+
 homeostasis (Berridge 2010; Popovics and Stewart 2012a). 
Accordingly, it might sound sensible to study PLCη2 levels in animal models of 
Alzheimer`s disease and in post mortem human brain with diagnosed disease. In 
addition, Neuro-2a cells might serve as good cellular tools to study the effect of 
elevated PLCη2 levels on Ca2+-dynamics or to evaluate how these cells cope with 
stress (oxidative stress or amyloid treatment).  
5.5. Splice variants of PLCη2 
My results and the study conducted by Zhou et al. revealed that two of the five splice 
variants of PLCη2 are dominantly expressed in mouse brain (21b/22/23 and 
21c/22/23). Interestingly, neither of these variants contains the PDZ-binding motif 
found on exon 23, due to a stop codon on the preceding exon (Zhou et al. 2005). In 
contrast, in the retina almost all spliceforms were detected including one with a PDZ 
sequence (21a/23). Further investigation is required to ascertain whether there are 
regional differences in the distribution of splice variants in the brain. Moreover, if the 
presence of multiple forms of PLCη2 is required for the processing of visual 
information in the retina, it would be interesting to investigate the participation of 
each spliceform in this process. In Chapter 4, splice variants were determined by RT-
PCR using spliceform-specific primers and by western blot. A possibly more 
accurate technique would be provided by the Northern blot analysis of RNA 
expression which may be used to determine the tissue-specific distribution of splice 
variants in the brain (Alwine et al. 1977). In addition, cloning of the different forms 
and their expression as GFP-fused proteins might reveal alterations in their cellular 
distribution. These suggested experiments are likely to reveal the importance of 
having 5 different spliceforms of PLCη2. 
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5.6. LIMK1-PLCη2 interaction: more evidence is required 
A B2H-screen provided some evidence for a putative interaction between PLCη2 and 
LIMK1. However, subsequent pull-down experiments failed to confirm the 
interaction. It is essential to further investigate this hypothetical interaction and 
uncover the mechanism by which PLCη2 regulates LIMK1 function. A sensitive 
technique which readily detects the interaction of proteins in a cellular context is 
conducted by the utilisation of FRET. The two proteins of interest are fused to two 
different fluorescent proteins which are capable of transferring energy upon 
excitation from one to another (from the donor to the acceptor protein). This only 
occurs if the fluorescent tags exhibit an overlap in their emission and absorption 
spectra. In addition, the FRET signal is generated if the distance between the two 
fusion proteins are in the range of 0.002 to 0.01 µm (Day et al. 2001). Interacting 
proteins are expected to reach a close proximity and therefore this technique may be 
employed to very efficiently and sensitively detect protein-protein interactions. 
FRET-analysis may be conducted to detect the interaction of PLCη2 and LIMK1 in 
live cells in basal and agonist-stimulated conditions. This may aid in determining 
whether this interaction occurs in the cell.  
5.7. What is the role of PLCη2 in nuclear signalling? 
The thesis provides evidence that PLCη2 has roles in regulating nuclear signalling. 
Its presence in the nucleus strongly suggests that PLCη2 responds to or triggers 
nuclear Ca
2+
 signals. In a study conducted by Zima et al., IP3R-dependent nuclear 
Ca
2+
 transients were detected in isolated cardiac nuclei by using the Ca
2+
 sensitive 
dye, fluo-4 dextran (Zima et al. 2007). A similar experiment may be employed by the 
isolation of nuclei from control and PLCη2 knock-down Neuro-2a cells. This would 
serve as a good tool to investigate the role of PLCη2 in nuclear Ca2+ signalling. It is 
also intriguing, how PLCη2 is involved in the regulation of transcriptional activity. 
This may be through regulation of intranuclear Ca
2+
 dynamics. Phospholipids, which 
have the potential to determine the subnuclear localisation of PLCη2, are known to 
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be present in the nucleus but it is not known how they are linked to the nuclear 
matrix. One theory is that they reside on the inner nuclear membrane and on 
invaginations of the nuclear envelope (Malhas et al. 2011; Martelli et al. 2011). 
Although, this would suggest that the nuclear phosphoinositide-binding proteins 
should translocate onto these membranes upon activation. Also, this requires these 
invaginations to frequently occur in the nucleus, however in primary neurons these 
structures were not even detected (Bezin et al. 2008). In contrast, when the 
localisation of PI(4,5)P2 and PI(3,4,5)P3 was detected by monoclonal antibodies their 
nuclear distribution greatly differed from what would have been indicated by their 
presence on only membraneous structures. Whereas PI(4,5)P2 specifically 
accumulates in dense structures, PI(3,4,5)P3 exhibits a more diffused appearance 
(Mazzotti et al. 1995; Kwon et al. 2010). These two lipids seem to regulate PLCη2 
localisation and activity according to the results of the thesis. Interestingly, PLCβ 
nuclear distribution is similar to that of PI(4,5)P2, although its PH domain was shown 
to bind phospholipids in a non-specific way (Evangelisti et al. 2006; McCullar et al. 
2007). As suggested before, immuno-electron microscopy would provide a much 
greater resolution which should be employed to map PLCη2 distribution in the 
nucleus. It has been suggested before, that proteins of the nuclear matrix exist in a 
highly complexed organisation (Martelli et al. 2011). This may reinforce the search 
for new interacting partners for PLCη2 in the nucleus. 
An additional question is how PLCη2 is transferred to the nucleus. Molecules that 
are larger than >50 kDa require a nuclear transport mechanism initiated by a nuclear 
localisation signal (NLS) sequence in the molecule (Poon and Jans 2005). Such 
signal was identified in PLCβ sequence as clustered basic residues on the C-terminus 
(Kim et al. 1996). It would be intriguing to ascertain where the NLS is mapped on 
PLCη2 and whether it is represented in both isoforms and all spliceforms. In 
addition, it also has to be highlighted, that PLCη2 is only transported to the nucleus 
in neurons (as detected so far). This strongly suggests that it has a specific role in 
neuronal nuclear signalling.  
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Since its initial description in 2005, PLCη2 research gave limited amount of 
information on its contribution to cellular and physiological processes. The work 
presented in this thesis has provided a fuller understanding of its physiological 
function and how its activity is regulated. The work suggested in this Chapter would 
provide even greater insight into the importance of PLCη2 and its various properties. 
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Appendix A - Sequences 
DNA sequence of PLCη2 (223-3717 bp of NM_175556.4 ) inserted into pcDNA3.1. 
The construct was provided by Prof. Kiyoko Fukami. 
223           ATGCCTGG TCCCCAGCCG 
241  TCTGCTGCCA GCCAGACCAC AGGAGCCGTG GCTTGCCTGG CAGAGGTACT CCTCTGGGTT 
301  GGAGGGAGCG TGGTAGTGTC ACCAAGATGG CAGCTCAGCC TTGTAGTGGA GCGATGCATG 
361  AGTGCCATGC AAGAGGGGAC CCAGATGGTG AAGCTCCGTG GCAGCTCCAA GGGATTGGTC 
421  CGCTTCTACT ACCTGGATGA GCACCGCTCC TGCCTCCGAT GGCGTCCCTC CCGCAAGAAC 
481  GAGAAAGCCA AGATTTCCAT CGACTCCATC CAGGAGGTGA GTGAGGGCCG GCAGTCTGAA 
541  ATCTTCCAGC GCTACCCGGA CAGCAGCTTT GACCCCAACT GCTGCTTCAG CATCTACCAT 
601  GGCAGCCACA GAGAGTCGCT GGACTTGGTC TCACCCAGCA GTGAAGAGGC ACGTACCTGG 
661  GTCACCGGCC TTCGCTACCT CATGGCTGGC ATCAGCGATG AAGACAGCCT AGCCCGTCGC 
721  CAGCGTACCA GGGACCAGTG GCTGAAGCAG ACGTTTGATG AGGCTGACAA GAACGGGGAC 
781  GGCAGCCTGA GCATCAGTGA GGTTCTGCAG CTGCTACATA AACTCAACGT GAACCTGCCC 
841  CGGCAGAGGG TGAAACAGAT GTTCAGGGAG GCGGACACAG ATGACCATCA GGGGACATTA 
901  GGCTTTGAGG AATTCTGCGC CTTCTACAAG ATGATGTCTA CCCGCCGAGA CCTCTACCTG 
961  CTCATGCTGA CCTACAGCAA CCATAAGGAC CACTTGGATG CCTCCGACCT GCAGCGCTTT 
1021 CTGGAGGTGG AGCAGAAGAT GAACGGTGTG ACCCTGGAGA GCTGTCAGAA CATCATTGAG 
1081 CAGTTTGAGC CTTGCCTGGA AAATAAGAGC AAGGGGATGC TGGGGATTGA TGGCTTTACC 
1141 AACTACACCC GGAGCCCCGC CGGTGACATC TTCAACCCTG AGCACAACAG AGTGCACCAA 
1201 GACATGACGC AGCCGCTGAG TCACTACTTC ATCACCTCGT CCCACAACAC CTACCTCGTG 
1261 GGTGACCAGC TCATGTCCCA GTCTCGGGTG GACATGTATG CCTGGGTCCT GCAGGCCGGC 
1321 TGCCGCTGTG TGGAGGTGGA CTGCTGGGAC GGGCCCGATG GAGAACCCAT TGTCCATCAT 
1381 GGCTACACTC TGACCTCCAA GATCCTTTTC AAAGATGTCA TCGAAACCAT CAACAAATAC 
1441 GCCTTCATCA AGAATGAGTA CCCAGTGATC CTGTCCATTG AGAACCACTG TAGTGTTGTT 
1501 CAGCAGAAGA AGATGGCCCA GTATCTGACT GACATCCTCG GGGACAAGCT GGACCTCTCC 
1561 TCAGTGAGCA GCGAAGATGC CACCATGCTT CCATCTCCAC AGATGCTCAA GGGCAAGATC 
1621 CTGGTGAAGG GGAAGAAGCT CCCTGCCAAT ATCAGTGAGG ATGCAGAAGA AGGCGAAGTA 
1681 TCTGATGAGG ACAGTGCTGA TGAGATGGAG GATGACTGCA AGCTCCTCAA TGGGGATGCC 
1741 TCCACCAATC GGAAGCGTGT GGAAAACATT GCAAAGAAGA AGCTGGATTC TCTGATCAAG 
1801 GAGTCAAAGA TCCGTGACTG TGAAGACCCC AATGACTTCT CTGTGTCCAC ACTATCCCCC 
1861 TCTGGAAAGC TTGGGCGCAA AGCAGAGGCC AAGAAGGGTC AGAGCAAGGT TGAGGAAGAC 
1921 GTGGAGGCCG GGGAAGACAG CGGGGTGAGC AGGCAGAATA GCCGCCTCTT CATGAGCAGC 
1981 TTCTCCAAGC GCAAGAAAAA AGGCAGCAAG ATAAAGAAGG TGGCCAGCGT GGAAGAGGGG 
2041 GACGAGACCC TGGACTCCCC AGGAAGCCAG AGCCGAGGGA CTGCCCGGCA AAAGAAGACC 
2101 ATGAAGCTGT CACGAGCCCT CTCGGACCTA GTGAAATATA CCAAGTCTGT GGGGACCCAT 
2161 GACGTGGAGA TAGAGGTGGT ATCTAGCTGG CAGGTGTCGT CCTTCAGTGA GACCAAGGCC 
2221 CATCAGATCC TGCAGCAGAA GCCCACCCAG TACCTGCGCT TCAACCAGCA CCAGCTCTCG 
2281 CGCATATACC CCTCCTCCTA CCGTGTGGAC TCCAGCAACT ACAATCCACA ACCCTTCTGG 
2341 AACGCTGGTT GCCAGATGGT TGCCCTGAAC TACCAGTCAG AGGGGCGGAT GCTACAGCTG 
2401 AACAGGGCCA AGTTCAGCGC CAACGGTGAC TGTGGCTACG TGCTCAAACC CCAGTGCATG 
2461 TGCCAGGGTG TCTTCAACCC CAACTCGGAG GATCCCCTGC CGGGGCAGCT CAAGAAGCAG 
2521 CTGGCCCTGA GGATCATCAG TGGCCAGCAG CTGCCCAAAC CACGGGACTC GGTGCTGGGC 
2581 GACCGTGGGG AGATCATCGA CCCCTTCGTG GAGGTGGAGG TCATTGGGCT CCCCGTGGAC 
2641 TGCAGCAAGG AGCAGACCCG AGTGGTGGAC GACAACGGAT TCAACCCCAT GTGGGAGGAG 
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2701 ACACTGGTGT TCACCGTGCA CATGCCAGAG ATTGCGCTTG TACGCTTCCT GGTCTGGGAC 
2761 CATGACCCCA TTGGACGTGA CTTCATCGGC CAGAGGACAC TAGCCTTCAG CAGCATAATG 
2821 CCAGGCTACC GGCATGTGTA CCTAGAAGGG ATGGAAGAGG CCTCTATCTT TGTTCATGTG 
2881 GCTGTCAGTG ACATTAGTGG TAAGGTCAAG CAGACTCTGG GTCTAAAAGG TCTCTTCCTC 
2941 CGAGGCACAA AGCCAGGCTC GCTGGACAGT CATGCTGCTG GACAGCCCCT CCCCCGGCCC 
3001 TCCGTTAGCC AGAGGCTCCT GCGGCGCACG GCCAGTGCCC CGACCAAAAG CCAGAAGCCA 
3061 AGTCGCAAGG GCTTCCCAGA GCTGGCCCTG GGCACACAGG ACGCAGGCTC CGAGGGGGCA 
3121 GCTGATGACG TGGCACCCTC TAGCCCCAAC CCAGCTCTGG AGGCCCCTAC TCAAGAGAGG 
3181 TCAGGCAGCA GCAGCCCCCG AGGTAAGGCA CCAGGAGGAG AAGCAACAGA AGAGAGGACA 
3241 CTGGCACAGG TGCGGTCCCC AAATGCCCCC GAAGGCCCTG GACCTGCAGG GATGGCCGCC 
3301 ACATGCATGA AGTGTGTGGT GGGCTCCTGC GCCGGTATGG ACGTTGAGGG CCTTCAAAGG 
3361 GAGCAACAAC CCAGCCCTGG GCCTGCAGGC AGCCACATGG CCATCAGCCA TCAGCCCAGG 
3421 GCCCGGGTAG ATTCACTGGG GGGCCCTTGC TGCAGCCCAA GTCCTCGAGC CACCCCAGGG 
3481 AGAAGCAAAG AGGCCCCCAA GGGTCCTAGG GCTCGGCGCC AGGGTCCAGG CGGCGGCTCT 
3541 GTGTCCTCGG ACTCCAGCAG CCCAGACAGC CCAGGCAGCC CCAAGGTGGC CCCCTGCCAG 
3601 CCGGAGGGTG CTCACAGGCA GCAGGGGGCG CTGCAGGGAG AGATGAACGC CTTGTTCGTT 
3661 CAAAAGCTGG AGGAGATCAG GAGTCATTCC CCCATGTTCT CCACCGTTAG GGATTGA 
 
The amino acid sequence encoded by the pcDNA3.1 PLCη2 plasmid (75-1238 
resudes of NP_780765.2). The sequence corresponds to the 21b/22/23 splice variant. 
75     MPGPQP SAASQTTGAV ACLAEVLLWV GGSVVVSPRW QLSLVVERCM 
121  SAMQEGTQMV KLRGSSKGLV RFYYLDEHRS CLRWRPSRKN EKAKISIDSI QEVSEGRQSE 
181  IFQRYPDSSF DPNCCFSIYH GSHRESLDLV SPSSEEARTW VTGLRYLMAG ISDEDSLARR 
241  QRTRDQWLKQ TFDEADKNGD GSLSISEVLQ LLHKLNVNLP RQRVKQMFRE ADTDDHQGTL 
301  GFEEFCAFYK MMSTRRDLYL LMLTYSNHKD HLDASDLQRF LEVEQKMNGV TLESCQNIIE 
361  QFEPCLENKS KGMLGIDGFT NYTRSPAGDI FNPEHNRVHQ DMTQPLSHYF ITSSHNTYLV 
421  GDQLMSQSRV DMYAWVLQAG CRCVEVDCWD GPDGEPIVHH GYTLTSKILF KDVIETINKY 
481  AFIKNEYPVI LSIENHCSVV QQKKMAQYLT DILGDKLDLS SVSSEDATML PSPQMLKGKI 
541  LVKGKKLPAN ISEDAEEGEV SDEDSADEME DDCKLLNGDA STNRKRVENI AKKKLDSLIK 
601  ESKIRDCEDP NDFSVSTLSP SGKLGRKAEA KKGQSKVEED VEAGEDSGVS RQNSRLFMSS 
661  FSKRKKKGSK IKKVASVEEG DETLDSPGSQ SRGTARQKKT MKLSRALSDL VKYTKSVGTH 
721  DVEIEVVSSW QVSSFSETKA HQILQQKPTQ YLRFNQHQLS RIYPSSYRVD SSNYNPQPFW 
781  NAGCQMVALN YQSEGRMLQL NRAKFSANGD CGYVLKPQCM CQGVFNPNSE DPLPGQLKKQ 
841  LALRIISGQQ LPKPRDSVLG DRGEIIDPFV EVEVIGLPVD CSKEQTRVVD DNGFNPMWEE 
901  TLVFTVHMPE IALVRFLVWD HDPIGRDFIG QRTLAFSSIM PGYRHVYLEG MEEASIFVHV 
961  AVSDISGKVK QTLGLKGLFL RGTKPGSLDS HAAGQPLPRP SVSQRLLRRT ASAPTKSQKP 
1021  SRKGFPELAL GTQDAGSEGA ADDVAPSSPN PALEAPTQER SGSSSPRGKA PGGEATEERT 
1081  LAQVRSPNAP EGPGPAGMAA TCMKCVVGSC AGMDVEGLQR EQQPSPGPAG SHMAISHQPR 
1141  ARVDSLGGPC CSPSPRATPG RSKEAPKGPR ARRQGPGGGS VSSDSSSPDS PGSPKVAPCQ 
1201  PEGAHRQQGA LQGEMNALFV QKLEEIRSHS PMFSTVRD 
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Amino acid sequences of the C-terminus in the five splice variants of PLCη2 (based on Zhou 
et al. 2005).  
 
21a/23 
VKQTLGLKGLFLRGTKPGSLDSHAAGQPLPRPSVSQRLLRRTASAPTKSQKPSRKGFPELALGTQDAG
SEGAADDVAPSSPNPALEAPTQERSGSSSPRDTRLFPLQRPISPLCSLEPIAEEPALGPGLPLQAAAP
TGPSQEGSQCPVGLGAKVTSSQQTSLGAFGTLQLRIGGGRENEEPPLRPHNGGISSGPREGTSGRQTD
SKSRSRVPGHLPVVRRAKSEGQVLSELSPTPAVYSDATGTDRLWQRLEPGSHRDSVSSSSSMSSNDTV
IDLSLPSLGLCRSRESIPGVSLGRLTSRPCLASAARPDLPPVTKSKSNPNLRVAGGLPTAPDELQPRP
LAPRLTGHHPRPPWHHLTLVGLRDCPVSAKSKSLGDLTADDFAPSFQGSTSSLSCGLGSLGVAHQVLE
PGIRRDALTEQLRWLTGFQQAGDITSPTSLGPAGDGSVGGPSFLRRSSSRSQSRVRAIASRARQAQER
QQRLRGQDSRGPPEEERGTPEGACSVGHEGCVDVPMPAKGAPEQVCGAADGQLLLR 
 
21a/22/23 
VKQTLGLKGLFLRGTKPGSLDSHAAGQPLPRPSVSQRLLRRTASAPTKSQKPSRKGFPELALGTQDAG
SEGAADDVAPSSPNPALEAPTQERSGSSSPRVRD 
 
21b/23 
VKQTLGLKGLFLRGTKPGSLDSHAAGQPLPRPSVSQRLLRRTASAPTKSQKPSRKGFPELALGTQDAG
SEGAADDVAPSSPNPALEAPTQERSGSSSPRGKAPGGEATEERTLAQVRSPNAPEGPGPAGMAATCMK
CVVGSCAGMDVEGLQREQQPSPGPAGSHMAISHQPRARVDSLGGPCCSPSPRATPGRSKEAPKGPRAR
RQGPGGGSVSSDSSSPDSPGSPKVAPCQPEGAHRQQGALQGEMNALFVQKLEEIRSHSPMFSTDTRLF
PLQRPISPLCSLEPIAEEPALGPGLPLQAAAPTGPSQEGSQCPVGLGAKVTSSQQTSLGAFGTLQLRI
GGGRENEEPPLRPHNGGISSGPREGTSGRQTDSKSRSRVPGHLPVVRRAKSEGQVLSELSPTPAVYSD
ATGTDRLWQRLEPGSHRDSVSSSSSMSSNDTVIDLSLPSLGLCRSRESIPGVSLGRLTSRPCLASAAR
PDLPPVTKSKSNPNLRVAGGLPTAPDELQPRPLAPRLTGHHPRPPWHHLTLVGLRDCPVSAKSKSLGD
LTADDFAPSFQGSTSSLSCGLGSLGVAHQVLEPGIRRDALTEQLRWLTGFQQAGDITSPTSLGPAGDG
SVGGPSFLRRSSSRSQSRVRAIASRARQAQERQQRLRGQDSRGPPEEERGTPEGACSVGHEGCVDVPM
PAKGAPEQVCGAADGQLLLRL 
 
21b/22/23 
VKQTLGLKGLFLRGTKPGSLDSHAAGQPLPRPSVSQRLLRRTASAPTKSQKPSRKGFPELALGTQDAG
SEGAADDVAPSSPNPALEAPTQERSGSSSPRGKAPGGEATEERTLAQVRSPNAPEGPGPAGMAATCMK
CVVGSCAGMDVEGLQREQQPSPGPAGSHMAISHQPRARVDSLGGPCCSPSPRATPGRSKEAPKGPRAR
RQGPGGGSVSSDSSSPDSPGSPKVAPCQPEGAHRQQGALQGEMNALFVQKLEEIRSHSPMFSTVRD 
 
21c/22/23 
VKQTLGLKGLFLRGTKPGSLDSHAAGQPLPRPSVSQRLLRRTASAPTKSQKPSRKGFPELALGTQDAG
SEGAADDVAPSSPNPALEAPTQERSGSSSPRGKAPGGEATEERTLAQVRSPNAPEGPGPAGMAATCMK
CVVGSCAGMDVEGLQREQQPSPGPAGSHMAISHQPRARVDSLGGPCCSPSPRATPGRSKEAPKGPRAR
RQGPGGGSVSSDSSSPDSPGSPKVAPCQPEGAHRQQGALQGEMNALFVQKLEEIRSHSPMFSTGKACR
SAASHALYTWHAVRD 
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Appendix B – Plasmid maps 
Plasmid map for pcDNA3.1D/V5-His-TOPO used for the cloning of ΔPH-PLCη2 
(insert contained a STOP codon after the coding sequence): 
 
Figure B.1.: Plasmid map of pcDNA3.1D/V5-His-TOPO. Figure was downloaded 
from: http://www.invitrogen.com/1/1/10253-pcdna3-1-directional-topo-expression-
kit.html. 
 
Plasmid map for pcDNA3.1/NT-GFP-TOPO used for the cloning of PLCη2 and its 
PH-lacking mutant (insert contained a STOP codon after the coding sequence): 
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Figure B.2.: Plasmid map of pcDNA3.1/NT-GFP-TOPO. Figure was downloaded 
from: https://products.invitrogen.com/ivgn/product/K481001. 
 
The map of the psi-H1 plasmid containing the the control shRNA: 
 
Figure B.3.: Plasmid map of psi-H1 encoding the control shRNA. Sequences of 
PLCη2 shRNAs are listed in Chapter 2. Figure was taken from the product insert 
(Genecopeia). 
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Appendix C – Abbreviations 
Abbreviations of amino acids throughout the thesis were: 
 
 
Amino Acid  three letter code one letter code 
Alanine  Ala  A 
Arginine  Arg  R 
Asparagine  Asn  N 
Aspartic Acid  Asp  D 
Cysteine  Cys  C 
Glutamine  Gln  Q 
Glutamic Acid  Glu  E 
Glycine  Gly  G 
Histidine  His  H 
Isoleucine  Ile  I 
Leucine  Leu  L 
Lysine  Lys  K 
Methionine  Met  M 
Phenylalanine  Phe  F 
Proline  Pro  P 
Serine  Ser  S 
Threonine  Thr  T 
Tryptophan  Trp  W 
Tyrosine  Tyr  Y 
Valine  Val  V 
Table C.1 Amino acid codes. 
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